Einstellungen in der Druckvorschau Ihres Browsers an.
| Für einen individuellen Ausdruck passen Sie bitte die Einstellungen in der Druckvorschau Ihres Browsers an. |
|
VO (EG) 1272/2008, Anhang VI, Teil 3
Tabelle 3 Die Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe ist in einem eigenen Band IIIa enthalten. 17Tabelle 3.1 Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe 12 17
gültig bis zum 30.11.2019
=> zur ab dem 01.12.2019 gültigen Fassung
| Index-Nr. | Internationale chemische Bezeichnung | EG-Nr. | CAS-Nr. | Einstufung | Kennzeichnung | Spez. Konzentra-tionsgrenzen, M-Fakt. | Anm. | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Kodierung der Gefahrenklassen und -kategorien | Kodierung der Gef.- hinweise |
Piktogr., Kodierung der Signalw. | Kodierung der Gef.- hinweise |
Kodierung der erg. Gef.- merkm. |
||||||
| 001-001-00-9 | hydrogen | 215-605-7 | 1333-74-0 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 001-002-00-4 | aluminium lithium hydride | 240-877-9 | 16853-85-3 | Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Gef. |
H260 H314 |
|||
| 001-003-00-X | sodium hydride | 231-587-3 | 7646-69-7 | Water-react. 1 | H260 | GHS02 Gef. |
H260 | |||
| 001-004-00-5 | calcium hydride | 232-189-2 | 7789-78-8 | Water-react. 1 | H260 | GHS02 Gef. |
H260 | |||
| 003-001-00-4 | lithium | 231-102-5 | 7439-93-2 | Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Gef. |
H260 H314 |
EUH014 | ||
| 003-002-00-X | n-hexyllithium | 404-950-0 | 21369-64-2 | Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Gef. |
H260 H250 H314 |
EUH014 | ||
| 003-003-00-5 | (2-methylpropyl)lithium; isobutyllithium |
440-620-2 | 920-36-5 | Water-react. 1 Pyr. Liq. 1 Skin Corr. 1a STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H314 H336 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H260 H250 H314 H336 H410 |
EUH014 | ||
| 004-001-00-7 | beryllium | 231-150-7 | 7440-41-7 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Gef. |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|||
| 004-002-00-2 | beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex | - | - | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
GHS06 GHS08 GHS09 Gef. |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
A | ||
| 004-003-00-8 | beryllium oxide | 215-133-1 | 1304-56-9 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Gef. |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|||
| 005-001-00-X | boron trifluoride | 231-569-5 | 7637-07-2 | Press. Gas Acute Tox. 2 * Skin Corr. 1A |
H330 H314 |
GHS04 GHS06 GHS05 Gef. |
H330 H314 |
EUH014 | U | |
| 005-002-00-5 | boron trichloride | 233-658-4 | 10294-34-5 | Press. Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B |
H330 H300 H314 |
GHS04 GHS06 GHS05 Gef. |
H330 H300 H314 |
EUH014 | U | |
| 005-003-00-0 | boron tribromide | 233-657-9 | 10294-33-4 | Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A |
H330 H300 H314 |
GHS06 GHS05 Gef. |
H330 H300 H314 |
EUH014 | ||
| 005-004-00-6 | trialkylboranes, solid | - | - | Pyr. Sol. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Gef. |
H250 H314 |
A | ||
| 005-004-01-3 | trialkylboranes, liquid | - | - | Pyr. Liq. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Gef. |
H250 H314 |
A | ||
| 005-005-00-1 | trimethyl borate | 204-468-9 | 121-43-7 | Flam. Liq. 3 Acute Tox. 4 * |
H226 H312 |
GHS02 GHS07 Gef. |
H226 H312 |
|||
| 005-006-00-7 | dibutyltin hydrogen borate | 401-040-5 | 75113-37-0 | Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H341 H372** H312 H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H360FD H341 H372** H312 H302 H318 H317 H410 |
|||
| 005-007-00-2 | boric acid; [1] boric acid; [2] |
233-139-2 [1] 234-343-4 [2] |
10043-35-3 [1] 11113-50-1 [2] |
Repr. 1B | H360FD | GHS08 Gef. |
H360FD | Repr. 1B; H360FD: C ≥ 5,5 % | ||
| 005-008-00-8 | diboron trioxide; boric oxide |
215-125-8 | 1303-86-2 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | Repr. 1B; H360FD: C ≥ 3,1 % | ||
| 005-009-00-3 | tetrabutylammonium butyltriphenylborate | 418-080-4 | 120307-06-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 005-010-00-9 | N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate | 422-050-6 | 118612-00-3 | Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Gef. |
H351 H302 H315 H318 |
|||
| 005-011-00-4 | disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3] |
215-540-4 [1] 235-541-3 [2] 237-560-2 [3] |
1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] |
Repr. 1B | H360FD | GHS08 Gef. |
H360FD | Repr. 1B; H360FD: C ≥ 4,5 % | ||
| 005-011-01-1 | disodium tetraborate decahydrate; borax decahydrate |
215-540-4 | 1303-96-4 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | Repr. 1B; H360FD: C ≥ 8,5 % | ||
| 005-011-02-9 | disodium tetraborate pentahydrate; borax pentahydrate |
215-540-4 | 12179-04-3 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | Repr. 1B; H360FD: C ≥ 6,5 % | ||
| 005-012-00-X | diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate | 418-070-1 | 141714-54-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 005-013-00-5 | diethylmethoxyborane | 425-380-9 | 7397-46-8 | Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Gef. |
H250 H332 H312 H302 H373** H314 H317 H413 |
|||
| 005-014-00-0 | 4-formylphenylboronic acid | 438-670-5 | 87199-17-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 005-015-00-6 | 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 414-380-4 | 140681-55-6 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Gef. |
H302 H318 H317 H412 |
|||
| 005-016-00-1 | tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate | 431-370-5 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 005-017-00-7 | sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Gef. |
H272 H360Df H302 H335 H318 |
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
||
| 005-017-01-4 | sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Gef. |
H272 H360Df H331 H302 H335 H318 |
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
||
| 005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B STOT SE 3 Eye Dam. 1 |
H360Df H335 H318 |
GHS05 GHS08 GHS07 Gef. |
H360Df H335 H318 |
Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
||
| 005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H360Df H332 H335 H318 |
GHS05 GHS08 GHS07 Gef. |
H360Df H332 H335 H318 |
Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
||
| 005-019-00-8 | perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Gef. |
H272 H360Df H302 H335 H318 |
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
||
| 005-019-01-5 | perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate [3] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Gef. |
H272 H360Df H331 H302 H335 H318 |
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
||
| 005-020-00-3 | Dinatriumoctaborat wasserfrei; [1] Dinatriumoctaborat Tetrahydrat [2] |
234-541-0 [1] 234-541-0 [2] |
12008-41-2 [1] 12280-03-4 [2] |
Repr. 1B | H360FD | GHS08 Gef. |
H360FD | |||
| 006-001-00-2 | carbon monoxide | 211-128-3 | 630-08-0 | Flam. Gas 1 Press. Gas Repr. 1a Acute Tox. 3 * STOT RE 1 |
H220 H360D *** H331 H372 ** |
GHS02 GHS04 GHS06 GHS08 Gef. |
H220 H360D *** H331 H372 ** |
U | ||
| 006-002-00-8 | phosgene; carbonyl chloride |
200-870-3 | 75-44-5 | Press. Gas Acute Tox. 2 * Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Gef. |
H330 H314 |
U | ||
| 006-003-00-3 | carbon disulphide | 200-843-6 | 75-15-0 | Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372 ** H319 H315 |
GHS02 GHS08 GHS07 Gef. |
H225 H361fd H372 ** H319 H315 |
Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0.2 % ≤C < 1 % |
||
| 006-004-00-9 | calcium carbide | 200-848-3 | 75-20-7 | Water-react. 1 | H260 | GHS02 Gef. |
H260 | T | ||
| 006-005-00-4 | thiram (ISO); tetramethylthiuram disulphide |
205-286-2 | 137-26-8 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H332 H302 H373 ** H319 H315 H317 H410 |
M=10 | ||
| 006-006-00-X | hydrogen cyanide; hydrocyanic acid |
200-821-6 | 74-90-8 | Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Gef. |
H224 H330 H410 |
|||
| 006-006-01-7 | hydrogen cyanide ... %; hydrocyanic acid ... % |
200-821-6 | 74-90-8 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
B | ||
| 006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
EUH032 | A | |
| 006-008-00-0 | antu (ISO); 1-(1-naphthyl)-2-thiourea |
201-706-3 | 86-88-4 | Acute Tox. 2 * Carc. 2 |
H300 H351 |
GHS06 GHS08 Gef. |
H300 H351 |
|||
| 006-009-00-6 | 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; isolan |
204-318-2 | 119-38-0 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 006-010-00-1 | 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan |
204-525-8 | 122-15-6 | Acute Tox. 3 * | H301 | GHS06 Gef. |
H301 | |||
| 006-011-00-7 | carbaryl (ISO); 1-naphthyl methylcarbamate |
200-555-0 | 63-25-2 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Achtg. |
H351 H332 H302 H400 |
M=100 | ||
| 006-012-00-2 | ziram (ISO); zinc bis dimethyldithiocarbamate |
205-288-3 | 137-30-4 | Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373 ** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H330 H302 H373 ** H335 H318 H317 H410 |
M=100 | ||
| 006-013-00-8 | metam-sodium (ISO); sodium methyldithiocarbamate |
205-293-0 | 137-42-8 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H314 H317 H410 |
EUH031 | ||
| 006-014-00-3 | nabam (ISO); disodium ethylenebis(N, N'-dithiocarbamate) |
205-547-0 | 142-59-6 | Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Gef. |
H302 H335 H317 H410 |
|||
| 006-015-00-9 | diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea |
206-354-4 | 330-54-1 | Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H302 H373** H410 |
M = 10 | ||
| 006-016-00-4 | propoxur (ISO); 2-isopropyloxyphenylN-methylcarbamate; 2-isopropoxyphenyl methylcarbamate |
204-043-8 | 114-26-1 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
|||
| 006-017-00-X | aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime |
204-123-2 | 116-06-3 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H311 H410 |
|||
| 006-018-00-5 | aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate |
217-990-7 | 2032-59-9 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
|||
| 006-019-00-0 | di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate |
218-961-1 | 2303-16-4 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H302 H410 |
|||
| 006-020-00-6 | barban (ISO); 4-chlorbut-2-ynylN-(3-chlorophenyl)carbamate |
202-930-4 | 101-27-9 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 006-021-00-1 | linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea |
206-356-5 | 330-55-2 | Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H360Df H351 H302 H373 ** H410 |
|||
| 006-022-00-7 | decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate |
- | 1563-67-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 006-023-00-2 | mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenylN-methylcarbamate |
217-991-2 | 2032-65-7 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
|||
| 006-024-00-8 | proxan-sodium (ISO); sodiumO-isopropyldithiocarbonate |
205-443-5 | 140-93-2 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Achtg. |
H302 H315 H411 |
|||
| 006-025-00-3 | allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1] S-bioallethrin; (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] |
209-542-4 [1] 249-013-5 [2] - [3] |
584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H302 H410 |
C | ||
| 006-026-00-9 | carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-ylN-methylcarbamate |
216-353-0 | 1563-66-2 | Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H410 |
|||
| 006-028-00-X | dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate |
213-546-1 | 973-21-7 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
|||
| 006-029-00-5 | dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenylN-methylcarbamate |
230-253-4 | 6988-21-2 | Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Gef. |
H301 H411 |
|||
| 006-030-00-0 | EPTC (ISO); S-ethyl dipropylthiocarbamate |
212-073-8 | 759-94-4 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-031-00-6 | formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate |
244-879-0 | 22259-30-9 | Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H317 H410 |
|||
| 006-032-00-1 | monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea |
217-129-5 | 1746-81-2 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 ** H410 |
|||
| 006-033-00-7 | metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea |
243-433-2 | 19937-59-8 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 006-034-00-2 | pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate |
214-215-4 | 1114-71-2 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 006-035-00-8 | Pirimicarb (ISO); 2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat | 245-430-1 | 23103-98-2 | Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H301 H317 H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H351 H331 H301 H317 H410 |
M = 10 M = 100 |
||
| 006-036-00-3 | benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea |
217-685-9 | 1929-88-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-037-00-9 | promecarb (ISO); 3-isopropyl-5-methylphenylN-methylcarbamate |
220-113-0 | 2631-37-0 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
|||
| 006-038-00-4 | sulfallate (ISO); 2-chloroallylN,N-dimethyldithiocarbamate |
202-388-9 | 95-06-7 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H410 |
|||
| 006-039-00-X | tri-allate (ISO); S - 2,3,3-trichloroallyl diisopropylthiocarbamate |
218-962-7 | 2303-17-5 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 ** H317 H410 |
|||
| 006-040-00-5 | 3-methylpyrazol-5-yl-dimethylcarbamate; monometilan |
- | 2532-43-6 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 006-041-00-0 | dimethylcarbamoyl chloride | 201-208-6 | 79-44-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H331 H302 H319 H335 H315 |
GHS06 GHS08 Gef. |
H350 H331 H302 H319 H335 H315 |
Carc. 1B; H350: C ≥ 0,001 % | ||
| 006-042-00-6 | monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea |
205-766-1 | 150-68-5 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H302 H410 |
|||
| 006-043-00-1 | 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA |
- | 140-41-0 | Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H319 H315 H410 |
|||
| 006-044-00-7 | isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea |
251-835-4 | 34123-59-6 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
M=10 | ||
| 006-045-00-2 | methomyl (ISO); 1-(methylthio)ethylideneaminoN-methylcarbamate |
240-815-0 | 16752-77-5 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Gef. |
H300 H410 |
M=100 | ||
| 006-046-00-8 | Bendiocarb (ISO); 2,2-Dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamat; 2,2-Dimethyl-1,3-benzodioxol-4-yl-methylcarbamat |
245-216-8 | 22781-23-3 | Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H300 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H300 H410 |
M = 10 M = 100 |
||
| 006-047-00-3 | bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenylN-methylcarbamate and 3-(1-ethylpropyl)phenylN-methylcarbamate |
- | 8065-36-9 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
|||
| 006-048-00-9 | ethiofencarb (ISO); 2-(ethylthiomethyl)phenylN-methylcarbamate |
249-981-9 | 29973-13-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 006-049-00-4 | dixanthogen; O,O-diethyl dithiobis(thioformate) |
207-944-4 | 502-55-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-050-00-X | 1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA |
- | 4482-55-7 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 006-051-00-5 | ferbam (ISO); iron tris(dimethyldithiocarbamate) |
238-484-2 | 14484-64-1 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H410 |
|||
| 006-052-00-0 | formetanate hydrochloride; 3-(N,N-dimethylaminomethyleneamino)phenylN-methylcarbamate |
245-656-0 | 23422-53-9 | Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H317 H410 |
|||
| 006-053-00-6 | isoprocarb (ISO); 2-isopropylphenylN-methylcarbamate |
220-114-6 | 2631-40-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 006-054-00-1 | mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenylN-methylcarbamate |
206-249-3 | 315-18-4 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Gef. |
H300 H312 H410 |
|||
| 006-055-00-7 | xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC |
219-364-9 | 2425-10-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 006-056-00-2 | metolcarb (ISO); m-tolyl methylcarbamate; MTMC |
214-446-0 | 1129-41-5 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 006-057-00-8 | nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine |
217-682-2 | 1929-82-4 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 006-058-00-3 | noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea |
- | 2163-79-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-059-00-9 | oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamineN-methylcarbamate; |
245-445-3 | 23135-22-0 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2 |
H330 H300 H312 H411 |
GHS06 GHS09 Gef. |
H330 H300 H312 H411 |
|||
| 006-060-00-4 | oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide |
226-066-2 | 5259-88-1 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 006-061-00-X | S-ethylN-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride |
243-193-9 | 19622-19-6 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 006-062-00-5 | methyl 3,4-dichlorophenylcarbanilate; SWEP. |
- | 1918-18-9 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-063-00-0 | thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate |
248-924-5 | 28249-77-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 006-064-00-6 | thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime |
254-346-4 | 39196-18-4 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 006-065-00-1 | 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid |
- | 15271-41-7 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2 |
H300 H311 H411 |
GHS06 GHS09 Gef. |
H300 H311 H411 |
|||
| 006-066-00-7 | vernolate (ISO); S-propyl dipropylthiocarbamate |
217-681-7 | 1929-77-7 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 006-067-00-2 | XMC; 3,5-xylyl methylcarbamate |
- | 2655-14-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 006-068-00-8 | diazomethane | 206-382-7 | 334-88-3 | Carc. 1B | H350 | GHS08 Gef. |
H350 | |||
| 006-069-00-3 | thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene |
245-740-7 | 23564-05-8 | Muta. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H332 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H341 H332 H317 H410 |
|||
| 006-070-00-9 | furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide |
262-302-0 | 60568-05-0 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
|||
| 006-071-00-4 | cyclooct-4-en-1-yl methyl carbonate | 401-620-8 | 87731-18-8 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 006-072-00-X | prosulfocarb (ISO); S-benzylN,N-dipropylthiocarbamate |
401-730-6 | 52888-80-9 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 006-073-00-5 | 3-(dimethylamino)propylurea | 401-950-2 | 31506-43-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 006-074-00-0 | 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate | 402-440-2 | 2094-99-7 | Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H314 H373 ** H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H330 H314 H373 ** H334 H317 H410 |
|||
| 006-076-00-1 | mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt |
- | 8018-01-7 | Repr. 2 Skin Sens. 1 Aquatic Acute 1 |
H361d*** H317 H400 |
GHS08 GHS07 GHS09 Achtg. |
H361d*** H317 H400 |
M=10 | ||
| 006-077-00-7 | maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) |
235-654-8 | 12427-38-2 | Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H332 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361d*** H332 H319 H317 H410 |
M=10 | ||
| 006-078-00-2 | zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric) |
235-180-1 | 12122-67-7 | STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Achtg. |
H335 H317 |
|||
| 006-079-00-8 | disulfiram; tetraethylthiuramdisulfide |
202-607-8 | 97-77-8 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 ** H317 H410 |
|||
| 006-080-00-3 | tetramethylthiuram monosulphide | 202-605-7 | 97-74-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 006-081-00-9 | zinc bis(dibutyldithiocarbamate) | 205-232-8 | 136-23-2 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H317 H410 |
|||
| 006-082-00-4 | zinc bis(diethyldithiocarbamate) | 238-270-9 | 14324-55-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H335 H315 H317 H410 |
|||
| 006-083-00-X | butocarboxim (ISO); 3-(methylthio)-2-butanoneO-[(methylamino)carbonyl]oxime |
252-139-3 | 34681-10-2 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H331 H311 H301 H319 H400 H410 |
GHS02 GHS06 GHS09 Gef. |
H226 H331 H311 H301 H319 H410 |
|||
| 006-084-00-5 | carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate |
259-565-9 | 55285-14-8 | Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H317 H400 H410 |
GHS06 GHS09 Gef. |
H330 H301 H317 H410 |
|||
| 006-085-00-0 | fenobucarb (ISO); 2-butylphenyl methylcarbamate |
223-188-8 | 3766-81-2 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 006-086-00-6 | fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate | 276-696-7 | 72490-01-8 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
M = 1 M = 10 000 |
||
| 006-087-00-1 | furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate |
265-974-3 | 65907-30-4 | Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H373** H319 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H301 H373** H319 H315 H317 H410 |
M = 100 | ||
| 006-088-00-7 | benfuracarb (ISO); ethylN-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate |
- | 82560-54-1 | Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H331 H302 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361f*** H331 H302 H410 |
|||
| 006-090-00-8 | 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate | 408-010-0 | 88558-41-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H332 H318 H412 |
GHS05 GHS07 Gef. |
H332 H318 H412 |
|||
| 006-091-00-3 | propineb (ISO); polymeric zinc propylenebis(dithiocarbamate) |
- | 9016-72-2 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 |
H332 H373** H317 H400 |
GHS08 GHS07 GHS09 Achtg. |
H332 H373** H317 H400 |
|||
| 006-092-00-9 | tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate | 425-420-5 | 98737-29-2 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 006-093-00-4 | 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) | 427-180-7 | - | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 006-094-00-X | O-isobutyl-N-ethoxy carbonylthiocarbamate | 434-350-4 | 103122-66-3 | Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H226 H350 H340 H302 H373** H317 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H226 H350 H340 H302 H373** H317 H411 |
|||
| 006-095-00-5 | fosetyl-aluminium (ISO); aluminium triethyl triphosphonate |
254-320-2 | 39148-24-8 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 006-096-00-0 | chlorpropham (ISO); isopropyl 3-chlorocarbanilate |
202-925-7 | 101-21-3 | Carc. 2 STOT RE 2 * Aquatic Chronic 2 |
H351 H373** H411 |
GHS08 GHS09 Achtg. |
H351 H373** H411 |
|||
| 006-097-00-6 | 1-phenyl-3-(p-toluenesulfonyl)urea | 424-620-1 | 13909-63-2 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Achtg. |
H302 H373** H412 |
|||
| 006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | 429-170-8 | 134575-17-0 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Gef. |
H302 H373** H318 H317 |
|||
| 006-099-00-7 | N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate |
432-520-2 | 232938-43-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 006-101-00-6 | reaction mass of:N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] |
423-070-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamate | 432-750-3 | - | Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H340 H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H302 H373** H317 H411 |
|||
| 006-103-00-7 | N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea | 445-760-8 | - | Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H400 H410 |
GHS05 GHS08 GHS09 Gef. |
H318 H334 H410 |
M=100 | ||
| 007-001-00-5 | ammonia, anhydrous | 231-635-3 | 7664-41-7 | Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H221 H331 H314 H400 |
GHS04 GHS06 GHS05 GHS09 Gef. |
H221 H331 H314 H400 |
U | ||
| 007-001-01-2 | ammonia ....% | 215-647-6 | 1336-21-6 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
STOT SE 3; H335: C ≥ 5 % | B | |
| 007-002-00-0 | nitrogen dioxide; [1] dinitrogen tetraoxide [2] |
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Gef. |
H270 H330 H314 |
* STOT SE 3; H335: C ≥ 0,5 % |
5 | |
| 007-003-00-6 | chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride |
213-666-4 | 999-81-5 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 007-004-00-1 | Salpetersäure ... % | 231-714-2 | 7697-37-2 | Ox. Liq. 2 Skin Corr. 1A |
H272 H314 |
GHS03 GHS05 Gef. |
H272 H314 |
EUH071 | Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 99 % > C ≥ 65 % |
B |
| 007-006-00-2 | ethyl nitrite | 203-722-6 | 109-95-5 | Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H220 H332 H312 H302 |
GHS02 GHS04 GHS07 Gef. |
H220 H332 H312 H302 |
U | ||
| 007-007-00-8 | ethyl nitrate | 210-903-3 | 625-58-1 | Unst. Expl. | H200 | GHS01 Gef. |
H200 | |||
| 007-008-00-3 | hydrazine | 206-114-9 | 302-01-2 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H350 H331 H311 H301 H314 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Gef. |
H226 H350 H331 H311 H301 H314 H317 H410 |
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % |
||
| 007-009-00-9 | dicyclohexylammonium nitrite | 221-515-9 | 3129-91-7 | Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Achtg. |
H332 H302 |
* | ||
| 007-010-00-4 | sodium nitrite | 231-555-9 | 7632-00-0 | Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Gef. |
H272 H301 H400 |
* | ||
| 007-011-00-X | potassium nitrite | 231-832-4 | 7758-09-0 | Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Gef. |
H272 H301 H400 |
* | ||
| 007-012-00-5 | N,N-dimethylhydrazine | 200-316-0 | 57-14-7 | Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H331 H301 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Gef. |
H225 H350 H331 H301 H314 H411 |
|||
| 007-013-00-0 | 1,2-dimethylhydrazine | - | 540-73-8 | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H311 H301 H411 |
Carc. 1B; H350: C ≥ 0.01 % | ||
| 007-014-00-6 | salts of hydrazine | - | - | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H311 H301 H317 H410 |
A | ||
| 007-015-00-1 | O-ethylhydroxylamine | 402-030-3 | 624-86-2 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
GHS02 GHS06 GHS08 GHS09 Gef. |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
|||
| 007-016-00-7 | butyl nitrite | 208-862-1 | 544-16-1 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H301 |
GHS02 GHS06 Gef. |
H225 H331 H301 |
|||
| 007-017-00-2 | isobutyl nitrite | 208-819-7 | 542-56-3 | Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H341 H332 H302 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H341 H332 H302 |
|||
| 007-018-00-8 | sec-butyl nitrite | 213-104-8 | 924-43-6 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Gef. |
H225 H332 H302 |
|||
| 007-019-00-3 | tert-butyl nitrite | 208-757-0 | 540-80-7 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Gef. |
H225 H332 H302 |
|||
| 007-020-00-9 | pentyl nitrite; [1] ’amyl nitrite’, mixed isomers [2] |
207-332-7 [1] 203-770-8 [2] |
463-04-7 [1] 110-46-3 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Gef. |
H225 H332 H302 |
|||
| 007-021-00-4 | hydrazobenzene; 1,2-diphenylhydrazine |
204-563-5 | 122-66-7 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H410 |
|||
| 007-022-00-X | hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) | 405-030-1 | - | Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H302 H314 H317 H412 |
GHS08 GHS05 GHS07 Gef. |
H350 H302 H314 H317 H412 |
|||
| 007-023-00-5 | sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate | 405-510-0 | - | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 007-024-00-0 | 2-(decylthio)ethylammonium chloride | 405-640-8 | 36362-09-1 | STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Gef. |
H373 ** H315 H318 H410 |
|||
| 007-025-00-6 | (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride | 406-090-1 | 81880-96-8 | Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H301 H372 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H341 H301 H372 ** H317 H410 |
|||
| 007-026-00-1 | oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide | 413-230-5 | 122035-71-6 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 007-027-00-7 | 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane | 420-190-2 | 771478-66-1 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H312 H302 H373 ** H314 H317 H410 |
|||
| 007-028-00-2 | hydroxylammonium nitrate | 236-691-2 | 13465-08-2 | Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
|||
| 007-029-00-8 | diethyldimethylammonium hydroxide | 419-400-5 | 95500-19-9 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
|||
| 008-001-00-8 | oxygen | 231-956-9 | 7782-44-7 | Ox. Gas 1 Press. Gas |
H270 | GHS03 GHS04 Gef. |
H270 | U | ||
| 008-003-00-9 | hydrogen peroxide solution ... % | 231-765-0 | 7722-84-1 | Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H271 H332 H302 H314 |
GHS03 GHS05 GHS07 Gef. |
H271 H332 H302 H314 |
Ox. Liq. 1; H271: C ≥ 70 %**** Ox. Liq. 2; H272: 50 % ≤ C < 70 %**** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 8 % STOT SE 3; H335; C ≥ 35 % |
B | |
| 009-001-00-0 | fluorine | 231-954-8 | 7782-41-4 | Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Gef. |
H270 H330 H314 |
|||
| 009-002-00-6 | hydrogen fluoride | 231-634-8 | 7664-39-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Gef. |
H330 H310 H300 H314 |
|||
| 009-003-00-1 | hydrofluoric acid ... % | 231-634-8 | 7664-39-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Gef. |
H330 H310 H300 H314 |
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C < 7 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
B | |
| 009-004-00-7 | sodium fluoride | 231-667-8 | 7681-49-4 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Gef. |
H301 H319 H315 |
EUH032 | ||
| 009-005-00-2 | potassium fluoride | 232-151-5 | 7789-23-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 009-006-00-8 | ammonium fluoride | 235-185-9 | 12125-01-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 009-007-00-3 | sodium bifluoride; sodium hydrogen difluoride |
215-608-3 | 1333-83-1 | Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Gef. |
H301 H314 |
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
||
| 009-008-00-9 | potassium bifluoride; potassium hydrogen difluoride |
232-156-2 | 7789-29-9 | Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Gef. |
H301 H314 |
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
||
| 009-009-00-4 | ammonium bifluoride; ammonium hydrogen difluoride |
215-676-4 | 1341-49-7 | Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Gef. |
H301 H314 |
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
||
| 009-010-00-X | fluoroboric acid ... % | 240-898-3 | 16872-11-0 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B | |
| 009-011-00-5 | fluorosilicic acid ... % | 241-034-8 | 16961-83-4 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | B | ||
| 009-012-00-0 | alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3] |
240-934-8 [1] 240-896-2 [2] 240-968-3 [3] |
16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
* | A | |
| 009-013-00-6 | fluorosilicates, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | * | A | |
| 009-014-00-1 | lead hexafluorosilicate | 247-278-1 | 25808-74-6 | Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H360Df H332 H302 H373 ** H410 |
1 | ||
| 009-015-00-7 | sulphuryl difluoride | 220-281-5 | 2699-79-8 | Press. Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H373 ** H400 |
GHS04 GHS06 GHS08 GHS09 Gef. |
H331 H373 ** H400 |
U | ||
009-016-00-2 |
trisodium hexafluoroaluminate [1] | 237-410-6 [1] | 13775-53-6 [1] | STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 |
H372 H332 H411 |
GHS07 GHS08 GHS09 Gef. |
H372 H332 H411 |
|||
| trisodium hexafluoroaluminate (cryolite) [2] | 239-148-8 [2] | 15096-52-3 [2] | ||||||||
| 009-017-00-8 | potassium mu-fluoro-bis(triethylaluminium) | 400-040-2 | 12091-08-6 | Flam. Sol. 1 Water-react. 1 Skin Corr. 1a Acute Tox. 4 * |
H228 H270 H314 H332 |
GHS02 GHS05 GHS07 Gef. |
H228 H270 H314 H332 |
EUH014 | T | |
| 009-018-00-3 | magnesium hexafluorosilicate | 241-022-2 | 16949-65-8 | Acute Tox. 3 * | H301 | GHS06 Gef. |
H301 | * | ||
| 011-001-00-0 | sodium | 231-132-9 | 7440-23-5 | Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Gef. |
H260 H314 |
EUH014 | ||
| 011-002-00-6 | sodium hydroxide; caustic soda |
215-185-5 | 1310-73-2 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % |
||
| 011-003-00-1 | sodium peroxide | 215-209-4 | 1313-60-6 | Ox. Sol. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Gef. |
H271 H314 |
|||
| 011-004-00-7 | sodium azide | 247-852-1 | 26628-22-8 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Gef. |
H300 H400 H410 |
EUH032 | ||
| 011-005-00-2 | sodium carbonate | 207-838-8 | 497-19-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 011-006-00-8 | sodium cyanate | 213-030-6 | 917-61-3 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 011-007-00-3 | propoxycarbazone-sodium | - | 181274-15-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | M=10 | ||
| 012-001-00-3 | magnesium powder (pyrophoric) | 231-104-6 | 7439-95-4 | Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Gef. |
H260 H250 |
T | ||
| 012-002-00-9 | magnesium, powder or turnings | 231-104-6 | - | Flam. Sol. 1 Water-react. 2 Self-heat. 1 |
H228 H261 H252 |
GHS02 Gef. |
H228 H261 H252 |
T | ||
| 012-003-00-4 | magnesium alkyls | - | - | Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Gef. |
H250 H260 H314 |
EUH014 | A | |
| 012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | 422-150-1 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 013-001-00-6 | aluminium powder (pyrophoric) | 231-072-3 | 7429-90-5 | Water-react. 2 Pyr. Sol. 1 |
H261 H250 |
GHS02 Gef. |
H261 H250 |
T | ||
| 013-002-00-1 | aluminium powder (stabilised) | 231-072-3 | 7429-90-5 | Water-react. 2 Flam. Sol. 1 |
H261 H228 |
GHS02 Gef. |
H261 H228 |
T | ||
| 013-003-00-7 | aluminium chloride, anhydrous | 231-208-1 | 7446-70-0 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 013-004-00-2 | aluminium alkyls | - | - | Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Gef. |
H250 H260 H314 |
EUH014 | A | |
| 013-005-00-8 | diethyl(ethyldimethylsilanolato)aluminium | 401-160-8 | 55426-95-4 | Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Gef. |
H260 H250 H314 |
EUH014 | ||
| 013-006-00-3 | (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised | 402-370-2 | - | Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Gef. |
H226 H318 |
|||
| 013-007-00-9 | poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) | 403-430-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 013-008-00-4 | di-n-octylaluminium iodide | 408-190-0 | 7585-14-0 | Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H314 H400 H410 |
GHS02 GHS05 GHS09 Gef. |
H250 H314 H410 |
EUH014 | ||
| 013-009-00-X | sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0.5 y = 1.5 | 418-720-2 | - | Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A |
H228 H260 H250 H332 H314 |
GHS02 GHS05 GHS07 Gef. |
H228 H260 H250 H332 H314 |
EUH014 | T | |
| 013-010-00-5 | hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide) | 430-650-4 | 151841-65-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-001-00-9 | trichlorosilane | 233-042-5 | 10025-78-2 | Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H224 H250 H332 H302 H314 |
GHS02 GHS05 GHS07 Gef. |
H224 H250 H332 H302 H314 |
EUH014 EUH029 |
* STOT SE 3; H335: C ≥ 1 % |
T |
| 014-002-00-4 | silicon tetrachloride | 233-054-0 | 10026-04-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
EUH014 | ||
| 014-003-00-X | dimethyldichlorosilane | 200-901-0 | 75-78-5 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Gef. |
H225 H319 H335 H315 |
|||
| 014-004-00-5 | trichloro(methyl)silane; methyltrichlorosilane |
200-902-6 | 75-79-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Gef. |
H225 H319 H335 H315 |
EUH014 | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
| 014-005-00-0 | tetraethyl silicate; ethyl silicate |
201-083-8 | 78-10-4 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H226 H332 H319 H335 |
GHS02 GHS07 Achtg. |
H226 H332 H319 H335 |
|||
| 014-006-00-6 | bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride | 401-380-4 | - | Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Achtg. |
H319 H411 |
|||
| 014-007-00-1 | triethoxyisobutylsilane | 402-810-3 | 17980-47-1 | Skin Irrit. 2 | H315 | GHS07 Achtg. |
H315 | |||
| 014-008-00-7 | (chloromethyl)bis(4-fluorophenyl)methylsilane | 401-200-4 | 85491-26-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-009-00-2 | isobutylisopropyldimethoxysilane | 402-580-4 | 111439-76-0 | Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H315 |
GHS02 GHS07 Achtg. |
H226 H332 H315 |
|||
| 014-010-00-8 | disodium metasilicate | 229-912-9 | 6834-92-0 | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
|||
| 014-011-00-3 | cyclohexyldimethoxymethylsilane | 402-140-1 | 17865-32-6 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 014-012-00-9 | bis(3-(trimethoxysilyl)propyl)amine | 403-480-3 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 014-013-00-4 | α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) | 404-920-7 | - | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H312 H302 H314 H411 |
GHS05 GHS07 GHS09 Gef. |
H312 H302 H314 H411 |
|||
| 014-014-00-X | etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane |
253-704-7 | 37894-46-5 | Repr. 1B Acute Tox. 4 * STOT RE 2 * |
H360D *** H302 H373 ** |
GHS08 GHS07 Gef. |
H360D *** H302 H373 ** |
|||
| 014-015-00-5 | α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane)) | 406-420-4 | 69430-40-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 014-016-00-0 | reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane |
406-490-6 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-017-00-6 | flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H - 1,2,4-triazol-1-ylmethyl)silane |
- | 85509-19-9 | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H351 H360D *** H302 H411 |
|||
| 014-018-00-1 | octamethylcyclotetrasiloxane | 209-136-7 | 556-67-2 | Repr. 2 Aquatic Chronic 4 |
H361f *** H413 |
GHS08 Achtg. |
H361f *** H413 |
|||
| 014-019-00-7 | reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H - 1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H - 1,2,4-triazole |
403-250-2 | - | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H351 H360D *** H302 H411 |
|||
| 014-020-00-2 | bis(1,1-dimethyl-2-propynyloxy)dimethylsilane | 414-960-7 | 53863-99-3 | Acute Tox. 4 * | H332 | GHS07 Achtg. |
H332 | |||
| 014-021-00-8 | tris(isopropenyloxy)phenyl silane | 411-340-8 | 52301-18-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H400 H410 |
|||
| 014-022-00-3 | reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) | 401-530-9 | - | Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H228 H370 ** H332 H312 H302 |
GHS02 GHS08 GHS07 Gef. |
H228 H370 ** H332 H312 H302 |
T | ||
| 014-023-00-9 | α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole | 408-160-7 | 125613-45-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-024-00-4 | 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene | 412-620-2 | 121626-74-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-025-00-X | 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine | 411-400-3 | 102089-33-8 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H373 ** H315 H318 H412 |
GHS08 GHS05 GHS07 Gef. |
H302 H373 ** H315 H318 H412 |
|||
| 014-026-00-5 | dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane | 407-180-3 | 770722-36-6 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | |||
| 014-027-00-0 | chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane | 410-270-5 | 770722-46-8 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | |||
| 014-028-00-6 | α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) | 415-290-8 | 193159-06-7 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 014-029-00-1 | O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] | 421-870-1 | 156145-66-3 | Repr. 2 Acute Tox. 4 * STOT RE 2 * |
H361f *** H302 H373 ** |
GHS08 GHS07 Achtg. |
H361f *** H302 H373 ** |
|||
| 014-030-00-7 | [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium | 422-060-0 | 137390-08-0 | Acute Tox. 2 * | H300 | GHS06 Gef. |
H300 | |||
| 014-031-00-2 | bis(1-methylethyl)-dimethoxysilane | 421-540-7 | 18230-61-0 | Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H226 H315 H317 H412 |
GHS02 GHS07 Achtg. |
H226 H315 H317 H412 |
|||
| 014-032-00-8 | dicyclopentyldimethoxysilane | 404-370-8 | 126990-35-0 | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 014-033-00-3 | 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica | 419-030-4 | 125804-20-8 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
|||
| 014-034-00-9 | 3-hexylheptamethyltrisiloxane | 428-700-5 | 1873-90-1 | Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Achtg. |
H332 H413 |
|||
| 014-035-00-4 | 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane | 425-050-4 | 10217-34-2 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | 405-020-7 | 105024-66-6 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H400 H410 |
GHS08 GHS09 Gef. |
H360F*** H410 |
M=1000 | ||
| 014-037-00-5 | 2-butanone-O,O',O''-(phenylsilylidyne)trioxime | 433-360-6 | 34036-80-1 | STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Achtg. |
H373** H317 H412 |
|||
| 014-038-00-0 | S-(3-(triethoxysilyl)propyl) octanethioate | 436-690-9 | 220727-26-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | 439-360-2 | 142877-45-0 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Gef. |
H315 H318 H412 |
|||
| 014-041-00-7 | N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane | 445-890-5 | 201290-01-9 | Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 014-042-00-2 | reaction mass of:O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-010-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | 432-200-2 | - | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H335 H315 H318 H412 |
GHS05 GHS07 Gef. |
H335 H315 H318 H412 |
|||
| 014-044-00-3 | 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane | 433-050-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 014-045-00-9 | magnesium sodium fluoride silicate | 442-650-1 | - | STOT RE 2 * | H373** | GHS08 Achtg. |
H373** | |||
| 014-046-00-4 | E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] | - | - | Carc. 1B | H350i | GHS08 Gef. |
H350i | A | ||
| 014-047-00-X | Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] | - | - | Carc. 2 | H351 (Einatmen) | GHS08 Achtg. |
H351 (Einatmen) | A | ||
| 015-001-00-1 | white phosphorus | 231-768-7 | 12185-10-3 | Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1a Aquatic Acute 1 |
H250 H330 H300 H314 H400 |
GHS02 GHS06 GHS05 GHS09 Gef. |
H250 H330 H300 H314 H400 |
|||
| 015-002-00-7 | red phosphorus | 231-768-7 | 7723-14-0 | Flam. Sol. 1 Aquatic Chronic 3 |
H228 H412 |
GHS02 Gef. |
H228 H412 |
|||
| 015-003-00-2 | Calciumphosphid; Tricalciumdiphosphid | 215-142-0 | 1305-99-3 | Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Eye Dam. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H318 H400 |
GHS02 GHS06 GHS05 GHS09 Gef. |
H260 H300 H311 H330 H318 H400 |
EUH029 EUH032 |
M = 100 | |
015-004-00-8 |
aluminium phosphide |
244-088-0 |
20859-73-8 |
Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Acute Tox. 1 | H330 | Gef. | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
015-005-00-3 |
magnesium phosphide; trimagnesium diphosphide |
235-023-7 |
12057-74-8 |
Water-react. 1 | H260 | GHS02 | H260 | EUH029 | M = 100 | |
| Acute Tox. 2 | H300 | GHS06 | H300 | EUH032 | ||||||
| Acute Tox. 3 | H311 | GHS09 | H311 | |||||||
| Acute Tox. 1 | H330 | Gef. | H330 | |||||||
| Aquatic Acute 1 | H400 | H400 | ||||||||
| 015-006-00-9 | trizinc diphosphide; zinc phosphide |
215-244-5 | 1314-84-7 | Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H260 H300 H400 H410 |
GHS02 GHS06 GHS09 Gef. |
H260 H300 H410 |
EUH029 EUH032 |
M=100 | T |
| 015-007-00-4 | phosphorus trichloride | 231-749-3 | 7719-12-2 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A |
H330 H300 H373 ** H314 |
GHS06 GHS08 GHS05 Gef. |
H330 H300 H373 ** H314 |
EUH014 EUH029 |
||
| 015-008-00-X | phosphorus pentachloride | 233-060-3 | 10026-13-8 | Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B |
H330 H302 H373 ** H314 |
GHS06 GHS08 GHS05 Gef. |
H330 H302 H373 ** H314 |
EUH014 EUH029 |
||
| 015-009-00-5 | phosphoryl trichloride | 233-046-7 | 10025-87-3 | Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A |
H330 H372 ** H302 H314 |
GHS06 GHS08 GHS05 Gef. |
H330 H372 ** H302 H314 |
EUH014 EUH029 |
||
| 015-010-00-0 | phosphorus pentoxide | 215-236-1 | 1314-56-3 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | |||
| 015-011-00-6 | phosphoric acid ... %, orthophosphoric acid ... % | 231-633-2 | 7664-38-2 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B | |
| 015-012-00-1 | tetraphosphorus trisulphide; phosphorus sesquisulphid |
215-245-0 | 1314-85-8 | Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H302 H400 |
GHS02 GHS07 GHS09 Gef. |
H228 H260 H302 H400 |
T | ||
| 015-013-00-7 | triethyl phosphate | 201-114-5 | 78-40-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 015-014-00-2 | tributyl phosphate | 204-800-2 | 126-73-8 | Carc. 2 Acute Tox. 4 * Skin Irrit. 2 |
H351 H302 H315 |
GHS08 GHS07 Achtg. |
H351 H302 H315 |
|||
| 015-015-00-8 | tricresyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-); tritolyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-); |
201-103-5 | 78-30-8 | STOT SE 1 Aquatic Chronic 2 |
H370 ** H411 |
GHS08 GHS09 Gef. |
H370 ** H411 |
STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 % |
C | |
| 015-016-00-3 | tricresyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-); tritolyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-); |
201-105-6 | 78-32-0 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Achtg. |
H312 H302 H411 |
* | C | |
| 015-019-00-X | dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate |
200-547-7 | 62-73-7 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 |
H330 H311 H301 H317 H400 |
GHS06 GHS09 Gef. |
H330 H311 H301 H317 H400 |
M=1000 | ||
| 015-020-00-5 | mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate |
232-095-1 | 7786-34-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
M=10000 | ||
| 015-021-00-0 | trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate |
200-149-3 | 52-68-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H400 H410 |
M=1000 | ||
| 015-022-00-6 | phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate |
236-116-5 | 13171-21-6 | Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H341 H300 H311 H410 |
|||
| 015-023-00-1 | pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate |
- | 108-34-9 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Gef. |
H330 H310 H300 |
|||
| 015-024-00-7 | triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide |
- | 1031-47-6 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-025-00-2 | TEPP (ISO); tetraethyl pyrophosphate |
203-495-3 | 107-49-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Gef. |
H310 H300 H400 |
|||
| 015-026-00-8 | schradan (ISO); octamethylpyrophosphoramide |
205-801-0 | 152-16-9 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-027-00-3 | sulfotep (ISO); O,O,O,O-tetraethyl dithiopyrophosphate |
222-995-2 | 3689-24-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
M=1000 | ||
| 015-028-00-9 | demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate |
206-053-8 | 298-03-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Gef. |
H310 H300 H400 |
|||
| 015-029-00-4 | demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate |
204-801-8 | 126-75-0 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-030-00-X | demeton-O-methyl (ISO); O-2-ethylthioethylO,O-dimethyl phosphorothioate |
212-758-1 | 867-27-6 | Acute Tox. 3 * | H301 | GHS06 Gef. |
H301 | |||
| 015-031-00-5 | demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate |
213-052-6 | 919-86-8 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H311 H301 H411 |
GHS06 GHS09 Gef. |
H311 H301 H411 |
|||
| 015-032-00-0 | prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate |
218-893-2 | 2275-18-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3 |
H310 H300 H412 |
GHS06 Gef. |
H310 H300 H412 |
|||
| 015-033-00-6 | phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate |
206-052-2 | 298-02-2 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
M=1000 | ||
| 015-034-00-1 | parathion (ISO); O,O-diethylO-4-nitrophenyl phosphorothioate |
200-271-7 | 56-38-2 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H300 H311 H372 ** H410 |
M=100 | ||
| 015-035-00-7 | parathion - methyl (ISO); O,O-dimethylO-4-nitrophenyl phosphorothioate |
206-050-1 | 298-00-0 | Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H330 H300 H311 H373 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Gef. |
H226 H330 H300 H311 H373 ** H410 |
M=100 | ||
| 015-036-00-2 | O-ethylO-4-nitrophenyl phenylphosphonothioate; EPN |
218-276-8 | 2104-64-5 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 015-037-00-8 | phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl)O,O-diethyl phosphorodithioate |
218-892-7 | 2275-14-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
|||
| 015-038-00-3 | coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-ylO,O-diethyl phosphorothioate |
200-285-3 | 56-72-4 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Gef. |
H300 H312 H410 |
|||
| 015-039-00-9 | azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate |
201-676-1 | 86-50-0 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H317 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H311 H317 H410 |
|||
| 015-040-00-4 | diazinon (ISO); O,O-diethylO-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate |
206-373-8 | 333-41-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H400 H410 |
|||
| 015-041-00-X | malathion (ISO); 1,2-bis(ethoxycarbonyl)ethylO,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] |
204-497-7 | 121-75-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
M=1000 | ||
| 015-042-00-5 | chlorthion O-(3-chloro-4-nitrophenyl)O,O-dimethyl phosphorothioate |
207-902-5 | 500-28-7 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
M=100 | ||
| 015-043-00-0 | phosnichlor (ISO); O-4-chloro-3-nitrophenylO,O-dimethyl phosphorothioate |
- | 5826-76-6 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Achtg. |
H332 H312 H302 |
|||
| 015-044-00-6 | carbophenothion (ISO); 4-chlorophenylthiomethylO,O-diethyl phosphorodithioate |
212-324-1 | 786-19-6 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
|||
| 015-045-00-1 | mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethylO,O-diethyl phosphorodithioate |
219-993-9 | 2595-54-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H400 H410 |
|||
| 015-046-00-7 | oxydemeton-methyl; S-2-(ethylsulphinyl)ethylO,O-dimethyl phosphorothioate |
206-110-7 | 301-12-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H311 H301 H400 |
GHS06 GHS09 Gef. |
H311 H301 H400 |
|||
| 015-047-00-2 | ethion (ISO); O,O,O',O'-tetraethylS,S'-methylenedi (phosphorodithioate); diethion |
209-242-3 | 563-12-2 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H301 H312 H410 |
M=10000 | ||
| 015-048-00-8 | fenthion (ISO); O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate |
200-231-9 | 55-38-9 | Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H312 H302 H372** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H341 H331 H312 H302 H372** H410 |
M=100 | ||
| 015-049-00-3 | endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate |
220-472-3 | 2778-04-3 | Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Gef. |
H311 H301 |
|||
| 015-050-00-9 | thiometon (ISO); S-2-ethylthioethylO,O-dimethyl phosphorodithioate |
211-362-6 | 640-15-3 | Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Gef. |
H301 H312 |
|||
| 015-051-00-4 | dimethoate (ISO); O,O-dimethyl methylcarbamoylmethyl phosphorodithioate |
200-480-3 | 60-51-5 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 015-052-00-X | fenchlorphos (ISO); O,O-dimethylO - 2,4,5-trichlorophenyl phosphorothioate |
206-082-6 | 299-84-3 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 015-053-00-5 | menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate |
201-123-4 | 78-57-9 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 015-054-00-0 | fenitrothion (ISO); O,O-dimethylO-4-nitro-m-tolyl phosphorothioate |
204-524-2 | 122-14-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 015-055-00-6 | naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate |
206-098-3 | 300-76-5 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H312 H302 H319 H315 H400 |
GHS07 GHS09 Achtg. |
H312 H302 H319 H315 H400 |
M=1000 | ||
| 015-056-00-1 | azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate |
220-147-6 | 2642-71-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
M=100 | ||
| 015-057-00-7 | formothion (ISO); N-formyl-N-methylcarbamoylmethylO,O-dimethyl phosphorodithioate |
219-818-6 | 2540-82-1 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 015-058-00-2 | morphothion (ISO); O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate |
205-628-0 | 144-41-2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
|||
| 015-059-00-8 | vamidothion (ISO); O,O-dimethylS-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate |
218-894-8 | 2275-23-2 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Gef. |
H301 H312 H400 |
|||
| 015-060-00-3 | disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate |
206-054-3 | 298-04-4 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 015-061-00-9 | dimefox (ISO); tetramethylphosphorodiamidic fluoride |
204-076-8 | 115-26-4 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-062-00-4 | mipafox (ISO); N,N'- di-isopropylphosphorodiamidic fluoride |
206-742-3 | 371-86-8 | STOT SE 1 | H370 ** | GHS08 Gef. |
H370 ** | |||
| 015-063-00-X | dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) |
201-107-7 | 78-34-2 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H311 H410 |
M=1000 | ||
| 015-064-00-5 | bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenylO,O-diethyl phosphorothioate |
225-399-0 | 4824-78-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H301 H312 H410 |
|||
| 015-065-00-0 | S-[2-(ethylsulphinyl)ethyl]O,O-dimethyl phosphorodithioate | - | 2703-37-9 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Gef. |
H330 H310 H300 H411 |
|||
| 015-066-00-6 | omethoate (ISO); O,O-dimethylS-methylcarbamoylmethyl phosphorothioate |
214-197-8 | 1113-02-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Gef. |
H301 H312 H400 |
|||
| 015-067-00-1 | phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl)O,O-diethyl phosphorodithioate |
218-996-2 | 2310-17-0 | Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H317 H400 H410 |
GHS06 GHS09 Gef. |
H301 H332 H312 H317 H410 |
M=1000 | ||
| 015-068-00-7 | dichlofenthion (ISO); O - 2,4-dichlorophenylO,O-diethyl phosphorothioate |
202-564-5 | 97-17-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H400 H410 |
|||
| 015-069-00-2 | methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate |
213-449-4 | 950-37-8 | Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Gef. |
H300 H312 H410 |
|||
| 015-070-00-8 | cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl)O,O-diethyl phosphorothioate |
223-099-4 | 3734-95-0 | Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Gef. |
H300 H311 |
|||
| 015-071-00-3 | chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate |
207-432-0 | 470-90-6 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
|||
| 015-072-00-9 | monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate |
230-042-7 | 6923-22-4 | Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H341 H330 H300 H311 H410 |
|||
| 015-073-00-4 | dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate |
205-494-3 | 141-66-2 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
|||
| 015-074-00-X | crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate |
206-083-1 | 299-86-5 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 015-075-00-5 | S-[2-(isopropylsulphinyl)ethyl]O,O-dimethyl phosphorothioate | - | 2635-50-9 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 015-076-00-0 | potasan; O, O-diethylO-(4-methylcoumarin-7-yl) phosphorothioate |
- | 299-45-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
M=1000 | ||
| 015-077-00-6 | 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate | - | 7076-53-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Gef. |
H331 H311 H301 |
|||
| 015-078-00-1 | demeton-S-methylsulphon (ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate |
241-109-5 | 17040-19-6 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H301 H312 H411 |
GHS06 GHS09 Gef. |
H301 H312 H411 |
|||
| 015-079-00-7 | acephate (ISO); O,S-dimethyl acetylphosphoramidothioate |
250-241-2 | 30560-19-1 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 015-080-00-2 | amidithion (ISO); 2-methoxyethylcarbamoylmethylO,O-dimethyl phosphorodithioate |
- | 919-76-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 015-081-00-8 | O,O,O',O'-tetrapropyl dithiopyrophosphate | 221-817-0 | 3244-90-4 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 015-082-00-3 | azothoate (ISO); O-4-(4-chlorophenylazo)phenylO,O-dimethyl phosphorothioate |
227-419-3 | 5834-96-8 | Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Achtg. |
H332 H302 |
|||
| 015-083-00-9 | bensulide (ISO); O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate |
212-010-4 | 741-58-2 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 015-084-00-4 | chlorpyrifos (ISO); O,O-diethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate |
220-864-4 | 2921-88-2 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H400 H410 |
M=10000 | ||
| 015-085-00-X | chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride |
204-105-4 | 115-78-6 | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H312 H319 H315 |
GHS06 Gef. |
H301 H312 H319 H315 |
|||
| 015-086-00-5 | coumithoate (ISO); O,O-diethylO - 7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate |
- | 572-48-5 | Acute Tox. 3 * | H301 | GHS06 Gef. |
H301 | |||
| 015-087-00-0 | cyanophos (ISO); O-4-cyanophenylO,O-dimethyl phosphorothioate |
220-130-3 | 2636-26-2 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 015-088-00-6 | dialifos (ISO); 2-chloro-1-phthalimidoethylO,O-diethyl phosphorodithioate |
233-689-3 | 10311-84-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H400 H410 |
|||
| 015-089-00-1 | ethoate-methyl (ISO); ethylcarbamoylmethylO,O-dimethyl phosphorodithioate |
204-121-1 | 116-01-8 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 015-090-00-7 | fensulfothion (ISO); O,O-diethylO-4-methylsulfinylphenyl phosphorothioate |
204-114-3 | 115-90-2 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 015-091-00-2 | fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate |
213-408-0 | 944-22-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 015-092-00-8 | phosacetim (ISO); O,O-bis(4-chlorophenyl)N-acetimidoylphosphoramidothioate |
223-874-7 | 4104-14-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
|||
| 015-093-00-3 | leptophos (ISO); O-4-bromo-2,5-dichlorophenylO-methyl phenylphosphorothioate |
244-472-8 | 21609-90-5 | Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H370 ** H312 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H301 H370 ** H312 H410 |
|||
| 015-094-00-9 | mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate |
213-447-3 | 950-10-7 | Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H310 H300 H411 |
GHS06 GHS09 Gef. |
H310 H300 H411 |
|||
| 015-095-00-4 | methamidophos (ISO); O,S-dimethyl phosphoramidothioate |
233-606-0 | 10265-92-6 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 |
H330 H300 H311 H400 |
GHS06 GHS09 Gef. |
H330 H300 H311 H400 |
|||
| 015-096-00-X | oxydisulfoton (ISO); O, O-diethylS-2-ethylsulphinylethyl phosphorodithioate |
219-679-1 | 2497-07-6 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
M=10 | ||
| 015-097-00-5 | phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate |
219-997-0 | 2597-03-7 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
M=100 | ||
| 015-098-00-0 | trichloronate (ISO); O-ethylO - 2,4,5-trichlorophenyl ethylphosphonothioate |
206-326-1 | 327-98-0 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
|||
| 015-099-00-6 | pirimiphos-ethyl (ISO); O,O-diethylO-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate |
245-704-0 | 23505-41-1 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H301 H312 H410 |
|||
| 015-100-00-X | phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile |
238-887-3 | 14816-18-3 | Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361f*** H302 H317 H410 |
M=1000 | ||
| 015-101-00-5 | phosmet (ISO); O,O-dimethyl phthalimidomethylS-phosphorodithioate |
211-987-4 | 732-11-6 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
M=100 | ||
| 015-102-00-0 | tris(2-chloroethyl)phosphate | 204-118-5 | 115-96-8 | Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360F*** H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H351 H360F*** H302 H411 |
|||
| 015-103-00-6 | phosphorus tribromide | 232-178-2 | 7789-60-8 | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
EUH014 | ||
| 015-104-00-1 | diphosphorus pentasulphide; phosphorus pentasulphide |
215-242-4 | 1314-80-3 | Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H332 H302 H400 |
GHS02 GHS07 GHS09 Gef. |
H228 H260 H332 H302 H400 |
EUH029 | T | |
| 015-105-00-7 | triphenyl phosphite | 202-908-4 | 101-02-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
||
| 015-106-00-2 | hexamethylphosphoric triamide; hexamethylphosphoramide |
211-653-8 | 680-31-9 | Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Gef. |
H350 H340 |
Carc. 1B; H350: C ≥ 0.01 % | ||
| 015-107-00-8 | ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate |
236-152-1 | 13194-48-4 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H301 H317 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H301 H317 H410 |
|||
| 015-108-00-3 | bromophos (ISO); O-4-bromo-2,5-dichlorophenylO,O-dimethyl phosphorothioate |
218-277-3 | 2104-96-3 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M=100 | ||
| 015-109-00-9 | crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate |
231-720-5 | 7700-17-6 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
M=10 | ||
| 015-110-00-4 | cyanofenphos (ISO); O-4-cyanophenylO-ethyl phenylphosphonothioate |
- | 13067-93-1 | Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H301 H370 ** H312 H319 H411 |
GHS06 GHS08 GHS09 Gef. |
H301 H370 ** H312 H319 H411 |
|||
| 015-111-00-X | phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate |
213-423-2 | 947-02-4 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-112-00-5 | thionazin (ISO); O,O-diethylO-pyrazin-2-yl phosphorothioate; |
206-049-6 | 297-97-2 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-113-00-0 | tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate |
260-515-3 | 57018-04-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 015-114-00-6 | chlormephos (ISO); S-chloromethylO,O-diethyl phosphorodithioate |
246-538-1 | 24934-91-6 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
M = 10 | ||
| 015-115-00-1 | chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates] |
244-663-6 | 21923-23-9 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
M = 1000 | ||
| 015-116-00-7 | demephion-O (ISO); O,O-dimethylO-2-methylthioethyl phosphorothioate |
211-666-9 | 682-80-4 | Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Gef. |
H300 H311 |
|||
| 015-117-00-2 | demephion-S (ISO); O,O-dimethylS-2-methylthioethyl phosphorothioate |
219-971-9 | 2587-90-8 | Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Gef. |
H300 H311 |
|||
| 015-118-00-8 | demeton | - | 8065-48-3 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Gef. |
H310 H300 H400 |
|||
| 015-119-00-3 | dimethyl 4-(methylthio)phenyl phosphate | - | 3254-63-5 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-120-00-9 | ditalimfos (ISO); O,O-diethyl phthalimidophosphonothioate |
225-875-8 | 5131-24-8 | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 015-121-00-4 | edifenphos (ISO); O-ethylS,S-diphenyl phosphorodithioate |
241-178-1 | 17109-49-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H312 H317 H410 |
|||
| 015-122-00-X | etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-ylO,O-dimethylphosphorothioate |
253-855-9 | 38260-54-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M=10 | ||
015-123-00-5 |
fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate |
244-848-1 |
22224-92-6 |
Acute Tox. 2 | H300 | GHS06 | H300 | M = 100 | ||
| Acute Tox. 2 | H310 | GHS09 | H310 | M = 100 | ||||||
| Acute Tox. 2 | H330 | Gef. | H330 | |||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 015-124-00-0 | fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate |
244-437-7 | 21548-32-3 | Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 015-125-00-6 | glyphosine (ISO); N,N-bis(phosphonomethyl)glycine |
219-468-4 | 2439-99-8 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 015-126-00-1 | heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate |
245-737-0 | 23560-59-0 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
M=100 | ||
| 015-127-00-7 | iprobenfos(ISO); S-benzyl diisopropyl phosphorothioate |
247-449-0 | 26087-47-8 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 015-128-00-2 | IPSP; S-ethylsulphinylmethylO,O-diisopropylphosphorodithioate |
- | 5827-05-4 | Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H301 H400 H410 |
GHS06 GHS09 Gef. |
H310 H301 H410 |
M=100 | ||
| 015-129-00-8 | isofenphos (ISO); O-ethylO-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate |
246-814-1 | 25311-71-1 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
M=100 | ||
| 015-130-00-3 | isothioate (ISO); S-2-isopropylthioethylO,O-dimethyl phosphorodithioate; |
- | 36614-38-7 | Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Gef. |
H311 H301 |
|||
| 015-131-00-9 | isoxathion (ISO); O,O-diethylO-5-phenylisoxazol-3-ylphosphorothioate |
242-624-8 | 18854-01-8 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
|||
| 015-132-00-4 | S-(chlorophenylthiomethyl)O,O-dimethylphosphorodithioate; methylcarbophenothione |
- | 953-17-3 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
M=1000 | ||
| 015-133-00-X | piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate |
- | 24151-93-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M=10 | ||
| 015-134-00-5 | pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl)O,O-dimethyl phosphorothioate |
249-528-5 | 29232-93-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 015-135-00-0 | profenofos (ISO) O-(4-bromo-2-chlorophenyl)O-ethylS-propyl phosphorothioate; |
255-255-2 | 41198-08-7 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
M=1000 | ||
| 015-136-00-6 | trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO) |
250-517-2 | 31218-83-4 | Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Gef. |
H301 H410 |
M=100 | ||
| 015-137-00-1 | pyrazophos (ISO); O,O-diethylO-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate |
236-656-1 | 13457-18-6 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H302 H410 |
|||
| 015-138-00-7 | quinalphos (ISO); O,O-diethyl-O-quinoxalin-2-yl phosphorothioate |
237-031-6 | 13593-03-8 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H301 H312 H410 |
M=1000 | ||
| 015-139-00-2 | terbufos (ISO); S -tert-butylthiomethylO, O-diethylphosphorodithioate; |
235-963-8 | 13071-79-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H310 H300 H410 |
M=1000 | ||
| 015-140-00-8 | triazophos (ISO); O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate |
245-986-5 | 24017-47-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H312 H410 |
M=100 | ||
| 015-141-00-3 | ethylenediammoniumO,O-bis(octyl) phosphorodithioate, mixed isomers | 400-520-1 | - | Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H314 H302 H410 |
|||
| 015-142-00-9 | butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate | 401-100-0 | - | Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 |
H225 H319 H411 |
GHS02 GHS07 GHS09 Gef. |
H225 H319 H411 |
T | ||
| 015-143-00-4 | reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers |
401-740-0 | - | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 015-144-00-X | reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate | 402-090-0 | 87025-52-3 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 015-145-00-5 | reaction mass of copper(I)O,O-diisopropyl phosphorodithioate and copper(I)O-isopropylO-(4-methylpent-2-yl) phosphorodithioate and copper(I)O,O-bis(4-methylpent-2-yl) phosphorodithioate | 401-520-4 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 015-146-00-0 | S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-ylO-(isopropyl or isobutyl or 2-ethylhexyl)O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate | 401-850-9 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 015-147-00-6 | reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) | 400-930-0 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H411 |
|||
| 015-148-00-1 | 2-(diphosphonomethyl)succinic acid | 403-070-4 | 51395-42-7 | Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Gef. |
H314 H317 |
|||
| 015-149-00-7 | reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide |
403-470-9 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 015-150-00-2 | (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide | 404-940-6 | 86608-70-0 | Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3 |
H302 H318 H373 ** H412 |
GHS08 GHS05 GHS07 Gef. |
H302 H318 H373 ** H412 |
|||
| 015-151-00-8 | tris(isopropyl/tert-butylphenyl) phosphate | 405-010-2 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 015-152-00-3 | dioxabenzofos (ISO); 2-methoxy-4H - 1,3,2-benzodioxaphosphorin 2-sulphide |
223-292-3 | 3811-49-2 | Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2 |
H311 H301 H370 ** H411 |
GHS06 GHS08 GHS09 Gef. |
H311 H301 H370 ** H411 |
|||
| 015-153-00-9 | isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl)O,O-diethyl phosphorothioate |
255-863-8 | 42509-80-8 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H311 H301 H373 ** H317 H410 |
|||
| 015-154-00-4 | ethephon; 2-chloroethylphosphonic acid | 240-718-3 | 16672-87-0 | Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 |
H311 H332 H302 H314 H411 |
GHS06 GHS05 GHS09 Gef. |
H311 H332 H302 H314 H411 |
EUH071 | ||
| 015-155-00-X | glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate |
278-636-5 | 77182-82-2 | Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H360Fd H332 H312 H302 H373** |
GHS08 GHS07 Gef. |
H360Fd H332 H312 H302 H373** |
|||
| 015-156-00-5 | methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] |
250-366-9 [1] - [2] |
30864-28-9 [1] 62610-77-9 [2] |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 015-157-00-0 | phosphonic acid; [1] phosphorous acid [2] |
237-066-7 [1] 233-663-1 [2] |
13598-36-2 [1] 10294-56-1 [2] |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Gef. |
H302 H314 |
|||
| 015-158-00-6 | (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) | 402-340-9 | 32760-80-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 015-159-00-1 | hydroxyphosphonoacetic acid | 405-710-8 | 23783-26-8 | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 |
H302 H373 ** H314 H317 |
GHS08 GHS05 GHS07 Gef. |
H302 H373 ** H314 H317 |
|||
| 015-160-00-7 | vanadyl pyrophosphate | 406-260-5 | 58834-75-6 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Achtg. |
H319 H317 H412 |
|||
| 015-161-00-2 | divanadyl pyrophosphate | 407-130-0 | 65232-89-5 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H317 H411 |
|||
| 015-162-00-8 | vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped | 407-350-7 | - | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H373 ** H318 H411 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H332 H373 ** H318 H411 |
|||
| 015-163-00-3 | bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide | 412-010-6 | 145052-34-2 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 015-164-00-9 | calciumP,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate | 400-480-5 | 36669-85-9 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 015-165-00-4 | reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate |
404-986-7 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 015-166-00-X | 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | 410-290-4 | 80693-00-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 015-167-00-5 | 3-(hydroxyphenylphosphinyl)propanoic acid | 411-200-6 | 14657-64-8 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 015-168-00-0 | fosthiazate (ISO); (RS)-S -sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate |
- | 98886-44-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H312 H317 H410 |
EUH070 | ||
| 015-169-00-6 | tributyltetradecylphosphonium tetrafluoroborate | 413-520-1 | - | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H302 H373 ** H314 H317 H410 |
|||
| 015-170-00-1 | reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate; 1-octane-N,N,N-trimethylammonium di-octylphosphate; 1-octane-N,N,N-trimethylammonium octylphosphate |
407-490-9 | - | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
|||
| 015-171-00-7 | O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate | 406-940-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 015-172-00-2 | reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate |
406-240-6 | - | Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 |
H226 H314 H411 |
GHS02 GHS05 GHS09 Gef. |
H226 H314 H411 |
|||
| 015-173-00-8 | methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate | 414-080-3 | 117291-73-3 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 015-174-00-3 | 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine | 411-370-1 | 82857-68-9 | Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2 |
H301 H318 H411 |
GHS06 GHS05 GHS09 Gef. |
H301 H318 H411 |
|||
| 015-175-00-9 | tert-butyl (triphenylphosphoranylidene) acetate | 412-880-7 | 35000-38-5 | Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H301 H373 ** H319 H317 H411 |
GHS06 GHS08 GHS09 Gef. |
H301 H373 ** H319 H317 H411 |
|||
| 015-176-00-4 | P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine | 413-430-2 | 116163-96-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 015-177-00-X | ((4-phenylbutyl)hydroxyphosphoryl)acetic acid | 412-170-7 | 83623-61-4 | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373 ** H318 H317 |
GHS08 GHS05 Gef. |
H373 ** H318 H317 |
|||
| 015-178-00-5 | (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate | 418-570-8 | 25383-07-7 | Repr. 2 Aquatic Chronic 2 |
H361f *** H411 |
GHS08 GHS09 Achtg. |
H361f *** H411 |
|||
| 015-179-00-0 | UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine | 422-720-8 | 166242-53-1 | Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H351 H302 H373 ** H314 H317 H410 |
|||
| 015-180-00-6 | [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt | 415-820-8 | 137590-32-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 015-181-00-1 | phosphine | 232-260-8 | 7803-51-2 | Flam. Gas 1 Press. Gas Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H220 H330 H314 H400 |
GHS02 GHS04 GHS06 GHS05 GHS09 Gef. |
H220 H330 H314 H400 |
U | ||
| 015-182-00-7 | tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate) | 430-630-5 | 10596-22-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Achtg. |
H302 H319 H317 |
|||
| 015-183-00-2 | (1-hydroxydodecylidene)diphosphonic acid | 425-230-2 | 16610-63-2 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 015-184-00-8 | Salts of glyphosate, with the exception of those specified elsewhere in this Annex | - | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | A | ||
| 015-186-00-9 | chlorpyrifos-methyl (ISO) O, O-dimethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate |
227-011-5 | 5598-13-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
M=10000 | ||
| 015-187-00-4 | reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate,N-oxide; trisodium ((tetrahydro-2-hydroxy-4H - 1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate,N-oxide,P-oxide |
417-540-1 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 015-189-00-5 | phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide | 423-340-5 | 162881-26-7 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 015-190-00-0 | bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane |
421-920-2 | 154862-43-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 015-191-00-6 | dodecyldiphenyl phosphate | 431-760-5 | 27460-02-2 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) | 442-960-7 | 332350-93-3 | Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H400 H410 |
GHS05 GHS06 GHS09 Gef. |
H301 H318 H410 |
|||
| 015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | 444-440-5 | 220689-12-3 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 015-195-00-8 | reaction mass of: potassiumo-toluenephosphonate; potassiumm-toluenephosphonate; potassiump-toluenephosphonate |
433-860-4 | - | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Achtg. |
H319 H317 H412 |
|||
| 015-196-00-3 | reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate |
435-960-3 | - | Carc. 1B Muta. 1B Skin Sens. 1 |
H350 H340 H317 |
GHS08 GHS07 Gef. |
H350 H340 H317 |
|||
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | 420-160-9 | 107667-02-7 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H302 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Gef. |
H226 H331 H302 H314 H411 |
|||
| 015-198-00-4 | (4-phenylbutyl)phosphinic acid | 420-450-5 | 86552-32-1 | Carc. 2 Eye Dam. 1 |
H351 H318 |
GHS05 GHS08 Gef. |
H351 H318 |
|||
| 015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08 Achtg. |
H351 | |||
| 015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 | Carc. 1B Repr. 2 STOT RE 1 |
H350 H361f H372 (Lunge) |
GHS08 Gef. |
H350 H361f H372 (Lunge) |
STOT RE 1; H372: C ≥ 0,1 % Carc 1B; H350: C ≥ 0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % |
||
| 015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08 Gef. |
H360F | |||
| 015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (verursacht Hodenatrophie) | GHS08 Achtg. |
H361f (verursacht Hodenatrophie) | |||
| 016-001-00-4 | hydrogen sulphide | 231-977-3 | 7783-06-4 | Flam. Gas 1 Press. Gas Acute Tox. 2 * Aquatic Acute 1 |
H220 H330 H400 |
GHS02 GHS04 GHS06 GHS09 Gef. |
H220 H330 H400 |
U | ||
| 016-002-00-X | barium sulphide | 244-214-4 | 21109-95-5 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Achtg. |
H332 H302 H400 |
EUH031 | ||
| 016-003-00-5 | barium polysulphides | 256-814-3 | 50864-67-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H400 |
EUH031 | ||
| 016-004-00-0 | calcium sulphide | 243-873-5 | 20548-54-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H400 |
EUH031 | ||
| 016-005-00-6 | calcium polysulphides | 215-709-2 | 1344-81-6 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H400 |
EUH031 | ||
| 016-006-00-1 | dipotassium sulphide; potassium sulphide |
215-197-0 | 1312-73-8 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
EUH031 | ||
| 016-007-00-7 | potassium polysulphides | 253-390-1 | 37199-66-9 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
EUH031 | ||
| 016-008-00-2 | ammonium polysulphides | 232-989-1 | 9080-17-5 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
EUH031 | EUH031: C ≥ 1 % | |
| 016-009-00-8 | disodium sulfide; sodium sulfide |
215-211-5 | 1313-82-2 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H311 H302 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H311 H302 H314 H400 |
|||
| 016-010-00-3 | sodium polysulphides | 215-686-9 | 1344-08-7 | Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H301 H314 H400 |
EUH031 | ||
| 016-011-00-9 | sulphur dioxide | 231-195-2 | 7446-09-5 | Press. Gas Acute Tox. 3 * Skin Corr. 1B |
H331 H314 |
GHS04 GHS06 GHS05 Gef. |
H331 H314 |
* | U5 | |
| 016-012-00-4 | disulphur dichloride; sulfur monochloride |
233-036-2 | 10025-67-9 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1a Aquatic Acute 1 |
H301 H332 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H301 H332 H314 H400 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % | |
| 016-013-00-X | sulphur dichloride | 234-129-0 | 10545-99-0 | Skin Corr. 1B STOT SE 3 Aquatic Acute 1 |
H314 H335 H400 |
GHS05 GHS07 GHS09 Gef. |
H314 H335 H400 |
EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-014-00-5 | sulphur tetrachloride | - | 13451-08-6 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-015-00-0 | thionyl dichloride; thionyl chloride |
231-748-8 | 7719-09-7 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H332 H302 H314 |
GHS05 GHS07 Gef. |
H332 H302 H314 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % | |
| 016-016-00-6 | sulphuryl chloride | 232-245-6 | 7791-25-5 | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
EUH014 | ||
| 016-017-00-1 | chlorosulphonic acid | 232-234-6 | 7790-94-5 | Skin Corr. 1a STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
EUH014 | ||
| 016-018-00-7 | fluorosulphonic acid | 232-149-4 | 7789-21-1 | Acute Tox. 4 * Skin Corr. 1A |
H332 H314 |
GHS05 GHS07 Gef. |
H332 H314 |
|||
| 016-019-00-2 | oleum ... % SO3 | - | - | Skin Corr. 1a STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
EUH014 | B | |
| 016-020-00-8 | sulphuric acid ... % | 231-639-5 | 7664-93-9 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % |
B | |
| 016-021-00-3 | methanethiol; methyl mercaptan |
200-822-1 | 74-93-1 | Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Gef. |
H220 H331 H410 |
U | ||
| 016-022-00-9 | ethanethiol; ethyl mercaptan |
200-837-3 | 75-08-1 | Flam. Liq. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H400 H410 |
GHS02 GHS07 GHS09 Gef. |
H225 H332 H410 |
|||
| 016-023-00-4 | dimethyl sulphate | 201-058-1 | 77-78-1 | Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H350 H341 H330 H301 H314 H317 |
GHS06 GHS08 GHS05 Gef. |
H350 H341 H330 H301 H314 H317 |
Carc. 1B; H350: C ≥ 0.01 % Muta. 2; H341: C ≥ 0.01 % STOT SE 3; H335: C ≥ 5 % |
||
| 016-024-00-X | dimexano(ISO); bis(methoxythiocarbonyl) disulphide |
215-993-8 | 1468-37-7 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 016-025-00-5 | disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES |
205-259-5 | 149-26-8 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Gef. |
H302 H315 H318 |
|||
| 016-026-00-0 | sulphamidic acid; sulphamic acid; sulfamic acid |
226-218-8 | 5329-14-6 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Achtg. |
H319 H315 H412 |
|||
| 016-027-00-6 | diethyl sulphate | 200-589-6 | 64-67-5 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H340 H332 H312 H302 H314 |
GHS05 GHS08 GHS07 Gef. |
H350 H340 H332 H312 H302 H314 |
|||
| 016-028-00-1 | sodium dithionite; sodium hydrosulphite |
231-890-0 | 7775-14-6 | Self-heat. 1 Acute Tox. 4 * |
H251 H302 |
GHS02 GHS07 Gef. |
H251 H302 |
EUH031 | ||
| 016-029-00-7 | p-toluenesulphonic acid, containing more than 5 % H2SO4 | - | - | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
||
| 016-030-00-2 | p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) | 203-180-0 | 104-15-4 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
STOT SE 3; H335: C ≥ 20 % | ||
| 016-031-00-8 | tetrahydrothiophene-1,1-dioxide; sulpholane |
204-783-1 | 126-33-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 016-032-00-3 | 1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide |
214-317-9 | 1120-71-4 | Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H350 H312 H302 |
GHS08 GHS07 Gef. |
H350 H312 H302 |
Carc. 1B; H350: C ≥ 0,01 % | ||
| 016-033-00-9 | dimethylsulfamoylchloride | 236-412-4 | 13360-57-1 | Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H330 H312 H302 H314 |
GHS06 GHS05 GHS08 Gef. |
H350 H330 H312 H302 H314 |
|||
| 016-034-00-4 | tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) | 400-010-9 | 81898-60-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-035-00-X | pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate | 400-120-7 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 016-036-00-5 | tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate | 400-130-1 | - | Resp. Sens. 1 Aquatic Chronic 2 |
H334 H411 |
GHS08 GHS09 Gef. |
H334 H411 |
|||
| 016-037-00-0 | disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate | 400-350-8 | 85153-93-1 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 016-038-00-6 | disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate | 400-380-1 | 86393-35-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-039-00-1 | tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate | 400-430-2 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-040-00-7 | reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate | 400-570-4 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 016-041-00-2 | calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate | 400-710-4 | - | Acute Tox. 4 * | H332 | GHS07 Achtg. |
H332 | |||
| 016-042-00-8 | tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate | 400-790-0 | 85665-97-0 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
|||
| 016-043-00-3 | dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate | 401-010-1 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-044-00-9 | disodiumS,S-hexane-1,6-diyldi(thiosulphate) dihydrate | 401-320-7 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 016-045-00-4 | lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate | 401-560-2 | 108624-00-6 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-046-00-X | sodium hydrogensulphate | 231-665-7 | 7681-38-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 016-047-00-5 | hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate | 401-650-1 | 85665-96-9 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-048-00-0 | sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate | 401-870-8 | - | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 016-049-00-6 | calcium octadecylxylenesulphonate | 402-040-8 | - | Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Gef. |
H314 H411 |
|||
| 016-050-00-1 | potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat | 402-150-6 | - | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 016-051-00-7 | trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate | 402-170-5 | 106359-91-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-052-00-2 | benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate | 402-240-5 | 102561-46-6 | Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Achtg. |
H332 H411 |
|||
| 016-053-00-8 | (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate | 402-460-1 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Achtg. |
H315 H317 H413 |
|||
| 016-054-00-3 | sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate | 400-030-8 | - | Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Sens. 1 |
H331 H372 ** H302 H319 H335 H317 |
GHS06 GHS08 Gef. |
H331 H372 ** H302 H319 H335 H317 |
|||
| 016-055-00-9 | tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) | 400-510-7 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 016-056-00-4 | potassium hydrogensulphate | 231-594-1 | 7646-93-7 | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
|||
| 016-057-00-X | styrene-4-sulfonyl chloride | 404-770-2 | 2633-67-2 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Gef. |
H315 H318 H317 |
|||
| 016-058-00-5 | thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol,tert-nonanethiol and C12-14 -tert-alkylamine | 404-820-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Achtg. |
H315 H317 H412 |
|||
| 016-059-00-0 | N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride | 405-300-9 | 17339-60-5 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H317 H410 |
|||
| 016-060-00-6 | diammonium peroxodisulphate; ammonium persulphate |
231-786-5 | 7727-54-0 | Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Gef. |
H272 H302 H319 H335 H315 H334 H317 |
|||
| 016-061-00-1 | dipotassium peroxodisulphate; potassium persulphate |
231-781-8 | 7727-21-1 | Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Gef. |
H272 H302 H319 H335 H315 H334 H317 |
|||
| 016-062-00-7 | bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane |
- | 17606-31-4 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 016-063-00-2 | sodium metabisulphite | 231-673-0 | 7681-57-4 | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
EUH031 | ||
| 016-064-00-8 | sodium hydrogensulphite . . . %; sodium bisulphite . . . % |
231-548-0 | 7631-90-5 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | EUH031 | B | |
| 016-065-00-3 | sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate | 400-100-8 | 84057-97-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 016-066-00-9 | tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) | 404-070-7 | 116912-62-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 016-067-00-4 | (4-methylphenyl)mesitylene sulfonate | 407-530-5 | 67811-06-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-068-00-X | sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate | 407-720-8 | 155160-86-4 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 016-069-00-5 | 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid | 407-990-7 | 141915-64-2 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 016-070-00-0 | 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone | 408-220-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-071-00-6 | trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate | 410-130-3 | 136248-03-8 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 016-072-00-1 | 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide | 411-520-6 | 112195-27-4 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H411 |
|||
| 016-073-00-7 | tetrakis(phenylmethyl)thioperoxydi(carbothioamide) | 404-310-0 | 10591-85-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 016-074-00-2 | 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene | 405-410-7 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H411 |
|||
| 016-075-00-8 | 2,2'-diallyl-4,4'-sulfonyldiphenol | 411-570-9 | 41481-66-7 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 016-076-00-3 | 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol | 411-290-7 | 131538-00-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 ** H410 |
|||
| 016-077-00-9 | 2-chloro-p-toluenesulfochloride | 412-890-1 | 42413-03-6 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H314 H317 H412 |
GHS05 GHS07 Gef. |
H314 H317 H412 |
|||
| 016-078-00-4 | 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide | 413-300-5 | 56187-04-3 | Aquatic Chronic 4 | H413 | - | ||||
| 016-079-00-X | N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide | 412-920-3 | 16695-22-0 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 016-080-00-5 | sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate | 412-320-1 | 31361-99-6 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 016-081-00-0 | hexahydrocyclopenta[c]pyrrole-1-(1H)-ammoniumN-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide | 418-350-1 | - | Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H302 H319 H317 H411 |
GHS08 GHS07 GHS09 Achtg. |
H341 H302 H319 H317 H411 |
|||
| 016-082-00-6 | ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea |
- | 126801-58-9 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 016-083-00-1 | acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acidS-methyl ester |
420-050-0 | 135158-54-2 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H317 H410 |
|||
| 016-084-00-7 | prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea |
- | 94125-34-5 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M=100 | ||
| 016-085-00-2 | flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea |
- | 104040-78-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 016-086-00-8 | tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | 402-590-9 | 109125-56-6 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 016-087-00-3 | reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate |
403-490-8 | 104558-95-4 | Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H317 H410 |
|||
| 016-088-00-9 | 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid | 407-280-7 | 71297-11-5 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 016-089-00-4 | reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene | 413-840-1 | - | Self-react. C **** Aquatic Chronic 4 |
H242 H413 |
GHS02 Gef. |
H242 H413 |
|||
| 016-090-00-X | 4-methyl-N-(methylsulfonyl)benzenesulfonamide | 415-040-8 | 14653-91-9 | Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Gef. |
H302 H335 H318 |
|||
| 016-091-00-5 | C12-14 -tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate | 414-110-5 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 016-092-00-0 | reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol |
427-050-1 | - | Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361f H315 H317 H410 |
|||
| 016-093-00-6 | reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) |
414-770-4 | 140698-96-0 | Self-react. C**** Carc. 2 |
H242 H351 |
GHS02 GHS08 Gef. |
H242 H351 |
|||
| 016-094-00-1 | sulfur | 231-722-6 | 7704-34-9 | Skin Irrit. 2 | H315 | GHS07 Achtg. |
H315 | |||
| 016-095-00-7 | reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) |
417-980-4 | - | Self-react. C**** Carc. 2 |
H242 H351 |
GHS02 GHS08 Gef. |
H242 H351 |
|||
| 016-096-00-2 | thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate |
- | 79277-27-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | 434-480-1 | 32047-53-3 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Gef. |
H302 H314 H317 H412 |
|||
| 017-001-00-7 | chlorine | 231-959-5 | 7782-50-5 | Ox. Gas 1 Press. Gas Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H270 H331 H319 H335 H315 H400 |
GHS03 GHS04 GHS06 GHS09 Gef. |
H270 H331 H319 H335 H315 H400 |
M = 100 | U | |
| 017-002-00-2 | hydrogen chloride | 231-595-7 | 7647-01-0 | Press. Gas Acute Tox. 3 * Skin Corr. 1A |
H331 H314 |
GHS04 GHS06 GHS05 Gef. |
H331 H314 |
U5 | ||
| 017-002-01-X | hydrochloric acid ... % | 231-595-7 | - | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B | |
| 017-003-00-8 | barium chlorate | 236-760-7 | 13477-00-4 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Gef. |
H271 H332 H302 H411 |
|||
| 017-004-00-3 | potassium chlorate | 223-289-7 | 3811-04-9 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Gef. |
H271 H332 H302 H411 |
|||
| 017-005-00-9 | sodium chlorate | 231-887-4 | 7775-09-9 | Ox. Sol. 1 Acute Tox. 4 * Aquatic Chronic 2 |
H271 H302 H411 |
GHS03 GHS07 GHS09 Gef. |
H271 H302 H411 |
|||
| 017-006-00-4 | perchloric acid ... % | 231-512-4 | 7601-90-3 | Ox. Liq. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Gef. |
H271 H314 |
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: |
B | |
| 017-007-00-X | barium perchlorate | 236-710-4 | 13465-95-7 | Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * |
H271 H332 H302 |
GHS03 GHS07 Gef. |
H271 H332 H302 |
|||
| 017-008-00-5 | potassium perchlorate | 231-912-9 | 7778-74-7 | Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Gef. |
H271 H302 |
|||
| 017-009-00-0 | ammonium perchlorate | 232-235-1 | 7790-98-9 | Expl. 1,1 Ox. Sol. 1 |
H201 H271 |
GHS01 Gef. |
H201 H271 |
T | ||
| 017-010-00-6 | sodium perchlorate | 231-511-9 | 7601-89-0 | Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Gef. |
H271 H302 |
|||
| 017-011-00-1 | sodium hypochlorite, solution ... % Cl active | 231-668-3 | 7681-52-9 | Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
EUH031 | EUH031: C ≥ 5 % | B |
| 017-012-00-7 | calcium hypochlorite | 231-908-7 | 7778-54-3 | Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H272 H302 H314 H400 |
GHS03 GHS05 GHS07 GHS09 Gef. |
H272 H302 H314 H400 |
EUH031 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 |
T |
| 017-013-00-2 | calcium chloride | 233-140-8 | 10043-52-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 017-014-00-8 | ammonium chloride | 235-186-4 | 12125-02-9 | Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 017-015-00-3 | (2-(aminomethyl)phenyl)acetylchloride hydrochloride | 417-410-4 | 61807-67-8 | Acute Tox. 4 * Skin Corr. 1a Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Gef. |
H302 H314 H317 |
|||
| 017-016-00-9 | methyltriphenylphosphonium chloride | 418-400-2 | 1031-15-8 | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H312 H302 H315 H318 H411 |
|||
| 017-017-00-4 | (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride | 426-210-6 | 120086-58-0 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 017-018-00-X | N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride | 405-660-7 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 017-019-00-5 | (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride | 415-110-8 | 54417-53-7 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 017-020-00-0 | ethyl propoxy aluminium chloride | 421-790-7 | 13014-29-4 | Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Gef. |
H260 H314 |
EUH014 | ||
| 017-021-00-6 | behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride | 423-420-1 | 136920-10-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H410 |
|||
| 017-023-00-7 | [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides | 425-520-9 | 197179-61-6 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 017-026-00-3 | chlorine dioxide | 233-162-8 | 10049-04-4 | Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H270 H330 H314 H400 |
GHS04 GHS03 GHS06 GHS05 GHS09 Gef. |
H270 H330 H314 H400 |
M = 10 | 5 | |
| 017-026-01-0 | chlorine dioxide ... % | 233-162-8 | 10049-04-4 | Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H301 H314 H400 |
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 |
B | |
| 019-001-00-2 | potassium | 231-119-8 | 7440-09-7 | Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Gef. |
H260 H314 |
EUH014 | ||
| 019-002-00-8 | potassium hydroxide; caustic potash |
215-181-3 | 1310-58-3 | Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Gef. |
H302 H314 |
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % |
||
| 019-003-00-3 | Kalium-(E,E)-hexa-2,4-dienoat | 246-376-1 | 24634-61-5 | Eye Irrit. 2 | H319 | GSH07 Achtg. |
H319 | |||
| 020-001-00-X | calcium | 231-179-5 | 7440-70-2 | Water-react. 2 | H261 | GHS02 Gef. |
H261 | |||
| 020-002-00-5 | calcium cyanide | 209-740-0 | 592-01-8 | Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Gef. |
H300 H410 |
EUH032 | ||
| 020-003-00-0 | reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] |
420-470-4 | - | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
|||
| 022-001-00-5 | titanium tetrachloride | 231-441-9 | 7550-45-0 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | EUH014 | ||
| 022-002-00-0 | titanium(4+) oxalate | 403-260-7 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 022-003-00-6 | bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium | 412-000-1 | 125051-32-3 | Flam. Sol. 1 Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H228 H361f *** H373 ** H411 |
GHS02 GHS08 GHS09 Gef. |
H228 H361f *** H373 ** H411 |
T | ||
| 022-004-00-1 | potassium titanium oxide (K2Ti6O13) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium | 419-840-8 | 169104-71-6 | Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H228 H314 H317 H413 |
GHS02 GHS05 GHS07 Gef. |
H228 H314 H317 H413 |
|||
| 023-001-00-8 | divanadium pentaoxide; vanadium pentoxide |
215-239-8 | 1314-62-1 | Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Chronic 2 |
H341 H361d *** H372 ** H332 H302 H335 H411 |
GHS08 GHS07 GHS09 Gef. |
H341 H361d *** H372 ** H332 H302 H335 H411 |
|||
| 024-001-00-0 | chromium (VI) trioxide | 215-607-8 | 1333-82-0 | Ox. Sol. 1 Carc. 1a Muta. 1B Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1a Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Gef. |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H410 |
STOT SE 3; H335: C ≥ 1 % | ||
| 024-002-00-6 | potassium dichromate | 231-906-6 | 7778-50-9 | Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Gef. |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
STOT SE 3; H335: C ≥ 5 % | 3 | |
| 024-003-00-1 | ammonium dichromate | 232-143-1 | 7789-09-5 | Ox. Sol. 2 **** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Gef. |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317: C ≥ 0,2 % |
G3 | |
| 024-004-00-7 | sodium dichromate | 234-190-3 | 10588-01-9 | Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS05 GHS08 GHS09 Gef. |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 |
Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317: C ≥ 0,2 % STOT SE 3; H335: C ≥ 5 % |
3 | |
| 024-005-00-2 | chromyl dichloride; chromic oxychloride |
239-056-8 | 14977-61-8 | Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1a Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350i H340 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Gef. |
H271 H350i H340 H314 H317 H410 |
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % |
T3 | |
| 024-006-00-8 | potassium chromate | 232-140-5 | 7789-00-6 | Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H340 H319 H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H340 H319 H335 H315 H317 H410 |
Skin Sens. 1; H317: C ≥ 0.5 % | 3 | |
| 024-007-00-3 | zinc chromates including zinc potassium chromate | - | - | Carc. 1a Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H317 H410 |
A | ||
| 024-008-00-9 | calcium chromate | 237-366-8 | 13765-19-0 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H410 |
|||
| 024-009-00-4 | strontium chromate | 232-142-6 | 7789-06-2 | Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H400 H410 |
|||
| 024-010-00-X | dichromium tris(chromate); chromium III chromate; chromic chromate |
246-356-2 | 24613-89-6 | Ox. Sol. 1 Carc. 1B Skin Corr. 1a Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Gef. |
H271 H350 H314 H317 H410 |
T | ||
| 024-011-00-5 | ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) | 400-110-2 | 109125-51-1 | Self-react. C **** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Gef. |
H242 H410 |
|||
| 024-012-00-0 | trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) | 400-810-8 | - | Muta. 2 | H341 | GHS08 Achtg. |
H341 | |||
| 024-013-00-6 | trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) | 402-500-8 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 024-014-00-1 | trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) | 402-870-0 | 93952-24-0 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 024-015-00-7 | disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) | 404-930-1 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H332 H318 H411 |
|||
| 024-016-00-2 | tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) | 405-110-6 | 88377-66-6 | STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Achtg. |
H373 ** H413 |
|||
| 024-017-00-8 | Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex | - | - | Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H317 H410 |
A | ||
| 024-018-00-3 | sodium chromate | 231-889-5 | 7775-11-3 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317: C ≥ 0,2 % |
3 | |
| 024-019-00-9 | Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) |
419-230-1 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 024-020-00-4 | trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) | 418-220-4 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 024-021-00-X | potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) | 425-830-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 025-001-00-3 | manganese dioxide | 215-202-6 | 1313-13-9 | Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Achtg. |
H332 H302 |
|||
| 025-002-00-9 | potassium permanganate | 231-760-3 | 7722-64-7 | Ox. Sol. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H400 H410 |
GHS03 GHS07 GHS09 Gef. |
H272 H302 H410 |
|||
| 025-003-00-4 | manganese sulphate | 232-089-9 | 7785-87-7 | STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Achtg. |
H373 ** H411 |
|||
| 025-004-00-X | bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate | 411-760-1 | 116633-53-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 025-005-00-5 | reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-); tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-); pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) |
417-660-4 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 026-001-00-6 | (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate | 407-840-0 | 100011-37-8 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 026-002-00-1 | (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate | 407-880-9 | 117549-13-0 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 026-003-00-7 | iron(II) sulfate | 231-753-5 | 7720-78-7 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Achtg. |
H302 H319 H315 |
|||
| 026-003-01-4 | iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate |
231-753-5 | 7782-63-0 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Achtg. |
H302 H319 H315 |
Skin Irrit. 2; H315: C ≥ 25 % | ||
| 026-004-00-2 | potassium ferrite | 430-010-4 | 12160-44-0 | Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Gef. |
H314 H317 |
|||
| 027-001-00-9 | cobalt | 231-158-0 | 7440-48-4 | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H334 H317 H413 |
GHS08 Gef. |
H334 H317 H413 |
|||
| 027-002-00-4 | cobalt oxide | 215-154-6 | 1307-96-6 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
M=10 | ||
| 027-003-00-X | cobalt sulfide | 215-273-3 | 1317-42-6 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
M=10 | ||
| 027-004-00-5 | cobalt dichloride | 231-589-4 | 7646-79-9 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360F*** H302 H334 H317 H410 |
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 | |
| 027-005-00-0 | cobalt sulfate | 233-334-2 | 10124-43-3 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360F*** H302 H334 H317 H410 |
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 | |
| 027-006-00-6 | cobalt di(acetate) | 200-755-8 | 71-48-7 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360F*** H334 H317 H410 |
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 | |
| 027-007-00-1 | zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex | 425-240-7 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 027-008-00-7 | complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3) | 427-390-9 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 027-009-00-2 | cobalt dinitrate | 233-402-1 | 10141-05-6 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360F*** H334 H317 H410 |
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 | |
| 027-010-00-8 | cobalt carbonate | 208-169-4 | 513-79-1 | Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360F*** H334 H317 H410 |
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 | |
| 028-001-00-1 | tetracarbonylnickel; nickel tetracarbonyl |
236-669-2 | 13463-39-3 | Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H351 H360D *** H330 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Gef. |
H225 H351 H360D *** H330 H410 |
|||
| 028-002-00-7 | nickel | 231-111-4 | 7440-02-0 | Carc. 2 STOT RE 1 Skin Sens. 1 |
H351 H372** H317 |
GHS08 GHS07 Gef. |
H351 H372** H317 |
S7 | ||
| 028-002-01-4 | nickel powder; [particle diameter < 1 mm] |
231-111-4 | 7440-02-0 | Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H372** H317 H412 |
GHS08 GHS07 Gef. |
H351 H372** H317 H412 |
|||
| 028-003-00-2 | nickel monoxide; [1] nickel oxide; [2] bunsenite [3] |
215-215-7 [1] 234-323-5 [2] - [3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Gef. |
H350i H372** H317 H413 |
|||
| 028-004-00-8 | nickel dioxide | 234-823-3 | 12035-36-8 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Gef. |
H350i H372** H317 H413 |
|||
| 028-005-00-3 | dinickel trioxide | 215-217-8 | 1314-06-3 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Gef. |
H350i H372** H317 H413 |
|||
| 028-006-00-9 | nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] |
240-841-2 [1] 234-349-7 [2] - [3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. 1a Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H372** H317 H410 |
|||
| 028-007-00-4 | trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] |
234-829-6 [1] - [2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. 1a Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H372** H317 H410 |
|||
| 028-008-00-X | nickel dihydroxide; [1] nickel hydroxide [2] |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. 1a Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 |
|||
| 028-009-00-5 | nickel sulfate | 232-104-9 | 7786-81-4 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
||
| 028-010-00-0 | nickel carbonate; basic nickel carbonate; carbonic acid, nickel (2+) salt; [1] carbonic acid, nickel salt; [2] [μ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3] [carbonato(2-)] tetrahydroxytrinickel [4] |
222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] |
3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|||
| 028-011-00-6 | nickel dichloride | 231-743-0 | 7718-54-9 | Carc. 1a Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
||
| 028-012-00-1 | nickel dinitrate; [1] nitric acid, nickel salt [2] |
236-068-5 [1] 238-076-4 [2] |
13138-45-9 [1] 14216-75-2 [2] |
Ox. Sol. 2 Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 |
GHS03 GHS05 GHS08 GHS07 GHS09 Gef. |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
||
| 028-013-00-7 | nickel matte | 273-749-6 | 69012-50-6 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | 295-859-3 | 92129-57-2 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | 305-433-1 | 94551-87-8 | Carc. 1a Muta. 2 Repr. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
|||
| 028-016-00-3 | nickel diperchlorate; perchloric acid, nickel(II) salt |
237-124-1 | 13637-71-3 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-017-00-9 | nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-018-00-4 | nickel bis(sulfamidate); nickel sulfamate |
237-396-1 | 13770-89-3 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-019-00-X | nickel bis(tetrafluoroborate) | 238-753-4 | 14708-14-6 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-021-00-0 | nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-022-00-6 | nickel di(acetate); [1] nickel acetate [2] |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
||
| 028-024-00-7 | nickel dibenzoate | 209-046-8 | 553-71-9 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | 223-463-2 | 3906-55-6 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-026-00-8 | nickel(II) stearate; nickel(II) octadecanoate |
218-744-1 | 2223-95-2 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-027-00-3 | nickel dilactate | - | 16039-61-5 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-028-00-9 | nickel(II) octanoate | 225-656-7 | 4995-91-9 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1a Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-029-00-4 | nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-030-00-X | nickel hexafluorosilicate | 247-430-7 | 26043-11-8 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-031-00-5 | nickel selenate | 239-125-2 | 15060-62-5 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-032-00-0 | nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
|||
| 028-033-00-6 | diammonium nickel hexacyanoferrate | - | 74195-78-1 | Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
|||
| 028-034-00-1 | nickel dicyanide | 209-160-8 | 557-19-7 | Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
EUH032 | ||
| 028-035-00-7 | nickel chromate | 238-766-5 | 14721-18-7 | Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
|||
| 028-036-00-2 | nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-037-00-8 | dinickel hexacyanoferrate | 238-946-3 | 14874-78-3 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-038-00-3 | trinickel bis(arsenate); nickel(II) arsenate |
236-771-7 | 13477-70-8 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H372** H317 H410 |
|||
| 028-039-00-9 | nickel oxalate; [1] oxalic acid, nickel salt [2] |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-040-00-4 | nickel telluride | 235-260-6 | 12142-88-0 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-041-00-X | trinickel tetrasulfide | - | 12137-12-1 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-042-00-5 | trinickel bis(arsenite) | - | 74646-29-0 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-043-00-0 | cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] |
269-051-6 [1] 261-346-8 [2] - [3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. 1a STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Gef. |
H350i H372** H317 |
|||
| 028-044-00-6 | nickel tin trioxide; nickel stannate |
234-824-9 | 12035-38-0 | Carc. 1a STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Gef. |
H350i H372** H317 |
|||
| 028-045-00-1 | nickel triuranium decaoxide | 239-876-6 | 15780-33-3 | Carc. 1a STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Gef. |
H350i H372** H317 |
|||
| 028-046-00-7 | nickel dithiocyanate | 237-205-1 | 13689-92-4 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
EUH032 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
| 028-047-00-2 | nickel dichromate | 239-646-5 | 15586-38-6 | Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-048-00-8 | nickel(II) selenite | 233-263-7 | 10101-96-9 | Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
|||
| 028-049-00-3 | nickel selenide | 215-216-2 | 1314-05-2 | Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-050-00-9 | silicic acid, lead nickel salt | - | 68130-19-8 | Carc. 1a Repr. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360Df H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H360Df H372** H317 H410 |
|||
| 028-051-00-4 | nickel diarsenide; [1] nickel arsenide [2] |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-052-00-X | nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 |
271-853-6 | 68610-24-2 | Carc. 1a STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Gef. |
H350i H372** H317 |
|||
| 028-053-00-5 | nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-054-00-0 | nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(d-gluconato-O1,O2)nickel; [18] nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C8-18 and C18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. 1a Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H341 H360D*** H372** H334 H317 H410 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
||
| 028-055-00-6 | nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. 1a STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Gef. |
H350i H372** H334 H317 H410 |
|||
| 028-056-00-1 | nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. 1a STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350i H372** H317 H410 |
|||
| 028-057-00-7 | dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. 1a STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Gef. |
H350i H372** H317 |
|||
| 028-058-00-2 | cobalt lithium nickel oxide | 442-750-5 | - | Carc. 1a Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H330 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350i H330 H372** H317 H410 |
|||
| 029-001-00-4 | copper chloride; copper (I) chloride; cuprous chloride |
231-842-9 | 7758-89-6 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H400 H410 |
|||
| 029-002-00-X | Dikupferoxid; Kupfer(I)-oxid |
215-270-7 | 1317-39-1 | Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Gef. |
H332 H302 H318 H410 |
M = 100 | ||
| 029-003-00-5 | Naphthenic acids, copper salts; copper naphthenate |
215-657-0 | 1338-02-9 | Flam. Liq. 3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H400 H410 |
GHS02 GHS07 GHS09 Achtg. |
H226 H302 H410 |
|||
| 029-004-00-0 | copper sulphate | 231-847-6 | 7758-98-7 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H315 H410 |
|||
| 029-005-00-6 | (tris(chloromethyl)phthalocyaninato)copper(II), reaction products withN-methylpiperazine and methoxyacetic acid | 401-260-1 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 029-006-00-1 | tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) | 403-210-4 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 029-007-00-7 | (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide | 404-670-9 | 89797-01-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | G | ||
| 029-008-00-2 | copper(II) methanesulfonate | 405-400-2 | 54253-62-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H410 |
|||
| 029-009-00-8 | phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex | 413-650-9 | 93971-95-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 029-010-00-3 | reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) | 407-700-9 | 101408-30-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 029-011-00-9 | sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex | 412-730-0 | 150522-10-4 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 029-012-00-4 | sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) | 407-340-2 | 124719-24-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | 407-580-8 | 130201-51-3 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 029-014-00-5 | reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex; 2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex |
419-610-7 | 171866-24-3 | STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Achtg. |
H373** H411 |
|||
| 029-015-00-0 | Kupferthiocyanat | 214-183-1 | 1111-67-7 | Aquatic Acute 1 Aquatic Chronic 1 | H400 H410 |
GHS09 Achtg. |
H410 | EUH032 | M = 10 | |
| 029-016-00-6 | Kupfer(II)-oxid | 215-269-1 | 1317-38-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | M = 100 | ||
| 029-017-00-1 | Dikupferchloridtrihydroxid | 215-572-9 | 1332-65-6 | Acute Tox. 4 Acute Tox. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H400 H410 |
GHS06 GHS09 Gef. |
H332 H301 H410 |
M = 10 | ||
| 029-018-00-7 | Tetrakupferhexahydroxidsulfat; [1] Tetrakupferhexahydroxidsulfathydrat; [2] |
215-582-3 [1] 215-582-3 [2] |
1333-22-8 [1] 12527-76-3 [2] |
Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M = 10 | ||
| 029-019-01-X | Kupferflocken (mit einem Überzug aus aliphatischer Säure) | - | - | Acute Tox. 3 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H319 H400 H410 |
GHS06 GHS09 Gef. |
H331 H302 H319 H410 |
M = 10 | ||
| 029-020-00-8 | Kupfer(II)-carbonat - Kupfer(II)-hydroxid (1:1) | 235-113-6 | 12069-69-1 | Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H319 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H302 H319 H410 |
M = 10 | ||
| 029-021-00-3 | Kupferdihydroxid; Kupfer(II)-hydroxid |
243-815-9 | 20427-59-2 | Acute Tox. 2 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H318 H400 H410 |
GHS06 GHS05 GHS09 Gef. |
H330 H302 H318 H410 |
M = 10 | ||
| 029-022-00-9 | Kupferkalkbrühe (Bordeauxbrühe); Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid |
- | 8011-63-0 | Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H318 H400 H410 |
GHS07 GHS05 GHS09 Gef. |
H332 H318 H410 |
M = 10 | ||
| 029-023-00-4 | Kupfersulfat-Pentahydrat | 231-847-6 | 7758-99-8 | Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS07 GHS05 GHS09 Gef. |
H302 H318 H410 |
M = 10 | ||
| 030-001-00-1 | zinc powder - zinc dust (pyrophoric) | 231-175-3 | 7440-66-6 | Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H400 H410 |
GHS02 GHS09 Gef. |
H260 H250 H410 |
T | ||
| 030-001-01-9 | zinc powder - zinc dust (stabilised) | 231-175-3 | 7440-66-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 030-003-00-2 | zinc chloride | 231-592-0 | 7646-85-7 | Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H314 H410 |
STOT SE 3; H335: C ≥ 5 % | ||
| 030-004-00-8 | dimethylzinc; [1] diethylzinc [2] |
208-884-1 [1] 209-161-3 [2] |
544-97-8 [1] 557-20-0 [2] |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H260 H314 H400 H410 |
GHS02 GHS05 GHS09 Gef. |
H250 H260 H314 H410 |
EUH014 | ||
| 030-005-00-3 | diamminediisocyanatozinc | 401-610-3 | - | Acute Tox. 4 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H318 H334 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H302 H318 H334 H317 H400 |
|||
| 030-006-00-9 | zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1] zinc sulphate (anhydrous) [2] |
231-793-3 [1] 231-793-3 [2] |
7446-19-7 [1] 7733-02-0 [2] |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H410 |
|||
| 030-007-00-4 | bis(3,5-di-tert-butylsalicylato-O1,O2)zinc | 403-360-0 | 42405-40-3 | Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Gef. |
H228 H302 H410 |
T | ||
| 030-008-00-X | hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) | 403-750-0 | 113036-91-2 | Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Achtg. |
H332 H411 |
|||
| 030-009-00-5 | zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate | 417-130-2 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 030-010-00-0 | 2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt | 430-740-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 030-011-00-6 | trizinc bis(orthophosphate) | 231-944-3 | 7779-90-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | H413 | ||||
| 030-013-00-7 | zinc oxide | 215-222-5 | 1314-13-2 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | 440-060-9 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 031-001-00-4 | Galliumarsenid | 215-114-8 | 1303-00-0 | Repr. 1B Carc. 1B STOT RE 1 |
H360F H350 H372 (Atmungssystem und hämatopoetisches System) |
GHS08 Gef. |
H360F H350 H372 (Atmungssystem und hämatopoetisches System) |
|||
| 033-001-00-X | arsenic | 231-148-6 | 7440-38-2 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H410 |
|||
| 033-002-00-5 | arsenic compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H410 |
* | A1 | |
| 033-003-00-0 | diarsenic trioxide; arsenic trioxide |
215-481-4 | 1327-53-3 | Carc. 1a Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H300 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H350 H300 H314 H410 |
|||
| 033-004-00-6 | diarsenic pentaoxide; arsenic pentoxide; arsenic oxide |
215-116-9 | 1303-28-2 | Carc. 1a Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H301 H410 |
|||
| 033-005-00-1 | arsenic acid and its salts with the exception of those specified elsewhere in this Annex | - | - | Carc. 1a Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H301 H410 |
A | ||
| 033-006-00-7 | arsine | 232-066-3 | 7784-42-1 | Flam. Gas 1 Press. Gas Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H330 H373 ** H400 H410 |
GHS02 GHS04 GHS06 GHS08 GHS09 Gef. |
H220 H330 H373 ** H410 |
U | ||
| 033-007-00-2 | tert-butylarsine | 423-320-6 | 4262-43-5 | Pyr. Liq. 1 Acute Tox. 2 * |
H250 H330 |
GHS02 GHS06 Gef. |
H250 H330 |
|||
| 034-001-00-2 | selenium | 231-957-4 | 7782-49-2 | Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 4 |
H331 H301 H373 ** H413 |
GHS06 GHS08 Gef. |
H331 H301 H373 ** H413 |
|||
| 034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H301 H373** H410 |
A | ||
| 034-003-00-3 | sodium selenite | 233-267-9 | 10102-18-8 | Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 2 |
H300 H331 H317 H411 |
GHS06 GHS09 Gef. |
H300 H331 H317 H411 |
EUH031 | ||
| 035-001-00-5 | bromine | 231-778-1 | 7726-95-6 | Acute Tox. 2 * Skin Corr. 1a Aquatic Acute 1 |
H330 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H330 H314 H400 |
|||
| 035-002-00-0 | hydrogen bromide | 233-113-0 | 10035-10-6 | Press. Gas Skin Corr. 1a STOT SE 3 |
H314 H335 |
GHS04 GHS05 GHS07 Gef. |
H314 H335 |
U | ||
| 035-002-01-8 | hydrobromic acid ... % | - | - | Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Gef. |
H314 H335 |
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % |
B | |
| 035-003-00-6 | potassium bromate | 231-829-8 | 7758-01-2 | Ox. Sol. 1 Carc. 1B Acute Tox. 3 * |
H271 H350 H301 |
GHS03 GHS06 GHS08 Gef. |
H271 H350 H301 |
|||
| 035-004-00-1 | 2-hydroxyethylammonium perbromide | 407-440-6 | - | Ox. Sol. 2 **** Acute Tox. 4 * Skin Corr. 1a Skin Sens. 1 Aquatic Acute 1 |
H272 H302 H314 H317 H400 |
GHS03 GHS05 GHS07 GHS09 Gef. |
H272 H302 H314 H317 H400 |
|||
| 040-001-00-3 | zirconium powder (pyrophoric) | 231-176-9 | 7440-67-7 | Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Gef. |
H260 H250 |
T | ||
| 040-002-00-9 | zirconium powder, dry (non pyrophoric) | - | - | Self-heat. 1 | H251 | GHS02 Gef. |
H251 | T | ||
| 040-003-00-4 | reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5 | 430-610-6 | 226996-19-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 042-001-00-9 | molybdenum trioxide | 215-204-7 | 1313-27-5 | Carc. 2 Eye Irrit. 2 STOT SE 3 |
H351 H319 H335 |
GHS08 GHS07 Achtg. |
H351 H319 H335 |
|||
| 042-002-00-4 | tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) | 404-760-8 | 117342-25-3 | Acute Tox. 3 * Eye Dam. 1 |
H331 H318 |
GHS06 GHS05 Gef. |
H331 H318 |
|||
| 042-003-00-X | tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) | 404-860-1 | 116810-46-9 | Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H318 H400 H410 |
GHS02 GHS05 GHS09 Gef. |
H228 H318 H410 |
T | ||
| 042-004-00-5 | Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) | 412-780-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Achtg. |
H315 H317 H411 |
|||
| 042-005-00-0 | reaction mass of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex |
434-240-6 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 046-001-00-X | tetraammine palladium(II) hydrogen carbonate | 425-270-0 | 134620-00-1 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H302 H373** H318 H317 H410 |
|||
| 047-001-00-2 | silver nitrate | 231-853-9 | 7761-88-8 | Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H272 H314 H400 H410 |
GHS03 GHS05 GHS09 Gef. |
H272 H314 H410 |
|||
| 047-002-00-8 | polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt | 416-850-4 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 047-003-00-3 | Silber-Zink-Zeolith (Zeolith, Linde Typ A, Oberfläche mit Silber- und Zinkionen modifiziert) [Dieser Eintrag betrifft Zeolith vom Typ LTa (Linde Typ A), dessen Oberfläche mit Silber- und Zinkionen mit einem Gehalt von Ag+ 0,5 %-6 %, Zn2+ 5 %-16 % und möglicherweise Phospor, NH4+, Mg2+ und/oder Ca2+ jeweils < 3 % modifiziert wurde.] |
- | 130328-20-0 | Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Gef. |
H361d H315 H318 H410 |
M = 100 M = 100 |
||
| 048-001-00-5 | cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex |
- | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
* | A1 | |
| 048-002-00-0 | cadmium (non-pyrophoric); [1] cadmium oxide (non-pyrophoric) [2] |
231-152-8 [1] 215-146-2 [2] |
7440-43-9 [1] 1306-19-0 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361fd H330 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H341 H361fd H330 H372 ** H410 |
|||
| 048-003-00-6 | cadmium diformate; cadmiumformate |
224-729-0 | 4464-23-7 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H301 H351 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,25 % |
||
| 048-004-00-1 | cadmium cyanide | 208-829-1 | 542-83-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H351 H373 ** H410 |
EUH032 | STOT RE 2; H373: C ≥ 0,1 % EUH032: C ≥ 1 % |
|
| 048-005-00-7 | cadmiumhexafluorosilicate(2-); cadmium fluorosilica |
241-084-0 | 17010-21-8 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H301 H351 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,1 % |
||
| 048-006-00-2 | cadmium fluoride | 232-222-0 | 7790-79-6 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H340 H360FD H330 H301 H372 ** H410 |
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C < 7 % |
||
| 048-007-00-8 | cadmium iodide | 232-223-6 | 7790-80-9 | Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H301 H351 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,1 % |
||
| 048-008-00-3 | cadmium chloride | 233-296-7 | 10108-64-2 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H340 H360FD H330 H301 H372 ** H410 |
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % |
||
| 048-009-00-9 | cadmium sulphate | 233-331-6 | 10124-36-4 | Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H340 H360FD H330 H301 H372 ** H410 |
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % |
||
| 048-010-00-4 | cadmium sulphide | 215-147-8 | 1306-23-6 | Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 4 |
H350 H341 H361fd H372 ** H302 H413 |
GHS08 GHS07 Gef. |
H350 H341 H361fd H372 ** H302 H413 |
* STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % |
1 | |
| 048-011-00-X | cadmium (pyrophoric) | 231-152-8 | 7440-43-9 | Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H250 H350 H341 H361fd H330 H372 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Gef. |
H250 H350 H341 H361fd H330 H372 ** H410 |
|||
| 048-012-00-5 | Cadmiumcarbonat | 208-168-9 | 513-78-0 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 |
A1 | ||
| 048-013-00-0 | Cadmiumhydroxid; Cadmiumdihydroxid |
244-168-5 | 21041-95-2 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 |
A1 | ||
| 048-014-00-6 | Cadmiumnitrat; Cadmiumdinitrat |
233-710-6 | 10325-94-7 | Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H332 H312 H302 H372 (Nieren, Knochen) H410 |
Carc. 1B; H350: C ≥ 0,01 % |
A1 | |
| 050-001-00-5 | tin tetrachloride; stannic chloride |
231-588-9 | 7646-78-8 | Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Gef. |
H314 H412 |
STOT SE 3; H335: C ≥ 5 % | ||
| 050-002-00-0 | cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide |
236-049-1 | 13121-70-5 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
M=1000 | ||
| 050-003-00-6 | fentin acetate (ISO); triphenyltin acetate |
212-984-0 | 900-95-8 | Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
M=10 | ||
| 050-004-00-1 | fentin hydroxide (ISO); triphenyltin hydroxide |
200-990-6 | 76-87-9 | Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
M=10 | ||
| 050-005-00-7 | trimethyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
* | A1 | |
| 050-006-00-2 | triethyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
* | A1 | |
| 050-007-00-8 | tripropyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
* | A1 | |
| 050-008-00-3 | Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführt | - | - | Repr. 1B Acute Tox. 3 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H301 H312 H372** H315 H319 H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360FD H301 H312 H372** H315 H319 H410 |
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; H315:C ≥ 1 % Eye Irrit. 2; H319:C ≥ 1 % M = 10 |
a 1 |
|
| 050-009-00-9 | fluorotripentylstannane; [1] hexapentyldistannoxane [2] |
243-546-7 [1] 247-143-7 [2] |
20153-49-5 [1] 25637-27-8 [2] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
* | 1 | |
| 050-010-00-4 | fluorotrihexylstannane | 243-547-2 | 20153-50-8 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
* | 1 | |
| 050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
* M=100 |
A1 | |
| 050-012-00-5 | tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3] |
215-910-5 [1] 221-437-5 [2] 230-358-5 [3] |
1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
* | A1 | |
| 050-013-00-0 | trioctyltin compounds, with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 |
H319 H335 H315 H413 |
GHS07 Achtg. |
H319 H335 H315 H413 |
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
A1 | |
| 050-017-00-2 | fenbutatin oxide (ISO); bis(tris(2-methyl-2-phenylpropyl)tin)oxide |
236-407-7 | 13356-08-6 | Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H319 H315 H400 H410 |
GHS06 GHS09 Gef. |
H330 H319 H315 H410 |
|||
| 050-018-00-8 | tin(II) methanesulphonate | 401-640-7 | 53408-94-9 | Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H302 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H302 H317 H411 |
|||
| 050-019-00-3 | azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H - 1,2,4-triazole |
255-209-1 | 41083-11-8 | Acute Tox. 2 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Gef. |
H330 H301 H335 H315 H318 H410 |
|||
| 050-020-00-9 | trioctylstannane | 413-320-4 | 869-59-0 | STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 |
H372 ** H315 H413 |
GHS08 GHS07 Gef. |
H372 ** H315 H413 |
|||
| 050-021-00-4 | dichlorodioctyl stannane | 222-583-2 | 3542-36-7 | Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H331 H372** H412 |
GHS06 GHS08 Gef. |
H331 H372** H412 |
|||
| 050-022-00-X | dibutyltin dichloride; (DBTC) |
211-670-0 | 683-18-1 | Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360FD H330 H301 H312 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H341 H360FD H330 H301 H312 H372** H314 H410 |
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam. 1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 |
||
| 050-023-00-5 | reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane |
422-920-5 | - | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Achtg. |
H373** H410 |
M=10 | ||
| 050-024-00-0 | reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane |
432-230-6 | - | STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H372** H302 H315 H318 H317 H410 |
|||
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08 Achtg. |
H361d | |||
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08 Achtg. |
H361d | |||
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08 Gef. |
H360D | |||
| 050-028-00-2 | 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-829-0 | 57583-35-4 | Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A |
H361d H302 H372 (Nervensystem, Immunsystem) H317 |
GHS08 GHS07 Gef. |
H361d H302 H372 (Nervensystem, Immunsystem) H317 |
|||
| 050-029-00-8 | dimethyltin dichloride | 212-039-2 | 753-73-1 | Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B |
H361d H330 H301 H311 H372 (Nervensystem, Immunsystem) H314 |
GHS08 GHS06 GHS05 Gef. |
H361d H330 H301 H311 H372 (Nervensystem, Immunsystem) H314 |
EUH071 | ||
| 050-030-00-3 | Dibutylzinndilaurat; Dibutyl[bis(dodecanoyloxy)]-stannan | 201-039-8 | 77-58-7 | Muta. 2 Repr. 1B STOT RE 1 |
H341 H360FD H372 (Immunsystem) |
GHS08 Gef. |
H341 H360FD H372 (Immunsystem) |
|||
| 051-001-00-8 | antimony trichloride | 233-047-2 | 10025-91-9 | Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Gef. |
H314 H411 |
STOT SE 3; H335: C ≥ 5 % | ||
| 051-002-00-3 | antimony pentachloride | 231-601-8 | 7647-18-9 | Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Gef. |
H314 H411 |
STOT SE 3; H335: C ≥ 5 % | ||
| 051-003-00-9 | antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Achtg. |
H332 H302 H411 |
* | A1 | |
| 051-004-00-4 | antimony trifluoride | 232-009-2 | 7783-56-4 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Gef. |
H331 H311 H301 H411 |
|||
| 051-005-00-X | antimony trioxide | 215-175-0 | 1309-64-4 | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 051-006-00-5 | diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate | 403-500-0 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 051-007-00-0 | bis(4-dodecylphenyl)iodonium hexafluoroantimonate | 404-420-9 | 71786-70-4 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 053-001-00-3 | iodine | 231-442-4 | 7553-56-2 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H312 H400 |
GHS07 GHS09 Achtg. |
H332 H312 H400 |
|||
| 053-002-00-9 | hydrogen iodide | 233-109-9 | 10034-85-2 | Press. Gas Skin Corr. 1A |
H314 | GHS04 GHS05 Gef. |
H314 | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥ 0,02 % |
U5 | |
| 053-002-01-6 | hydriodic acid ... % | - | - | Skin Corr. 1B | H314 | GHS05 Gef. |
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B | ||
| 053-003-00-4 | iodoxybenzene | - | 696-33-3 | Expl. **** | **** | **** | **** | |||
| 053-004-00-X | calcium iodoxybenzoate | - | - | Expl. **** | **** | **** | **** | C | ||
| 053-005-00-5 | (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) | 422-960-3 | 178233-72-2 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H312 H302 H373 ** H410 |
|||
| 056-001-00-1 | barium peroxide | 215-128-4 | 1304-29-6 | Ox. Sol. 2 Acute Tox. 4 * Acute Tox. 4 * |
H272 H332 H302 |
GHS03 GHS07 Gef. |
H272 H332 H302 |
|||
| 056-002-00-7 | barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Achtg. |
H332 H302 |
* | A1 | |
| 056-003-00-2 | barium carbonate | 208-167-3 | 513-77-9 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 056-004-00-8 | barium chloride | 233-788-1 | 10361-37-2 | Acute Tox. 3 * Acute Tox. 4 * |
H301 H332 |
GHS06 Gef. |
H301 H332 |
|||
| 064-001-00-8 | gadolinium(III)sulfite trihydrate | 456-900-2 | 51285-81-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 072-001-00-4 | hafnium tetra-n-butoxide | 411-740-2 | 22411-22-9 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 074-001-00-X | hexasodium tungstate hydrate | 412-770-9 | 12141-67-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 074-002-00-5 | Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione | 408-250-6 | - | Flam. Liq. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H314 H317 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H225 H332 H314 H317 H410 |
|||
| 076-001-00-5 | osmium tetraoxide; osmic acid |
244-058-7 | 20816-12-0 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B |
H330 H310 H300 H314 |
GHS06 GHS05 Gef. |
H330 H310 H300 H314 |
|||
| 078-001-00-0 | tetrachloroplatinates with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H318 H334 H317 |
A | ||
| 078-002-00-6 | diammonium tetrachloroplatinate | 237-499-1 | 13820-41-2 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H315 H318 H334 H317 |
|||
| 078-003-00-1 | disodium tetrachloroplatinate | 233-051-4 | 10026-00-3 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H315 H318 H334 H317 |
|||
| 078-004-00-7 | dipotassium tetrachloroplatinate | 233-050-9 | 10025-99-7 | Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H315 H318 H334 H317 |
|||
| 078-005-00-2 | hexachloroplatinates with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H318 H334 H317 |
A | ||
| 078-006-00-8 | disodium hexachloroplatinate | 240-983-5 | 16923-58-3 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H318 H334 H317 |
|||
| 078-007-00-3 | dipotassium hexachloroplatinate | 240-979-3 | 16921-30-5 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H318 H334 H317 |
|||
| 078-008-00-9 | diammonium hexachloroplatinate | 240-973-0 | 16919-58-7 | Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H318 H334 H317 |
|||
| 078-009-00-4 | hexachloroplatinic acid | 241-010-7 | 16941-12-1 | Acute Tox. 3 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H301 H314 H334 H317 |
GHS06 GHS05 GHS08 Gef. |
H301 H314 H334 H317 |
|||
| 078-010-00-X | tetraammine platinum(II) hydrogen carbonate | 426-730-3 | 123439-82-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 078-011-00-5 | hydroxydisulfito platinum(II) acid | 423-310-1 | 61420-92-6 | Acute Tox. 4 * STOT RE 2 * Skin Corr. 1a Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 H314 H334 H317 H412 |
GHS05 GHS08 GHS07 Gef. |
H302 H373 H314 H334 H317 H412 |
|||
| 078-012-00-0 | platinum(IV) nitrate/nitric acid solution | 432-400-1 | - | Skin Corr. 1a Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 080-001-00-0 | mercury | 231-106-7 | 7439-97-6 | Repr. 1B Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360D*** H330 H372** H410 |
|||
| 080-002-00-6 | inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,1 % |
A1 | |
| 080-003-00-1 | dimercury dichloride; mercurous chloride; calomel |
233-307-5 | 10112-91-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H335 H315 H410 |
|||
| 080-004-00-7 | organic compounds of mercury with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,1 % |
A1 | |
| 080-005-00-2 | mercury difulminate; mercuric fulminate; fulminate of mercury |
211-057-8 | 628-86-4 | Unst. Expl. Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H200 H331 H311 H301 H373 ** H400 H410 |
|||
| 080-005-01-X | mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser] |
211-057-8 | 628-86-4 | Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H331 H311 H301 H373 ** H400 H410 |
|||
| 080-006-00-8 | dimercury dicyanide oxide; mercuric oxycyanide |
215-629-8 | 1335-31-5 | Expl. 1,1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H331 H311 H301 H373** H410 |
|||
| 080-007-00-3 | dimethylmercury; [1] diethylmercury [2] |
209-805-3 [1] 211-000-7 [2] |
593-74-8 [1] 627-44-1 [2] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H373 ** H410 |
* STOT RE 2; H373: C ≥ 0,05 % |
1 | |
| 080-008-00-9 | phenylmercury nitrate; [1] phenylmercury hydroxide; [2] basic phenylmercury nitrate [3] |
200-242-9 [1] 202-866-7 [2] - [3] |
55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H301 H372 ** H314 H410 |
|||
| 080-009-00-4 | 2-methoxyethylmercury chloride | 204-659-7 | 123-88-6 | Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H301 H372 ** H314 H410 |
|||
| 080-010-00-X | mercury dichloride; mercuric chloride |
231-299-8 | 7487-94-7 | Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H361f*** H300 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H341 H361f*** H300 H372** H314 H410 |
|||
| 080-011-00-5 | phenylmercury acetate | 200-532-5 | 62-38-4 | Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H301 H372 ** H314 H410 |
|||
| 081-001-00-3 | thallium | 231-138-1 | 7440-28-0 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Gef. |
H330 H300 H373 ** H413 |
|||
| 081-002-00-9 | thallium compounds, with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Gef. |
H330 H300 H373 ** H411 |
A | ||
| 081-003-00-4 | dithallium sulphate; thallic sulphate |
231-201-3 | 7446-18-6 | Acute Tox. 2 * STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H300 H372 ** H315 H411 |
GHS06 GHS08 GHS09 Gef. |
H300 H372 ** H315 H411 |
|||
| 082-001-00-6 | lead compounds with the exception of those specified elsewhere in this Annex | - | - | Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H360Df H332 H302 H373 ** H410 |
Repr. 2; H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥ 0,5 % |
A1 | |
| 082-002-00-1 | lead alkyls | - | - | Repr. 1a Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360Df H330 H310 H300 H373 ** H410 |
Repr. 1A; H360D: C ≥ 0,1 % * STOT RE 2; H373: C ≥ 0,05 % |
A1 | |
| 082-003-00-7 | lead diazide; lead azide |
236-542-1 | 13424-46-9 | Unst. Expl. Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Gef. |
H200 H360Df H332 H302 H373 ** H410 |
1 | ||
| 082-003-01-4 | lead diazide; lead azide [≥ 20 % phlegmatiser] |
236-542-1 | 13424-46-9 | Expl. 1.1 Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Gef. |
H201 H360Df H332 H302 H373 ** H410 |
1 | ||
| 082-004-00-2 | lead chromate | 231-846-0 | 7758-97-6 | Carc. 1B Repr. 1a STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Gef. |
H350 H360Df H373** H410 |
1 | ||
| 082-005-00-8 | lead di(acetate) | 206-104-4 | 301-04-2 | Repr. 1a STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Gef. |
H360Df H373 ** H410 |
1 | ||
| 082-006-00-3 | trilead bis(orthophosphate) | 231-205-5 | 7446-27-7 | Repr. 1a STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Gef. |
H360Df H373 ** H410 |
1 | ||
| 082-007-00-9 | lead acetate, basic | 215-630-3 | 1335-32-6 | Carc. 2 Repr. 1a STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H373 ** H400 H410 |
GHS08 GHS09 Gef. |
H351 H360Df H373 ** H410 |
1 | ||
| 082-008-00-4 | lead(II) methanesulphonate | 401-750-5 | 17570-76-2 | Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H360Df H332 H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Gef. |
H360Df H332 H302 H373 ** H315 H318 |
1 | ||
| 082-009-00-X | lead sulfochromate yellow; C.I. Pigment Yellow 34; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] |
215-693-7 | 1344-37-2 | Carc. 1B Repr. 1a STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Gef. |
H350 H360Df H373** H410 |
1 | ||
| 082-010-00-5 | lead chromate molybdate sulfate red; C.I. Pigment Red 104; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] |
235-759-9 | 12656-85-8 | Carc. 1B Repr. 1a STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Gef. |
H350 H360Df H373** H410 |
1 | ||
| 082-011-00-0 | lead hydrogen arsenate | 232-064-2 | 7784-40-9 | Carc. 1a Repr. 1a Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H331 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H360Df H331 H301 H373 ** H410 |
1 | ||
| 082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | 431-780-4 | 199876-46-5 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373** H411 |
|||
| 082-013-00-1 | Bleipulver; [Partikeldurchmesser < 1 mm] |
231-100-4 | 7439-92-1 | Repr. 1 a Lakt. |
H360FD H362 |
GHS08 Gef. |
H360FD H362 |
Repr. 1 A; H360D: C ≥ 0,03 % | ||
| 082-014-00-7 | Blei, massiv: [Partikeldurchmesser ≥ 1 mm] |
231-100-4 | 7439-92-1 | Repr. 1 a Lakt. |
H360FD H362 |
GHS08 Gef. |
H360FD H362 |
|||
| 092-001-00-8 | uranium | 231-170-6 | 7440-61-1 | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Gef. |
H330 H300 H373 ** H413 |
|||
| 092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Gef. |
H330 H300 H373** H411 |
A | ||
| 601-001-00-4 | methane | 200-812-7 | 74-82-8 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 601-002-00-X | ethane | 200-814-8 | 74-84-0 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 601-003-00-5 | propane | 200-827-9 | 74-98-6 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 601-004-00-0 | butane; [1] and isobutane [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | C U | ||
| 601-004-01-8 | butane (containing ≥ 0.1 % butadiene (203-450-8)); [1] isobutane (containing ≥ 0.1 % butadiene (203-450-8)) [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas Carc. 1a Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Gef. |
H220 H350 H340 |
C S U | ||
| 601-005-00-6 | 2,2-dimethylpropane; neopentane |
207-343-7 | 463-82-1 | Flam. Gas 1 Press. Gas Aquatic Chronic 2 |
H220 H411 |
GHS02 GHS04 GHS09 Gef. |
H220 H411 |
U | ||
| 601-006-00-1 | pentane | 203-692-4 | 109-66-0 | Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H336 H411 |
EUH066 | C | |
| 601-007-00-7 | hexane (containing < 5 %n-hexane (203-777-6)); 2-methylpentane; [1] 3-methylpentane; [2] 2,2-dimethylbutane; [3] 2,3-dimethylbutane [4] |
203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] |
107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H411 |
C | ||
| 601-008-00-2 | heptane; n-heptane; [1] 2,4-dimethylpentane; [2] 2,2,3-trimethylbutane; [3] 3,3-dimethylpentane; [4] 2,3-dimethylpentane; [5] 3-methylhexane; [6] 2,2-dimethylpentane; [7] 2-methylhexane; [8] 3-ethylpentane; [9] isoheptane; [10] |
205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] |
142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H410 |
C | ||
| 601-009-00-8 | octane; n-octane; [1] 2,2,4-trimethylpentane; [2] 2,3,3-trimethylpentane; [3] 3,3-dimethylhexane; [4] 2,2,3-trimethylpentane; [5] 2,3,4-trimethylpentane; [6] 3,4-dimethylhexane; [7] 2,3-dimethylhexane; [8] 2,4-dimethylhexane; [9] 4-methylheptane; [10] 3-methylheptane; [11] 2,2-dimethylhexane; [12] 2,5-dimethylhexane; [13] 2-methylheptane; [14] 2,2,3,3-tetramethylbutane; [15] 3-ethyl-2-methylpentane; [16] 3-ethylhexane; [17] 3-ethyl-3-methylpentane; [18] isooctane; [19] |
203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] |
111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H410 |
C | ||
| 601-010-00-3 | ethylene | 200-815-3 | 74-85-1 | Flam. Gas 1 Press. Gas STOT SE 3 |
H220 H336 |
GHS02 GHS04 GHS07 Gef. |
H220 H336 |
U | ||
| 601-011-00-9 | propene; propylene |
204-062-1 | 115-07-1 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 601-012-00-4 | but-1-ene; [1] butene, mixed-1-and-2-isomers; [2] 2-methylpropene; [3] (Z)-but-2-ene; [4] (E)-but-2-ene [5] |
203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] |
106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] |
Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | C U | ||
| 601-013-00-X | 1,3-butadiene; buta-1,3-diene |
203-450-8 | 106-99-0 | Flam. Gas 1 Press. Gas Carc. 1a Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Gef. |
H220 H350 H340 |
D U | ||
| 601-014-00-5 | isoprene (stabilised) 2-methyl-1,3-butadiene |
201-143-3 | 78-79-5 | Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 |
H224 H350 H341 H412 |
GHS02 GHS08 Gef. |
H224 H350 H341 H412 |
D | ||
| 601-015-00-0 | acetylene; ethyne |
200-816-9 | 74-86-2 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | EUH006 | U | |
| 601-016-00-6 | cyclopropane | 200-847-8 | 75-19-4 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 601-017-00-1 | cyclohexane | 203-806-2 | 110-82-7 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H410 |
|||
| 601-018-00-7 | methylcyclohexane | 203-624-3 | 108-87-2 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H411 |
|||
| 601-019-00-2 | 1,4-dimethylcyclohexane | 209-663-2 | 589-90-2 | Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H304 H315 H336 H411 |
|||
| 601-020-00-8 | benzene | 200-753-7 | 71-43-2 | Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H350 H340 H372 ** H304 H319 H315 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H340 H372 ** H304 H319 H315 |
E | ||
| 601-021-00-3 | toluene | 203-625-9 | 108-88-3 | Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 |
H225 H361d *** H304 H373 ** H315 H336 |
GHS02 GHS08 GHS07 Gef. |
H225 H361d *** H304 H373 ** H315 H336 |
|||
| 601-022-00-9 | o-xylene; [1] p-xylene; [2] m-xylene; [3] xylene [4] |
202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] |
95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H312 H315 |
GHS02 GHS07 Achtg. |
H226 H332 H312 H315 |
* | C | |
| 601-023-00-4 | ethylbenzene | 202-849-4 | 100-41-4 | Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 |
H225 H332 H373 (Hörorgane) H304 |
GHS02 GHS07 GHS08 Gef. |
H225 H332 H373 (Hörorgane) H304 |
|||
| 601-024-00-X | cumene; [1] propylbenzene [2] |
202-704-5 [1] 203-132-9 [2] |
98-82-8 [1] 103-65-1 [2] |
Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H226 H304 H335 H411 |
C | ||
| 601-025-00-5 | mesitylene; 1,3,5-trimethylbenzene |
203-604-4 | 108-67-8 | Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 |
H226 H335 H411 |
GHS02 GHS07 GHS09 Achtg. |
H226 H335 H411 |
STOT SE 3; H335: C ≥ 25 % | ||
| 601-026-00-0 | styrene | 202-851-5 | 100-42-5 | Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 |
H226 H361d H332 H372 (Hörorgane) H315 H319 |
GHS02 GHS08 GHS07 Gef. |
H226 H361d H332 H372 (Hörorgane) H315 H319 |
* | D | |
| 601-027-00-6 | 2-phenylpropene; α-methylstyrene |
202-705-0 | 98-83-9 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H226 H319 H335 H411 |
GHS02 GHS07 GHS09 Achtg. |
H226 H319 H335 H411 |
STOT SE 3; H335: C ≥ 25 % | ||
| 601-028-00-1 | 2-methylstyrene; 2-vinyltoluene |
210-256-7 | 611-15-4 | Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Achtg. |
H332 H411 |
|||
| 601-029-00-7 | dipentene; limonene; [1] (R)-p-mentha-1,8-diene; d-limonene; [2] (S)-p-mentha-1,8-diene; l-limonene; [3] trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4] (±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] |
205-341-0 [1] 227-813-5 [2] 227-815-6 [3] 229-977-3 [4] 231-732-0 [5] |
138-86-3 [1] 5989-27-5 [2] 5989-54-8 [3] 6876-12-6 [4] 7705-14-8 [5] |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H315 H317 H400 H410 |
GHS02 GHS07 GHS09 Achtg. |
H226 H315 H317 H410 |
C | ||
| 601-030-00-2 | cyclopentane | 206-016-6 | 287-92-3 | Flam. Liq. 2 Aquatic Chronic 3 |
H225 H412 |
GHS02 Gef. |
H225 H412 |
|||
| 601-031-00-8 | 2,4,4-trimethylpent-1-ene | 203-486-4 | 107-39-1 | Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Gef. |
H225 H411 |
|||
| 601-032-00-3 | benzo[a]pyrene; benzo[def]chrysene |
200-028-5 | 50-32-8 | Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H360FD H317 H410 |
Carc. 1B; H350: C ≥ 0,01 % | ||
| 601-033-00-9 | benz[a]anthracene | 200-280-6 | 56-55-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
M=100 | ||
| 601-034-00-4 | benz[e]acephenanthrylene | 205-911-9 | 205-99-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
|||
| 601-035-00-X | benzo[j]fluoranthene | 205-910-3 | 205-82-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
|||
| 601-036-00-5 | benzo[k]fluoranthene | 205-916-6 | 207-08-9 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
|||
| 601-037-00-0 | n-hexane | 203-777-6 | 110-54-3 | Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H361f *** H304 H373 ** H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H361f *** H304 H373 ** H315 H336 H411 |
STOT RE 2; H373: C ≥ 5 % | ||
| 601-041-00-2 | dibenz[a,h]anthracene | 200-181-8 | 53-70-3 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
Carc. 1B; H350: C ≥ 0,01 % M=100 |
||
| 601-042-00-8 | biphenyl; diphenyl |
202-163-5 | 92-52-4 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H410 |
|||
| 601-043-00-3 | 1,2,4-trimethylbenzene | 202-436-9 | 95-63-6 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Achtg. |
H226 H332 H319 H335 H315 H411 |
|||
| 601-044-00-9 | 3a,4,7,7a-tetrahydro-4,7-methanoindene | 201-052-9 | 77-73-6 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H332 H302 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Gef. |
H225 H332 H302 H319 H335 H315 H411 |
|||
| 601-045-00-4 | 1,2,3,4-tetrahydronaphthalene | 204-340-2 | 119-64-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H411 |
EUH019 | ||
| 601-046-00-X | 7-methylocta-1,6-diene | 404-210-7 | 42152-47-6 | Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H400 H410 |
GHS02 GHS09 Achtg. |
H226 H410 |
|||
| 601-047-00-5 | m-mentha-1,3(8)-diene | 404-150-1 | 17092-80-7 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 601-048-00-0 | chrysene | 205-923-4 | 218-01-9 | Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H400 H410 |
GHS08 GHS09 Gef. |
H350 H341 H410 |
|||
| 601-049-00-6 | benzo[e]pyrene | 205-892-7 | 192-97-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
|||
| 601-051-00-7 | 4-phenylbut-1-ene | 405-980-7 | 768-56-9 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 601-052-00-2 | naphthalene | 202-049-5 | 91-20-3 | Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS07 GHS08 GHS09 Achtg. |
H351 H302 H410 |
|||
| 601-053-00-8 | nonylphenol; [1] 4-nonylphenol, branched [2] |
246-672-0 [1] 284-325-5 [2] |
25154-52-3 [1] 84852-15-3 [2] |
Repr. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H361fd H302 H314 H410 |
|||
| 601-054-00-3 | reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene |
405-570-8 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 601-055-00-9 | reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes |
410-190-0 | 132983-41-6 | Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Achtg. |
H319 H413 |
|||
| 601-056-00-4 | reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane |
405-470-4 | 73807-39-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 601-057-00-X | N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate | 421-130-8 | 156679-41-3 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H410 |
|||
| 601-058-00-5 | di-L-para-menthene | 417-870-6 | 83648-84-4 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 601-059-00-0 | methyl 2-benzylidene-3-oxobutyrate | 420-940-9 | 15768-07-7 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H411 |
|||
| 601-060-00-6 | 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 | 417-610-1 | 155522-09-1 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 601-061-00-1 | (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) | 418-960-8 | - | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H411 |
|||
| 601-062-00-7 | reaction mass of: branched triacontane; branched dotriacontane; branched tetratriacontane; branched hexatriacontane |
417-030-9 | 151006-59-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 601-063-00-2 | reaction mass of isomers of branched tetracosane | 417-060-2 | 151006-61-0 | Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Achtg. |
H332 H413 |
|||
| 601-064-00-8 | branched hexatriacontane | 417-070-7 | 151006-62-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 601-065-00-3 | reaction mass of: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) |
416-930-9 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 601-066-00-9 | 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone | 426-820-2 | 78531-60-9 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 601-067-00-4 | triethyl arsenate | 427-700-2 | 15606-95-8 | Carc. 1a Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H301 H410 |
|||
| 601-068-00-X | 1,2-diacetoxybut-3-ene | 421-720-5 | 18085-02-4 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 601-069-00-5 | 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide | 422-680-1 | 287933-44-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 601-070-00-0 | reaction mass of: branched icosane; branched docosane; branched tetracosane |
417-050-8 | 151006-58-5 | Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Achtg. |
H332 H413 |
|||
| 601-071-00-6 | 1-dimethoxymethyl-2-nitro-benzene | 423-830-9 | 20627-73-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 601-072-00-1 | reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane |
430-690-2 | 52783-21-8 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 601-073-00-7 | 1-bromo-3,5-difluorobenzene | 416-710-2 | 461-96-1 | Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373 ** H315 H317 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Achtg. |
H226 H302 H373 ** H315 H317 H410 |
|||
| 601-074-00-2 | reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] |
422-040-1 | - | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H411 |
|||
| 601-075-00-8 | 4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane | 418-770-5 | 151882-81-4 | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 601-076-00-3 | ethynyl cyclopropane | 425-430-1 | 6746-94-7 | Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H315 H318 H412 |
GHS02 GHS05 Gef. |
H225 H315 H318 H412 |
|||
| 601-077-00-9 | reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane |
426-510-7 | 196965-91-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 601-078-00-4 | reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane |
427-040-5 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 601-079-00-X | reaction mass of:trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene |
429-620-3 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Achtg. |
H315 H317 H413 |
|||
| 601-080-00-5 | reaction mass of:sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers |
431-100-6 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 601-081-00-0 | cyclohexadeca-1,9-diene | 431-730-1 | 4277-06-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Achtg. |
H315 H317 H413 |
|||
| 601-082-00-6 | reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane |
434-420-4 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | 435-000-3 | 22094-83-3 | Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 |
H304 H315 H413 |
GHS08 GHS07 Gef. |
H304 H315 H413 |
|||
| 601-084-00-7 | reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) |
435-180-3 | - | Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H315 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H304 H315 H410 |
|||
| 601-085-00-2 | isopentane; 2-methylbutane |
201-142-8 | 78-78-4 | Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H224 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H224 H304 H336 H411 |
EUH066 | ||
601-087-00-3 |
2,4,4-trimethylpentene |
246-690-9 |
25167-70-8 |
Flam. Liq. 2 | H225 | GHS02 | H225 | D |
||
| Asp. Tox. 1 | H304 | GHS07 | H304 | |||||||
| STOT SE 3 | H336 | GHS08 Gef. |
H336 | |||||||
| 601-088-00-9 | 4-vinylcyclohexene | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 601-089-00-4 | muscalure; cis-tricos-9-ene | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07 Achtg. |
H317 | |||
| 602-001-00-7 | chloromethane; methyl chloride |
200-817-4 | 74-87-3 | Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 * |
H220 H351 H373 ** |
GHS02 GHS04 GHS08 Gef. |
H220 H351 H373 ** |
U | ||
| 602-002-00-2 | bromomethane; methylbromide |
200-813-2 | 74-83-9 | Press. Gas Muta. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 |
H341 H331 H301 H373 ** H319 H335 H315 H400 H420 |
GHS04 GHS06 GHS08 GHS09 Gef. |
H341 H331 H301 H373 ** H319 H335 H315 H400 H420 |
U | ||
| 602-003-00-8 | dibromomethane | 200-824-2 | 74-95-3 | Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Achtg. |
H332 H412 |
* | ||
| 602-004-00-3 | dichloromethane; methylene chloride |
200-838-9 | 75-09-2 | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 602-005-00-9 | methyl iodide; iodomethane |
200-819-5 | 74-88-4 | Carc. 2 Acute Tox. 4 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 |
H351 H312 H331 H301 H335 H315 |
GHS06 GHS08 Gef. |
H351 H312 H331 H301 H335 H315 |
|||
602-006-00-4 |
chloroform; trichloromethane |
200-663-8 |
67-66-3 |
Carc. 2 | H351 | GHS06 | H351 | |||
| Repr. 2 | H361d | GHS08 | H361d | |||||||
| Acute Tox. 3 | H331 | Gef. | H331 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 | H372 | ||||||||
| Eye Irrit. 2 | H319 | H319 | ||||||||
| Skin Irrit. 2 | H315 | H315 | ||||||||
| 602-007-00-X | bromoform; tribromomethane |
200-854-6 | 75-25-2 | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H331 H302 H319 H315 H411 |
GHS06 GHS09 Gef. |
H331 H302 H319 H315 H411 |
|||
| 602-008-00-5 | carbon tetrachloride; tetrachloromethane |
200-262-8 | 56-23-5 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 Ozone 1 |
H351 H331 H311 H301 H372 ** H412 H420 |
GHS06 GHS08 Gef. |
H351 H331 H311 H301 H372 ** H412 H420 |
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
||
| 602-009-00-0 | chloroethane | 200-830-5 | 75-00-3 | Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 |
H220 H351 H412 |
GHS02 GHS04 GHS08 Gef. |
H220 H351 H412 |
U | ||
| 602-010-00-6 | 1,2-dibromoethane | 203-444-5 | 106-93-4 | Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H331 H311 H301 H319 H335 H315 H411 |
GHS06 GHS08 GHS09 Gef. |
H350 H331 H311 H301 H319 H335 H315 H411 |
* | ||
| 602-011-00-1 | 1,1-dichloroethane | 200-863-5 | 75-34-3 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H225 H302 H319 H335 H412 |
GHS02 GHS07 Gef. |
H225 H302 H319 H335 H412 |
* | ||
| 602-012-00-7 | 1,2-dichloroethane; ethylene dichloride |
203-458-1 | 107-06-2 | Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H302 H319 H335 H315 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H302 H319 H335 H315 |
|||
| 602-013-00-2 | 1,1,1-trichloroethane; methyl chloroform |
200-756-3 | 71-55-6 | Acute Tox. 4 * Ozone 1 |
H332 H420 |
GHS07 Achtg. |
H332 H420 |
F | ||
| 602-014-00-8 | 1,1,2-trichloroethane | 201-166-9 | 79-00-5 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H351 H332 H312 H302 |
GHS08 GHS07 Achtg. |
H351 H332 H312 H302 |
EUH066 | * | |
| 602-015-00-3 | 1,1,2,2-tetrachloroethane | 201-197-8 | 79-34-5 | Acute Tox. 2 * Acute Tox. 1 Aquatic Chronic 2 |
H330 H310 H411 |
GHS06 GHS09 Gef. |
H330 H310 H411 |
|||
| 602-016-00-9 | 1,1,2,2-tetrabromoethane | 201-191-5 | 79-27-6 | Acute Tox. 2 * Eye Irrit. 2 Aquatic Chronic 3 |
H330 H319 H412 |
GHS06 Gef. |
H330 H319 H412 |
|||
| 602-017-00-4 | pentachloroethane | 200-925-1 | 76-01-7 | Carc. 2 STOT RE 1 Aquatic Chronic 2 |
H351 H372 ** H411 |
GHS08 GHS09 Gef. |
H351 H372 ** H411 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
||
| 602-018-00-X | 1-chloropropane; [1] 2-chloropropane [2] |
208-749-7 [1] 200-858-8 [2] |
540-54-5 [1] 75-29-6 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 |
C | ||
| 602-019-00-5 | 1-bromopropane; n-propyl bromide |
203-445-0 | 106-94-5 | Flam. Liq. 2 Repr. 1B STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 |
H225 H360FD H373 ** H319 H335 H315 H336 |
GHS02 GHS08 GHS07 Gef. |
H225 H360FD H373 ** H319 H335 H315 H336 |
|||
| 602-020-00-0 | 1,2-Dichlorpropan; Propylendichlorid |
201-152-2 | 78-87-5 | Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* |
H225 H350 H332 H302 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H332 H302 |
|||
| 602-021-00-6 | 1,2-dibromo-3-chloropropane | 202-479-3 | 96-12-8 | Carc. 1B Muta. 1B Repr. 1a Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H340 H360F *** H301 H373 ** H412 |
GHS06 GHS08 Gef. |
H350 H340 H360F *** H301 H373 ** H412 |
|||
| 602-022-00-1 | 1-chloropentane; [1] 2-chloropentane; [2] 3-chloropentane [3] |
208-846-4 [1] 210-885-7 [2] 210-467-4 [3] |
543-59-9 [1] 625-29-6 [2] 616-20-6 [3] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 |
C | ||
| 602-023-00-7 | vinyl chloride; chloroethylene |
200-831-0 | 75-01-4 | Press. Gas Flam. Gas 1 Carc. 1A |
H220 H350 |
GHS02 GHS08 Gef. |
H220 H350 |
D U | ||
| 602-024-00-2 | bromoethylene | 209-800-6 | 593-60-2 | Press. Gas Flam. Gas 1 Carc. 1B |
H220 H350 |
GHS02 GHS08 Gef. |
H220 H350 |
U | ||
| 602-025-00-8 | 1,1-dichloroethylene; vinylidene chloride |
200-864-0 | 75-35-4 | Flam. Liq. 1 Carc. 2 Acute Tox. 4 * |
H224 H351 H332 |
GHS02 GHS08 GHS07 Gef. |
H224 H351 H332 |
* | D | |
| 602-026-00-3 | 1,2-dichloroethylene; [1] cis-dichloroethylene; [2] trans-dichloroethylene [3] |
208-750-2 [1] 205-859-7 [2] 205-860-2 [3] |
540-59-0 [1] 156-59-2 [2] 156-60-5 [3] |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H225 H332 H412 |
GHS02 GHS07 Gef. |
H225 H332 H412 |
* | C | |
| 602-027-00-9 | trichloroethylene; trichloroethene |
201-167-4 | 79-01-6 | Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H350 H341 H319 H315 H336 H412 |
GHS08 GHS07 Gef. |
H350 H341 H319 H315 H336 H412 |
|||
| 602-028-00-4 | tetrachloroethylene | 204-825-9 | 127-18-4 | Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Achtg. |
H351 H411 |
|||
| 602-029-00-X | 3-chloropropene; allyl chloride |
203-457-6 | 107-05-1 | Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
D | ||
| 602-030-00-5 | 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Gef. |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 |
C D | ||
| 602-031-00-0 | 1,1-dichloropropene | 209-253-3 | 563-58-6 | Flam. Liq. 2 Acute Tox. 3 * Aquatic Chronic 3 |
H225 H301 H412 |
GHS02 GHS06 Gef. |
H225 H301 H412 |
|||
| 602-032-00-6 | 3-chloro-2-methylpropene | 209-251-2 | 563-47-3 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H225 H332 H302 H314 H317 H411 |
|||
| 602-033-00-1 | Chlorbenzol | 203-628-5 | 108-90-7 | Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H315 H411 |
GHS02 GHS07 GHS09 Achtg. |
H226 H332 H315 H411 |
|||
| 602-034-00-7 | 1,2-dichlorobenzene; o-dichlorobenzene |
202-425-9 | 95-50-1 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H335 H315 H410 |
* | ||
| 602-035-00-2 | 1,4-dichlorobenzene; p-dichlorobenzene |
203-400-5 | 106-46-7 | Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H319 H410 |
|||
| 602-036-00-8 | chloroprene (stabilised); 2-chlorobuta-1,3-diene (stabilised) |
204-818-0 | 126-99-8 | Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
D | ||
| 602-037-00-3 | α-chlorotoluene; benzyl chloride |
202-853-6 | 100-44-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H373 ** H335 H315 H318 |
GHS06 GHS08 GHS05 Gef. |
H350 H331 H302 H373 ** H335 H315 H318 |
|||
| 602-038-00-9 | α, α,α-trichlorotoluene; benzotrichloride |
202-634-5 | 98-07-7 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Gef. |
H350 H331 H302 H335 H315 H318 |
|||
| 602-039-00-4 | polychlorobiphenyls; PCB |
215-648-1 | 1336-36-3 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Achtg. |
H373 ** H410 |
STOT RE 2; H373: C ≥ 0,005 % | C | |
| 602-040-00-X | 2-chlorotoluene; [1] 3-chlorotoluene; [2] 4-chlorotoluene; [3] chlorotoluene [4] |
202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] |
95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Achtg. |
H332 H411 |
C | ||
| 602-041-00-5 | penthachloronaphthalene | 215-320-8 | 1321-64-8 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H319 H315 H410 |
C | ||
| 602-042-00-0 | 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex | - | - | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H301 H312 H410 |
a C | ||
| 602-043-00-6 | lindane (ISO); γ-HCH or γ-BHC; γ-1,2,3,4,5,6-hexachlorocyclohexane |
200-401-2 | 58-89-9 | Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H373 ** H362 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H301 H332 H312 H373 ** H362 H410 |
M=10 | ||
| 602-044-00-1 | camphechlor (ISO); toxaphene; |
232-283-3 | 8001-35-2 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H301 H312 H335 H315 H410 |
|||
| 602-045-00-7 | DDT (ISO); clofenotane (INN); dicophane; 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane |
200-024-3 | 50-29-3 | Carc. 2 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H301 H372 ** H410 |
|||
| 602-046-00-2 | heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene |
200-962-3 | 76-44-8 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H311 H301 H373 ** H410 |
|||
| 602-047-00-8 | chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan |
200-349-0 | 57-74-9 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H312 H302 H410 |
|||
| 602-048-00-3 | aldrin (ISO) | 206-215-8 | 309-00-2 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H311 H301 H372 ** H410 |
|||
| 602-049-00-9 | dieldrin (ISO) | 200-484-5 | 60-57-1 | Carc. 2 Acute Tox. 1 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H310 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H310 H301 H372 ** H410 |
|||
| 602-050-00-4 | isodrin; (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene |
207-366-2 | 465-73-6 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
M=100 | ||
| 602-051-00-X | endrin (ISO); 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene |
200-775-7 | 72-20-8 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Gef. |
H300 H311 H410 |
|||
| 602-052-00-5 | endosulfan (ISO); 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite |
204-079-4 | 115-29-7 | Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H312 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H312 H410 |
|||
| 602-053-00-0 | isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran |
206-045-4 | 297-78-9 | Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Gef. |
H310 H300 H400 |
|||
| 602-054-00-6 | 3-iodpropene; allyl iodide |
209-130-4 | 556-56-9 | Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Gef. |
H225 H314 |
|||
| 602-055-00-1 | bromoethane; ethyl bromide |
200-825-8 | 74-96-4 | Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H351 H332 H302 |
GHS02 GHS08 GHS07 Gef. |
H225 H351 H332 H302 |
|||
| 602-056-00-7 | α, α,α-trifluorotoluene; benzotrifluoride |
202-635-0 | 98-08-8 | Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Gef. |
H225 H411 |
|||
| 602-057-00-2 | α-bromotoluene; benzyl bromide |
202-847-3 | 100-39-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
|||
| 602-058-00-8 | α, α-dichlorotoluene; benzylidene chloride; benzal chloride |
202-709-2 | 98-87-3 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H351 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Gef. |
H351 H331 H302 H335 H315 H318 |
|||
| 602-059-00-3 | 1-chlorobutane; butyl chloride |
203-696-6 | 109-69-3 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 602-060-00-9 | bromobenzene | 203-623-8 | 108-86-1 | Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H315 H411 |
GHS02 GHS07 GHS09 Achtg. |
H226 H315 H411 |
|||
| 602-061-00-4 | hexafluoropropene; hexafluoropropylene |
204-127-4 | 116-15-4 | Press. Gas Acute Tox. 4 * STOT SE 3 |
H332 H335 |
GHS07 Achtg. |
H332 H335 |
U | ||
| 602-062-00-X | 1,2,3-trichloropropane | 202-486-1 | 96-18-4 | Carc. 1B Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H350 H360F *** H332 H312 H302 |
GHS08 GHS07 Gef. |
H350 H360F *** H332 H312 H302 |
D | ||
| 602-063-00-5 | heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane |
213-831-0 | 1024-57-3 | Carc. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H301 H373 ** H410 |
|||
| 602-064-00-0 | 1,3-dichloro-2-propanol | 202-491-9 | 96-23-1 | Carc. 1B Acute Tox. 3 * Acute Tox. 4 * |
H350 H301 H312 |
GHS06 GHS08 Gef. |
H350 H301 H312 |
|||
| 602-065-00-6 | hexachlorobenzene | 204-273-9 | 118-74-1 | Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372 ** H400 H410 |
GHS08 GHS09 Gef. |
H350 H372 ** H410 |
|||
| 602-066-00-1 | tetrachloro-p-benzoquinone | 204-274-4 | 118-75-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
|||
| 602-067-00-7 | 1,3-dichlorbenzene | 208-792-1 | 541-73-1 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 602-068-00-2 | ethylene bis(trichloroacetate) | 219-732-9 | 2514-53-6 | Skin Irrit. 2 | H315 | GHS07 Achtg. |
H315 | |||
| 602-069-00-8 | dichloroacetylene | - | 7572-29-4 | Unst. Expl. Carc. 2 STOT RE 2 * |
H200 H351 H373 ** |
GHS01 GHS08 Achtg. |
H200 H351 H373 ** |
|||
| 602-070-00-3 | 3-chloro-4,5,α, α,α-pentafluorotoluene | 401-930-3 | 77227-99-7 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H332 H302 H400 |
GHS02 GHS07 GHS09 Achtg. |
H226 H332 H302 H400 |
|||
| 602-071-00-9 | bromobenzylbromotoluene, reaction mass of isomers | 402-210-1 | 99688-47-8 | STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H373 ** H317 H410 |
|||
| 602-072-00-4 | dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) |
278-404-3 | 76253-60-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 602-073-00-X | 1,4-dichlorobut-2-ene | 212-121-8 | 764-41-0 | Carc. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H330 H311 H301 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H350 H330 H311 H301 H314 H410 |
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 % |
||
| 602-074-00-5 | pentachlorobenzene | 210-172-0 | 608-93-5 | Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Gef. |
H228 H302 H410 |
T | ||
| 602-075-00-0 | 4,4,5,5-tetrachloro-1,3-dioxolan-2-one | 404-060-2 | 22432-68-4 | Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS05 Gef. |
H330 H302 H314 |
|||
| 602-076-00-6 | 2,3,4-trichlorobut-1-ene | 219-397-9 | 2431-50-7 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H302 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H331 H302 H319 H335 H315 H410 |
Carc. 2; H351: C ≥ 0,1 % | ||
| 602-077-00-1 | dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex |
219-196-6 | 2385-85-5 | Carc. 2 Repr. 2 Lact. Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H362 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H361fd H362 H312 H302 H410 |
|||
| 602-078-00-7 | hexachlorocyclopentadiene | 201-029-3 | 77-47-4 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H302 H314 H400 H410 |
GHS06 GHS05 GHS09 Gef. |
H330 H311 H302 H314 H410 |
|||
| 602-079-00-2 | 2,3-dichloropropene; 2,3-dichloropropylene |
201-153-8 | 78-88-6 | Flam. Liq. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
GHS02 GHS08 GHS05 GHS07 Gef. |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
|||
| 602-080-00-8 | alkanes, C10-13, chloro; chlorinated paraffins, C10-13 |
287-476-5 | 85535-84-8 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
EUH066 | ||
| 602-081-00-3 | 2-chloro-4,5-difluorobenzoic acid | 405-380-5 | - | Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H312 H302 H318 H317 |
GHS05 GHS07 Gef. |
H312 H302 H318 H317 |
|||
| 602-082-00-9 | 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol | 408-020-5 | 109678-33-3 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 602-083-00-4 | diphenyl ether, pentabromo derivative pentabromodiphenyl ether | 251-084-2 | 32534-81-9 | STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H362 H400 H410 |
GHS08 GHS09 Achtg. |
H373 ** H362 H410 |
|||
| 602-084-00-X | 1,1-dichloro-1-fluoroethane | 404-080-1 | 1717-00-6 | Aquatic Chronic 3 Ozone 1 |
H412 H420 |
GHS07 Achtg. |
H412 H420 |
|||
| 602-085-00-5 | 2-bromopropane | 200-855-1 | 75-26-3 | Flam. Liq. 2 Repr. 1a STOT RE 2 * |
H225 H360F *** H373 ** |
GHS02 GHS08 Gef. |
H225 H360F *** H373 ** |
EUH066 | ||
| 602-086-00-0 | trifluoroiodomethane; trifluoromethyl iodide |
219-014-5 | 2314-97-8 | Muta. 2 | H341 | GHS08 Achtg. |
H341 | |||
| 602-087-00-6 | 1,2,4-trichlorobenzene | 204-428-0 | 120-82-1 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H315 H410 |
|||
| 602-088-00-1 | 2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol |
202-480-9 | 96-13-9 | Carc. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H350 H361f *** H311 H332 H302 H412 |
GHS08 GHS07 Gef. |
H350 H361f *** H311 H332 H302 H412 |
|||
| 602-089-00-7 | 4-bromo-2-chlorofluorobenzene | 405-580-2 | 60811-21-4 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H315 H410 |
|||
| 602-090-00-2 | 1-allyl-3-chloro-4-fluorobenzene | 406-630-6 | 121626-73-1 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 602-091-00-8 | 1,3-dichloro-4-fluorobenzene | 406-160-1 | 1435-48-9 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 |
H302 H373 ** H315 H411 |
GHS08 GHS07 Achtg. |
H302 H373 ** H315 H411 |
|||
| 602-092-00-3 | 1-bromo-3,4,5-trifluorobenzene | 418-480-9 | 138526-69-9 | Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H351 H315 H318 H411 |
GHS02 GHS08 GHS05 GHS09 Gef. |
H226 H351 H315 H318 H411 |
|||
| 602-093-00-9 | α, α,α,4-tetrachlorotoluene; p-chlorobenzotrichloride |
226-009-1 | 5216-25-1 | Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H350 H361f *** H372 ** H312 H302 H335 H315 |
GHS08 GHS07 Gef. |
H350 H361f *** H372 ** H312 H302 H335 H315 |
|||
| 602-094-00-4 | diphenylether; octabromo derivate | 251-087-9 | 32536-52-0 | Repr. 1B | H360Df | GHS08 Gef. |
H360Df | |||
| 602-095-00-X | alkanes, C14-17, chloro; chlorinated paraffins, C14-17 |
287-477-0 | 85535-85-9 | Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Achtg. |
H362 H410 |
EUH066 | ||
| 602-096-00-5 | malachite green hydrochloride; [1] malachite green oxalate [2] |
209-322-8 [1] 219-441-7 [2] |
569-64-2 [1] 2437-29-8 [2] |
Repr. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H361d *** H302 H318 H410 |
|||
| 602-097-00-0 | 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane | 422-850-5 | 148757-89-5 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 602-098-00-6 | 2-(3-bromophenoxy)tetrahydro-2H-pyran | 429-030-6 | 57999-49-2 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 602-099-00-1 | 3-(4-fluorophenyl)-2-methylpropionylchloride | 426-370-7 | - | Skin Corr. 1a Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Gef. |
H314 H302 H412 |
EUH014 EUH029 |
||
| 602-100-00-5 | reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane |
420-640-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 602-101-00-0 | 2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate | 427-020-6 | 141772-37-4 | STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H373** H317 H410 |
|||
| 602-102-00-6 | 1,1,1,3,3-pentafluorobutane | 430-250-1 | 406-58-6 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 602-103-00-1 | 1-(chlorophenylmethyl)-2-methylbenzene | 431-450-1 | 41870-52-4 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 602-104-00-7 | 1,1,2,2,3,3,4-heptafluorocyclopentane | 430-710-1 | 15290-77-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | 422-100-7 | 102061-82-5 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 602-106-00-8 | 2-bromo-4,6-difluoroaniline | 429-430-0 | 444-14-4 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | 439-500-2 | 33831-83-3 | Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Achtg. |
H302 H315 H411 |
|||
| 602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | 443-840-7 | 4084-38-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Achtg. |
H302 H319 H317 |
|||
602-109-00-4 |
Hexabromocyclododecane [1] | 247-148-4 [1] | 25637-99-4[1] | Repr. 2 Lact. |
H361 H362 |
GHS08 Achtg. |
H361 H362 |
|||
| 1,2,5,6,9,10-hexabromocyclododecane [2] | 221-695-9[2] | 3194-55-6[2] | ||||||||
| 603-001-00-X | methanol | 200-659-6 | 67-56-1 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 |
H225 H331 H311 H301 H370 ** |
GHS02 GHS06 GHS08 Gef. |
H225 H331 H311 H301 H370 ** |
* STOT SE 1; H370: C ≥ 10 % STOT SE 2; H371: 3 % ≤ C < 10 % |
||
| 603-002-00-5 | ethanol; ethyl alcohol |
200-578-6 | 64-17-5 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 603-003-00-0 | propan-1-ol; n-propanol |
200-746-9 | 71-23-8 | Flam. Liq. 2 Eye Dam. 1 STOT SE 3 |
H225 H318 H336 |
GHS02 GHS05 GHS07 Gef. |
H225 H318 H336 |
|||
| 603-004-00-6 | butan-1-ol; n-butanol |
200-751-6 | 71-36-3 | Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H302 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Gef. |
H226 H302 H335 H315 H318 H336 |
|||
| 603-005-00-1 | 2-methylpropan-2-ol; tert-butyl alcohol |
200-889-7 | 75-65-0 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Gef. |
H225 H332 H319 H335 |
|||
| 603-006-00-7 | pentanol isomers, with the exception fo those specified elsewhere in this Annex | 250-378-8 | Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 |
H226 H332 H335 |
GHS02 GHS07 Achtg. |
H226 H332 H335 |
EUH066 | C | ||
| 603-007-00-2 | 2-methylbutan-2-ol; tert-pentanol |
200-908-9 | 75-85-4 | Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H225 H332 H335 H315 |
GHS02 GHS07 Gef. |
H225 H332 H335 H315 |
|||
| 603-008-00-8 | 4-methylpentan-2-ol; methyl isobutyl carbinol |
203-551-7 | 108-11-2 | Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Achtg. |
H226 H335 |
STOT SE 3; H335: C ≥ 25 % | ||
| 603-009-00-3 | cyclohexanol | 203-630-6 | 108-93-0 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H332 H302 H335 H315 |
GHS07 Achtg. |
H332 H302 H335 H315 |
|||
| 603-010-00-9 | 2-methylcyclohexanol, mixed isomers; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] |
209-512-0 [1] 231-187-9 [2] 231-186-3 [3] |
583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] |
Acute Tox. 4 * | H332 | GHS07 Achtg. |
H332 | C | ||
| 603-011-00-4 | 2-methoxyethanol; ethylene glycol monomethyl ether |
203-713-7 | 109-86-4 | Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Gef. |
H226 H360FD H332 H312 H302 |
|||
| 603-012-00-X | 2-ethoxyethanol; ethylene glycol monoethyl ether |
203-804-1 | 110-80-5 | Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H226 H360FD H331 H302 |
GHS02 GHS08 GHS06 Gef. |
H226 H360FD H331 H302 |
|||
| 603-013-00-5 | 2-isopropoxyethanol; ethylene glycol monoisopropyl ether |
203-685-6 | 109-59-1 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H332 H312 H319 |
GHS07 Achtg. |
H332 H312 H319 |
|||
| 603-014-00-0 | 2-butoxyethanol; ethylene glycol monobutyl ether; butyl cellosolve |
203-905-0 | 111-76-2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H332 H312 H302 H319 H315 |
GHS07 Achtg. |
H332 H312 H302 H319 H315 |
|||
| 603-015-00-6 | allyl alcohol | 203-470-7 | 107-18-6 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H331 H311 H301 H319 H335 H315 H400 |
GHS02 GHS06 GHS09 Gef. |
H225 H331 H311 H301 H319 H335 H315 H400 |
|||
| 603-016-00-1 | 4-hydroxy-4-methylpentan-2-one; diacetone alcohol |
204-626-7 | 123-42-2 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | Eye Irrit. 2; H319: C ≥ 10 % | ||
| 603-018-00-2 | furfuryl alcohol | 202-626-1 | 98-00-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 |
H351 H331 H312 H302 H373** H319 H335 |
GHS06 GHS08 Gef. |
H351 H331 H312 H302 H373** H319 H335 |
|||
| 603-019-00-8 | dimethyl ether | 204-065-8 | 115-10-6 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 603-020-00-3 | ethyl methyl ether | - | 540-67-0 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | U | ||
| 603-021-00-9 | methyl vinyl ether | 203-475-4 | 107-25-5 | Flam. Gas 1 Press. Gas |
H220 | GHS02 GHS04 Gef. |
H220 | D U | ||
| 603-022-00-4 | diethyl ether; ether |
200-467-2 | 60-29-7 | Flam. Liq. 1 Acute Tox. 4 * STOT SE 3 |
H224 H302 H336 |
GHS02 GHS07 Gef. |
H224 H302 H336 |
EUH019 EUH066 |
||
| 603-023-00-X | ethylene oxide; oxirane |
200-849-9 | 75-21-8 | Press. Gas Flam. Gas 1 Carc. 1B Muta. 1B Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H220 H350 H340 H331 H319 H335 H315 |
GHS02 GHS04 GHS06 GHS08 Gef. |
H220 H350 H340 H331 H319 H335 H315 |
U | ||
| 603-024-00-5 | 1,4-dioxane | 204-661-8 | 123-91-1 | Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS08 GHS07 Gef. |
H225 H351 H319 H335 |
EUH019 EUH066 |
D | |
| 603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS07 GHS08 Gef. |
H225 H351 H319 H335 |
EUH019 | STOT SE 3; H335: C ≥ 25 % Eye Irrit.2; H319: C ≥ 25 % |
|
| 603-026-00-6 | 1-chloro-2,3-epoxypropane; epichlorhydrin |
203-439-8 | 106-89-8 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Gef. |
H226 H350 H331 H311 H301 H314 H317 |
* | ||
| 603-027-00-1 | ethanediol; ethylene glycol |
203-473-3 | 107-21-1 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 603-028-00-7 | 2-chloroethanol; ethylene chlorohydrin |
203-459-7 | 107-07-3 | Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Gef. |
H330 H310 H300 |
|||
| 603-029-00-2 | bis(2-chloroethyl) ether | 203-870-1 | 111-44-4 | Carc. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H351 H330 H310 H300 |
GHS06 GHS08 Gef. |
H351 H330 H310 H300 |
|||
| 603-030-00-8 | 2-aminoethanol; ethanolamine |
205-483-3 | 141-43-5 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H332 H312 H302 H314 |
GHS05 GHS07 Gef. |
H332 H312 H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 603-031-00-3 | 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME |
203-794-9 | 110-71-4 | Flam. Liq. 2 Repr. 1B Acute Tox. 4 * |
H225 H360FD H332 |
GHS02 GHS08 GHS07 Gef. |
H225 H360FD H332 |
EUH019 | ||
| 603-032-00-9 | ethylene dinitrate; ethylene glycol dinitrate |
211-063-0 | 628-96-6 | Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 |
H200 H330 H310 H300 H373** |
GHS01 GHS06 GHS08 Gef. |
H200 H330 H310 H300 H373** |
|||
| 603-033-00-4 | oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate |
211-745-8 | 693-21-0 | Unst. Expl Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H200 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Gef. |
H200 H330 H310 H300 H373 ** H412 |
|||
| 603-033-01-1 | oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate; [>25 % phlegmatiser] |
211-745-8 | 693-21-0 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H201 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Gef. |
H201 H330 H310 H300 H373 ** H412 |
|||
| 603-034-00-X | glycerol trinitrate; nitroglycerine |
200-240-8 | 55-63-0 | Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H200 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H200 H330 H310 H300 H373 ** H411 |
|||
| 603-034-01-7 | glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser] |
200-240-8 | 55-63-0 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H201 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H330 H310 H300 H373 ** H411 |
|||
| 603-035-00-5 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N. |
201-084-3 | 78-11-5 | Unst. Expl. | H200 | GHS01 Gef. |
H200 | |||
| 603-035-01-2 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.; [>20 % phlegmatiser] |
201-084-3 | 78-11-5 | Expl. 1.1 | H201 | GHS01 Gef. |
H201 | T | ||
| 603-036-00-0 | mannitol hexanitrate; nitromannite |
239-924-6 | 15825-70-4 | Unst. Expl. | H200 | GHS01 Gef. |
H200 | |||
| 603-036-01-8 | mannitol hexanitrate; nitromannite; [≥40 % phlegmatiser] |
239-924-6 | 15825-70-4 | Expl. 1.1 | H201 | GHS01 Gef. |
H201 | |||
| 603-037-00-6 | cellulose nitrate; nitrocellulose |
- | - | Expl. 1.1 | H201 | GHS01 Gef. |
H201 | T | ||
| 603-038-00-1 | allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether |
203-442-4 | 106-92-3 | Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
GHS02 GHS08 GHS05 GHS07 Gef. |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
|||
| 603-039-00-7 | butyl glycidyl ether; butyl 2,3-epoxypropyl ether |
219-376-4 | 2426-08-6 | Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H332 H302 H335 H317 H412 |
GHS02 GHS08 GHS07 Achtg. |
H226 H351 H341 H332 H302 H335 H317 H412 |
|||
| 603-040-00-2 | sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3] |
204-699-5 [1] 212-736-1 [2] 212-737-7 [3] |
124-41-4 [1] 865-33-8 [2] 865-34-9 [3] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Gef. |
H251 H314 |
EUH014 | T | |
| 603-041-00-8 | potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2] |
213-029-0 [1] 205-487-5 [2] |
917-58-8 [1] 141-52-6 [2] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Gef. |
H251 H314 |
EUH014 | T | |
| 603-042-00-3 | aluminium-tri-isopropoxide | 209-090-8 | 555-31-7 | Flam. Sol. 1 | H228 | GHS02 Gef. |
H228 | T | ||
| 603-043-00-9 | triarimol (ISO); 2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol |
- | 26766-27-8 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 603-044-00-4 | dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol |
204-082-0 | 115-32-2 | Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H315 H317 H410 |
|||
| 603-045-00-X | diisopropyl ether; [1] dipropyl ether [2] |
203-560-6 [1] 203-869-6 [2] |
108-20-3 [1] 111-43-3 [2] |
Flam. Liq. 2 STOT SE 3 |
H225 H336 |
GHS02 GHS07 Gef. |
H225 H336 |
EUH019 EUH066 |
C | |
| 603-046-00-5 | bis(chloromethyl) ether; oxybis(chloromethane) |
208-832-8 | 542-88-1 | Flam. Liq. 2 Carc. 1a Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * |
H225 H350 H330 H311 H302 |
GHS02 GHS06 GHS08 Gef. |
H225 H350 H330 H311 H302 |
Carc. 1A; H350: C ≥ 0,001 % | ||
| 603-047-00-0 | 2-dimethylaminoethanol; N,N-dimethylethanolamine |
203-542-8 | 108-01-0 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Gef. |
H226 H332 H312 H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 603-048-00-6 | 2-diethylaminoethanol; N,N-diethylethanolamine |
202-845-2 | 100-37-8 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H226 H332 H312 H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 603-049-00-1 | chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol |
201-246-3 | 80-06-8 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 603-050-00-7 | 1-(2-butoxypropoxy)propan-2-ol | 246-011-6 | 24083-03-2 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 603-051-00-2 | 2-ethylbutan-1-ol | 202-621-4 | 97-95-0 | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 603-052-00-8 | 3-butoxypropan-2-ol; propylene glycol monobutyl ether |
225-878-4 | 5131-66-8 | Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Achtg. |
H319 H315 |
|||
| 603-053-00-3 | 2-methylpentane-2,4-diol | 203-489-0 | 107-41-5 | Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Achtg. |
H319 H315 |
|||
| 603-054-00-9 | di-n-butyl ether; dibutyl ether |
205-575-3 | 142-96-1 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H226 H319 H335 H315 H412 |
GHS02 GHS07 Achtg. |
H226 H319 H335 H315 H412 |
STOT SE 3; H335: C ≥ 10 % | ||
| 603-055-00-4 | Propylenoxid; 1,2-Epoxypropan; Methyloxiran |
200-879-2 | 75-56-9 | Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 |
H224 H350 H340 H331 H311 H302 H335 H319 |
GHS02 GHS08 GHS06 Gef. |
H224 H350 H340 H331 H311 H302 H335 H319 |
|||
| 603-056-00-X | [(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2] 2,3-epoxypropylo-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4] |
218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] |
2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] |
Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H315 H317 H411 |
GHS08 GHS07 GHS09 Achtg. |
H341 H315 H317 H411 |
C | ||
| 603-057-00-5 | benzyl alcohol | 202-859-9 | 100-51-6 | Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Achtg. |
H332 H302 |
|||
| 603-058-00-0 | 1,3-propylene oxide | 207-964-3 | 503-30-0 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 |
|||
| 603-059-00-6 | hexan-1-ol | 203-852-3 | 111-27-3 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 603-060-00-1 | 2,2'-bioxirane; 1,2:3,4-diepoxybutane |
215-979-1 | 1464-53-5 | Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H350 H340 H330 H311 H301 H314 |
GHS06 GHS08 GHS05 Gef. |
H350 H340 H330 H311 H301 H314 |
|||
| 603-061-00-7 | tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol |
202-625-6 | 97-99-4 | Repr. 1B Eye Irrit. 2 |
H360Df H319 |
GHS08 GHS07 Gef. |
H360Df H319 |
|||
| 603-062-00-2 | tetrahydrofuran-2,5-diyldimethanol | 203-239-0 | 104-80-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
STOT SE 3; H335: C ≥ 10 % | ||
| 603-063-00-8 | 2,3-epoxypropan-1-ol; glycidol; oxiranemethanol |
209-128-3 | 556-52-5 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
GHS06 GHS08 Gef. |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
|||
| 603-064-00-3 | 1-methoxy-2-propanol; monopropylene glycol methyl ether |
203-539-1 | 107-98-2 | Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Achtg. |
H226 H336 |
|||
| 603-065-00-9 | resorcinol diglycidyl ether; 1,3-bis(2,3-epoxypropoxy)benzene |
202-987-5 | 101-90-6 | Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H351 H341 H312 H302 H319 H315 H317 H412 |
GHS08 GHS07 Achtg. |
H351 H341 H312 H302 H319 H315 H317 H412 |
|||
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide |
203-437-7 | 106-87-6 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H351 H331 H311 H301 |
GHS06 GHS08 Gef. |
H351 H331 H311 H301 |
* | ||
| 603-067-00-X | phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropane |
204-557-2 | 122-60-1 | Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H332 H335 H315 H317 H412 |
GHS08 GHS07 Gef. |
H350 H341 H332 H335 H315 H317 H412 |
|||
| 603-068-00-5 | 2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether |
- | 130014-35-6 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
|||
| 603-069-00-0 | 2,4,6-tris(dimethylaminomethyl)phenol | 202-013-9 | 90-72-2 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Achtg. |
H302 H319 H315 |
|||
| 603-070-00-6 | 2-amino-2-methylpropanol | 204-709-8 | 124-68-5 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Achtg. |
H319 H315 H412 |
|||
| 603-071-00-1 | 2,2'-iminodiethanol; diethanolamine |
203-868-0 | 111-42-2 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Gef. |
H302 H373 ** H315 H318 |
|||
| 603-072-00-7 | 1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether |
219-371-7 | 2425-79-8 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H312 H319 H315 H317 |
GHS07 Achtg. |
H332 H312 H319 H315 H317 |
|||
| 603-073-00-2 | bis-[4-(2,3-epoxipropoxi)phenyl]propane | 216-823-5 | 1675-54-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |
||
| 603-074-00-8 | reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700) |
500-033-5 | 25068-38-6 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H317 H411 |
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |
||
| 603-075-00-3 | chlormethyl methyl ether; chlorodimethyl ether |
203-480-1 | 107-30-2 | Flam. Liq. 2 Carc. 1a Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H332 H312 H302 |
GHS02 GHS08 GHS07 Gef. |
H225 H350 H332 H312 H302 |
|||
| 603-076-00-9 | but-2-yne-1,4-diol; 2-butyne-1,4-diol |
203-788-6 | 110-65-6 | Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H331 H301 H312 H373 ** H317 |
GHS06 GHS05 GHS08 Gef. |
H314 H331 H301 H312 H373 ** H317 |
Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 25 % ≤ C < 50 % Eye Irrit. 2; H319: 25 % ≤ C < 50 % |
D | |
| 603-077-00-4 | 1-dimethylaminopropan-2-ol; dimepranol (INN) |
203-556-4 | 108-16-7 | Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B |
H226 H302 H314 |
GHS02 GHS05 GHS07 Gef. |
H226 H302 H314 |
|||
| 603-078-00-X | prop-2-yn-1-ol; propargyl alcohol |
203-471-2 | 107-19-7 | Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H311 H301 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Gef. |
H226 H331 H311 H301 H314 H411 |
|||
| 603-079-00-5 | 2,2'-(methylimino)diethanol; N-methyldiethanolamine |
203-312-7 | 105-59-9 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-080-00-0 | 2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol |
203-710-0 | 109-83-1 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 603-081-00-6 | 2,2'-thiodiethanol; thiodiglycol |
203-874-3 | 111-48-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-082-00-1 | 1-aminopropan-2-ol; isopropanolamine |
201-162-7 | 78-96-6 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 603-083-00-7 | 1,1'-iminodipropan-2-ol; di-isopropanolamine |
203-820-9 | 110-97-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-084-00-2 | styrene oxide; (epoxyethyl)benzene; phenyloxirane |
202-476-7 | 96-09-3 | Carc. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H312 H319 |
GHS08 GHS07 Gef. |
H350 H312 H319 |
|||
| 603-085-00-8 | bronopol (INN); 2-bromo-2-nitropropane-1,3-diol |
200-143-0 | 52-51-7 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H312 H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Gef. |
H312 H302 H335 H315 H318 H400 |
M=10 | ||
| 603-086-00-3 | ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol |
245-949-3 | 23947-60-6 | Acute Tox. 4 * | H312 | GHS07 Achtg. |
H312 | |||
| 603-087-00-9 | 2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol |
202-377-9 | 94-96-2 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-088-00-4 | 2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide |
222-598-4 | 3547-33-9 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-089-00-X | 7,7-dimethyl-3-oxa-6-azaoctan-1-ol | 400-390-6 | - | Skin Corr. 1a Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Gef. |
H314 H302 |
|||
| 603-090-00-5 | 2-(2-bromoethoxy)anisole | 402-010-4 | 4463-59-6 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-091-00-0 | exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol | 402-470-6 | 87172-89-2 | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 603-092-00-6 | 2-methyl-4-phenylpentanol | 402-770-7 | 92585-24-5 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 603-093-00-1 | cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane |
402-410-9 | 87818-31-3 | Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Gef. |
H332 H411 |
|||
| 603-094-00-7 | 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane | 241-536-7 | 17557-23-2 | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 603-095-00-2 | 2-(propyloxy)ethanol; EGPE |
220-548-6 | 2807-30-9 | Acute Tox. 4 * Eye Irrit. 2 |
H312 H319 |
GHS07 Achtg. |
H312 H319 |
|||
| 603-096-00-8 | 2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether |
203-961-6 | 112-34-5 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-097-00-3 | 1,1′,1″-nitrilotripropan-2-ol; triisopropanolamine |
204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-098-00-9 | 2-phenoxyethanol | 204-589-7 | 122-99-6 | Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 603-099-00-4 | 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride | 403-440-5 | 93633-79-5 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-100-00-8 | 1,2-dimethoxypropane | 404-630-0 | 7778-85-0 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | EUH019 | ||
| 603-101-00-3 | tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis andtrans) | 405-040-6 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-102-00-9 | 1,2-Epoxybutan | 203-438-2 | 106-88-7 | Flam. Liq. 2 Carc. 2 Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 |
H225 H351 H302 H312 H332 H335 H315 H319 |
GHS02 GHS08 GHS07 Gef. |
H225 H351 H302 H312 H332 H335 H315 H319 |
|||
| 603-103-00-4 | oxirane, mono[(C12-14-alkyloxy)methyl] derivs. | 271-846-8 | 68609-97-2 | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 603-104-00-X | fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol |
262-095-7 | 60168-88-9 | Repr. 2 Lact. Aquatic Chronic 2 |
H361fd H362 H411 |
GHS08 GHS09 Achtg. |
H361fd H362 H411 |
|||
| 603-105-00-5 | furan | 203-727-3 | 110-00-9 | Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
GHS02 GHS08 GHS07 Gef. |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
EUH019 | ||
| 603-106-00-0 | 2-methoxypropanol | 216-455-5 | 1589-47-5 | Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H360D *** H335 H315 H318 |
GHS02 GHS08 GHS05 GHS07 Gef. |
H226 H360D *** H335 H315 H318 |
|||
| 603-107-00-6 | 2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether |
203-906-6 | 111-77-3 | Repr. 2 | H361d *** | GHS08 Achtg. |
H361d *** | |||
| 603-108-00-1 | 2-methylpropan-1-ol; iso-butanol |
201-148-0 | 78-83-1 | Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Gef. |
H226 H335 H315 H318 H336 |
|||
| 603-109-00-7 | reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane |
425-340-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-110-00-2 | reaction mass of:cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane |
426-130-1 | 166301-21-9 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 603-111-00-8 | reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane |
426-530-6 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 603-112-00-3 | cyclopentyl 2-phenylethyl ether | 428-340-9 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 603-113-00-9 | 6-glycidyloxynapht-1-yl oxymethyloxirane | 429-960-2 | 27610-48-6 | Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H341 H312 H315 H317 H412 |
GHS08 GHS07 Achtg. |
H341 H312 H315 H317 H412 |
|||
| 603-114-00-4 | 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene | 430-830-2 | 26912-64-1 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 603-115-00-X | reaction mass of:O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-580-0 | - | STOT RE 2 * Aquatic Chronic 4 |
H373** H413 |
GHS08 Achtg. |
H373** H413 |
|||
| 603-116-00-5 | (Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride | 424-740-2 | 138271-16-6 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 603-117-00-0 | propan-2-ol; isopropyl alcohol; isopropanol |
200-661-7 | 67-63-0 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
|||
| 603-118-00-6 | 6-dimethylaminohexan-1-ol | 404-680-3 | 1862-07-3 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Gef. |
H302 H314 H412 |
|||
| 603-119-00-1 | 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) | 405-840-5 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 603-120-00-7 | 2-methyl-5-phenylpentanol | 405-890-8 | 25634-93-9 | Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Achtg. |
H319 H315 |
|||
| 603-121-00-2 | 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone | 406-057-1 | 114565-66-1 | Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Achtg. |
H351 H317 H413 |
|||
| 603-122-00-8 | sodium 2-ethylhexanolate | 406-150-7 | 38411-13-1 | Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 |
H228 H314 H412 |
GHS02 GHS05 Gef. |
H228 H314 H412 |
T | ||
| 603-123-00-3 | 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol | 406-330-5 | 122760-84-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Achtg. |
H315 H317 H411 |
|||
| 603-124-00-9 | 1,4-bis[2-(vinyloxy)ethoxy]benzene | 406-900-3 | 84563-49-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-125-00-4 | 2-(2,4-dichlorophenyl)-1-(1H - 1,2,4-triazol-1-yl)pent-4-en-2-ol | 407-850-5 | 89544-40-1 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 603-126-00-X | 2-((4-methyl-2-nitrophenyl)amino)ethanol | 408-090-7 | 100418-33-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Achtg. |
H302 H317 H412 |
|||
| 603-127-00-5 | butan-2-ol; [1] (S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4] |
201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] |
78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H226 H319 H335 H336 |
GHS02 GHS07 Achtg. |
H226 H319 H335 H336 |
C | ||
| 603-128-00-0 | 2-(phenylmethoxy)naphthalene | 405-490-3 | 613-62-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-129-00-6 | 1-tert-butoxypropan-2-ol | 406-180-0 | 57018-52-7 | Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Gef. |
H226 H318 |
|||
| 603-130-00-1 | reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) | 406-325-8 | - | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-131-00-7 | reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) |
407-290-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-132-00-2 | 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane | 408-200-3 | 63187-91-7 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Gef. |
H315 H318 H412 |
|||
| 603-133-00-8 | reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) |
408-240-1 | - | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-134-00-3 | reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. | 410-450-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-135-00-9 | bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium | 410-500-4 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 603-136-00-4 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | 410-910-3 | 104226-19-9 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 603-137-00-X | reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol |
411-130-6 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-138-00-5 | 3-(2,2-dimethyl-3-hydroxypropyl)toluene; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol |
403-140-4 | 103694-68-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-139-00-0 | bis(2-methoxyethyl) ether | 203-924-4 | 111-96-6 | Flam. Liq. 3 Repr. 1B |
H226 H360FD |
GHS02 GHS08 Gef. |
H226 H360FD |
EUH019 | ||
| 603-140-00-6 | 2,2' -oxybisethanol; diethylene glycol |
203-872-2 | 111-46-6 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 603-141-00-1 | reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane |
413-780-6 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-142-00-7 | 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane | 407-360-1 | 116230-20-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H373 ** H315 H318 |
GHS06 GHS08 GHS05 Gef. |
H312 H302 H373 ** H315 H318 |
|||
| 603-143-00-2 | R - 2,3-epoxy-1-propanol | 404-660-4 | 57044-25-4 | Self-react. C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
GHS02 GHS06 GHS08 GHS05 Gef. |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
|||
| 603-144-00-8 | reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol |
413-530-6 | 111850-00-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-145-00-3 | 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane | 406-970-5 | 129228-11-1 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 603-146-00-9 | 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol | 406-080-7 | 83016-70-0 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Gef. |
H302 H314 H412 |
|||
| 603-147-00-4 | (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 406-030-4 | 105812-81-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 603-148-00-X | 1,4-bis[(vinyloxy)methyl]cyclohexane | 413-370-7 | 17351-75-6 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 603-149-00-5 | reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane | 407-640-3 | 63767-86-2 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H411 |
|||
| 603-150-00-0 | (±)trans - 3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol | 411-580-3 | 107898-54-4 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 603-151-00-6 | (±)-2-(2,4-dichlorophenyl)-3-(1H - 1,2,4-triazol-1-yl)propan-1-ol | 413-570-4 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-152-00-1 | 2-(4-tert-butylphenyl)ethanol | 410-020-5 | 5406-86-0 | Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H373 ** H318 H411 |
GHS08 GHS05 GHS09 Gef. |
H361f *** H373 ** H318 H411 |
|||
| 603-153-00-7 | 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol | 410-010-0 | 104333-00-8 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-154-00-2 | 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol | 412-300-2 | 139504-68-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-156-00-3 | 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane | 411-210-0 | 89544-48-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 603-157-00-9 | 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol | 411-450-6 | 143747-72-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-158-00-4 | reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene | 412-460-3 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 603-159-00-X | 2-cyclododecylpropan-1-ol | 411-410-8 | 118562-73-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-160-00-5 | 1,2-diethoxypropane | 412-180-1 | 10221-57-5 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | EUH019 | ||
| 603-161-00-0 | 1,3-diethoxypropane | 413-140-6 | 3459-83-4 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | |||
| 603-162-00-6 | α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] | 413-420-8 | 144736-29-8 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H411 |
|||
| 603-163-00-1 | 2-phenyl-1,3-propanediol | 411-810-2 | 1570-95-2 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-164-00-7 | 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole | 412-420-5 | 133909-99-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-165-00-2 | reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol |
417-470-1 | - | Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Achtg. |
H341 H317 |
|||
| 603-166-00-8 | R-1-chloro-2,3-epoxypropane | 424-280-2 | 51594-55-9 | Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Gef. |
H226 H350 H331 H311 H301 H314 H317 |
|||
| 603-167-00-3 | 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol | 407-920-5 | 6390-69-8 | Aquatic Chronic 4 | H413 | GHS05 Gef. |
H413 | |||
| 603-168-00-9 | 3-(2-ethylhexyloxy)propane-1,2-diol | 408-080-2 | 70445-33-9 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 603-169-00-4 | (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 415-550-0 | 109887-53-8 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 603-170-00-X | reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol |
415-990-3 | 67739-11-1 | Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Achtg. |
H319 H411 |
|||
| 603-171-00-5 | 5-thiazolylmethanol | 414-780-9 | 38585-74-9 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 603-172-00-0 | mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanoltrans-butenedioate | 415-180-1 | 773058-82-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 603-173-00-6 | 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane | 421-750-9 | 57280-22-5 | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 603-174-00-1 | 4-cyclohexyl-2-methyl-2-butanol | 420-630-3 | 83926-73-2 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 603-175-00-7 | 2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol |
203-988-3 | 112-59-4 | Acute Tox. 4 * Eye Dam. 1 |
H312 H318 |
GHS05 GHS07 Gef. |
H312 H318 |
|||
| 603-176-00-2 | 1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme |
203-977-3 | 112-49-2 | Repr. 1B | H360Df | GHS08 Gef. |
H360Df | EUH019 | ||
| 603-177-00-8 | 1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEa [2] |
216-374-5 [1] 259-370-9 [2] |
1569-02-4 [1] 54839-24-6 [2] |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Achtg. |
H226 H336 |
|||
| 603-178-00-3 | 2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol |
203-951-1 | 112-25-4 | Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
|||
| 603-179-00-9 | ergocalciferol (ISO); Vitamin D2 |
200-014-9 | 50-14-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Gef. |
H330 H311 H301 H372 ** |
|||
| 603-180-00-4 | colecalciferol; Vitamin D3 |
200-673-2 | 67-97-0 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Gef. |
H330 H311 H301 H372 ** |
|||
| 603-181-00-X | tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane |
216-653-1 | 1634-04-4 | Flam. Liq. 2 Skin Irrit. 2 |
H225 H315 |
GHS02 GHS07 Gef. |
H225 H315 |
|||
| 603-182-00-5 | reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L.,Brassica rapa L.,Helianthus annuus L.,Glycine hispida,Gossypium hirsutumL.,Cocos nucifera L.,Elaeis guineensis) withO,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide | 428-630-5 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 603-183-00-0 | 2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutyl ether; butoxytriethylene glycol |
205-592-6 | 143-22-6 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | Eye Dam. 1; H318: C ≥ 30 % Eye Irrit. 2; H319: 20 % ≤ C < 30 % |
||
| 603-184-00-6 | 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol | 416-380-1 | 146925-83-9 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-185-00-1 | 2,4-dichloro-3-ethyl-6-nitrophenol | 420-740-1 | 99817-36-4 | Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Gef. |
H301 H318 H317 H410 |
|||
| 603-186-00-7 | trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | 419-050-3 | 79944-37-9 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 603-187-00-2 | 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride | 419-360-9 | 163661-77-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-188-00-8 | reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene |
426-970-9 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-189-00-3 | reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol | 405-250-8 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-190-00-9 | 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane | 424-030-2 | 62406-73-9 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 603-191-00-4 | 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol | 419-740-4 | 137658-79-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-192-00-X | (E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol | 423-240-1 | 125474-34-2 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 603-193-00-5 | disodium 9,10-anthracenedioxide | 426-030-8 | 46492-07-3 | Skin Corr. 1A | H314 | GHS05 Gef. |
H314 | |||
| 603-194-00-0 | 2-(2-aminoethylamino)ethanol; (AEEA) |
203-867-5 | 111-41-1 | Repr. 1B Skin Corr. 1B Skin Sens. 1 |
H360Df H314 H317 |
GHS05 GHS08 GHS07 Gef. |
H360Df H314 H317 |
STOT SE 3; H335: C ≥ 5 % | ||
| 603-195-00-6 | 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol | 430-810-3 | 154825-62-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-196-00-1 | 2-(7-ethyl-1H-indol-3-yl)ethanol | 431-020-1 | 41340-36-7 | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 ** H411 |
|||
| 603-197-00-7 | Tebuconazol (ISO); 1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol | 403-640-2 | 107534-96-3 | Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H302 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361d*** H302 H410 |
M = 1 M = 10 |
||
| 603-199-00-8 | etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole |
- | 153233-91-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | M=100 | ||
| 603-200-00-1 | 1-pentanol; [1] 3-pentanol [2] |
200-752-1 [1] 209-526-7 [2] |
71-41-0 [1] 584-02-1 [2] |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H226 H332 H335 H315 |
GHS02 GHS07 Achtg. |
H226 H332 H335 H315 |
|||
| 603-201-00-7 | (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol | 416-120-5 | - | Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Achtg. |
H315 H413 |
|||
| 603-202-00-2 | 4,4,5,5,5-pentafluoropentan-1-ol | 421-360-9 | 148043-73-6 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 603-203-00-8 | (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane | 427-580-1 | - | Skin Irrit. 2 | H315 | GHS07 Achtg. |
H315 | |||
| 603-204-00-3 | reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane |
428-110-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-205-00-9 | (1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride | 426-200-1 | 172015-79-1 | STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H372** H302 H318 H317 H412 |
GHS05 GHS08 GHS07 Gef. |
H372** H302 H318 H317 H412 |
|||
| 603-206-00-4 | 2,2-dichloro-1,3-benzodioxol | 426-850-6 | 2032-75-9 | Flam. Liq. 3 Skin Corr. 1a Acute Tox. 4 * Skin Sens. 1 |
H226 H314 H302 H317 |
GHS02 GHS05 GHS07 Gef. |
H226 H314 H302 H317 |
EUH014 | ||
| 603-207-00-X | 2-isobutyl-2-isopropyl-1,3-dimethoxypropane | 430-800-9 | 129228-21-3 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 603-208-00-5 | 1,2-diethoxyethane | 211-076-1 | 629-14-1 | Flam. Liq. 2 Repr. 1a Eye Irrit. 2 |
H225 H360Df H319 |
GHS02 GHS08 GHS07 Gef. |
H225 H360Df H319 |
EUH019 | ||
| 603-209-00-0 | spinosad (ISO) (reaction mass of spinosyn a and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3] |
- [1] - [2] - [3] |
- [1] 131929-60-7 [2] 131929-63-0 [3] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | M=10 | ||
| 603-210-00-6 | 2,4-diethyl-1,5-pentanediol | 429-310-8 | 57987-55-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride ... %; glycidyl trimethylammonium chloride ... % |
221-221-0 | 3033-77-0 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Gef. |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
B | ||
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) |
214-946-9 | 1222-05-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 603-213-00-2 | 2-methoxy-2-methylbutane; tert-amyl methyl ether |
213-611-4 | 994-05-8 | Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 |
H225 H302 H336 |
GHS02 GHS07 Gef. |
H225 H302 H336 |
|||
| 603-214-00-8 | 1,1-diisopropoxycyclohexane | 413-740-8 | 1132-95-2 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 418-330-2 | 162241-33-0 | Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H302 H373** H318 H317 H400 H410 |
GHS01 GHS05 GHS08 GHS07 GHS09 Gef. |
H201 H302 H373** H318 H317 H410 |
|||
| 603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | 422-660-2 | 7480-35-5 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 603-217-00-4 | 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | 423-560-1 | 161717-32-4 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | 432-890-5 | 72955-94-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] |
433-580-2 | 214353-17-0 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H314 H411 |
|||
| 603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] |
433-580-2 | 214353-17-0 | Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H350 H302 H314 H411 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H350 H302 H314 H411 |
|||
| 603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | 433-820-6 | 118058-74-5 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 603-223-00-7 | 2-cyclopentylidene cyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol |
434-270-1 | 6261-30-9 | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Gef. |
H315 H318 H412 |
|||
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | 435-790-1 | 297730-93-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-225-00-8 | erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) |
437-070-0 | 13127-18-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-226-00-3 | 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | 444-500-0 | 1440-00-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate |
445-060-2 | 203574-04-3 | **** Aquatic Acute 1 Aquatic Chronic 1 |
**** H400 H410 |
**** GHS09 Achtg. |
**** H410 |
|||
| 603-228-00-4 | (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane |
419-620-1 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 603-229-00-X | sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | 420-800-7 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | 440-030-5 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 |
H315 H318 H413 |
GHS05 Gef. |
H315 H318 H413 |
|||
| 603-231-00-0 | (S)-1,1-diphenyl-1,2-propanediol | 443-220-6 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | 444-420-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 603-233-00-1 | reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol |
444-430-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | 444-480-3 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 603-235-00-2 | Linalool: 3,7-Dimethyl-1,6-octadien-3-ol; DL-Linalool; [1] Coriandrol; (S)-3,7-Dimethyl-1,6-octadien-3-ol; D- Linalool; [2] Licareol; (R)-3,7-Dimethyl-1,6-octadien-3-ol; L- Linalool [3] |
201-134-4 [1] 204-810-7 [2] 204-811-2 [3] |
78-70-6 [1] 126-90-9 [2] 126-91-0 [3] |
Skin Sens. 1B | H317 | GHS07 Achtg. | H317 | |||
| 604-001-00-2 | phenol; carbolic acid; monohydroxybenzene; phenylalcohol |
203-632-7 | 108-95-2 | Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B |
H341 H331 H311 H301 H373 ** H314 |
GHS06 GHS08 GHS05 Gef. |
H341 H331 H311 H301 H373 ** H314 |
* Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315: 1 % ≤ C < 3 % Eye Irrit. 2; H319: 1 % ≤ C < 3 % |
||
| 604-002-00-8 | pentachlorophenol | 201-778-6 | 87-86-5 | Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H330 H311 H301 H319 H335 H315 H410 |
|||
| 604-003-00-3 | sodium pentachlorophenolate; [1] potassium pentachlorophenolate [2] |
205-025-2 [1] 231-911-3 [2] |
131-52-2 [1] 7778-73-6 [2] |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H330 H311 H301 H319 H335 H315 H410 |
|||
| 604-004-00-9 | m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] |
203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] |
108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Gef. |
H311 H301 H314 |
* | C | |
| 604-005-00-4 | 1,4-dihydroxybenzene; hydroquinone; quinol |
204-617-8 | 123-31-9 | Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H302 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H351 H341 H302 H318 H317 H400 |
M=10 | ||
| 604-006-00-X | 3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7] |
202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] |
95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H301 H314 H411 |
GHS06 GHS05 GHS09 Gef. |
H311 H301 H314 H411 |
C | ||
| 604-007-00-5 | 2-naphthol | 205-182-7 | 135-19-3 | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Achtg. |
H332 H302 H400 |
|||
| 604-008-00-0 | 2-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4] |
202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] |
95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H312 H302 H411 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H411 |
C | ||
| 604-009-00-6 | pyrogallol; 1,2,3-trihydroxybenzene |
201-762-9 | 87-66-1 | Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H341 H332 H312 H302 H412 |
GHS08 GHS07 Achtg. |
H341 H332 H312 H302 H412 |
* | ||
| 604-010-00-1 | resorcinol; 1,3-benzenediol |
203-585-2 | 108-46-3 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H302 H319 H315 H400 |
GHS07 GHS09 Achtg. |
H302 H319 H315 H400 |
* | ||
| 604-011-00-7 | 2,4-dichlorophenol | 204-429-6 | 120-83-2 | Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Gef. |
H311 H302 H314 H411 |
|||
| 604-012-00-2 | 4-chloro-o-cresol; 4-chloro-2-methyl phenol |
216-381-3 | 1570-64-5 | Acute Tox. 3 * Skin Corr. 1a Aquatic Acute 1 |
H331 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H331 H314 H400 |
STOT SE 3; H335: C ≥ 1 % | ||
| 604-013-00-8 | 2,3,4,6-tetrachlorophenol | 200-402-8 | 58-90-2 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H315 H400 H410 |
GHS06 GHS09 Gef. |
H301 H319 H315 H410 |
* Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |
||
| 604-014-00-3 | chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol |
200-431-6 | 59-50-7 | Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H312 H302 H318 H317 H400 |
GHS05 GHS07 GHS09 Gef. |
H312 H302 H318 H317 H400 |
* | ||
| 604-015-00-9 | 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene |
200-733-8 | 70-30-4 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H311 H301 H410 |
* | ||
| 604-016-00-4 | 1,2-dihydroxybenzene; pyrocatechol |
204-427-5 | 120-80-9 | Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H312 H302 H319 H315 |
GHS07 Achtg. |
H312 H302 H319 H315 |
|||
| 604-017-00-X | 2,4,5-trichlorophenol | 202-467-8 | 95-95-4 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H315 H410 |
* Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |
||
| 604-018-00-5 | 2,4,6-trichlorophenol | 201-795-9 | 88-06-2 | Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H302 H319 H315 H410 |
|||
| 604-019-00-0 | dichlorophen (ISO) | 202-567-1 | 97-23-4 | Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H410 |
|||
| 604-020-00-6 | 2-phenylphenol (ISO) biphenyl-2-ol; 2-hydroxybiphenyl; |
201-993-5 | 90-43-7 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H400 |
|||
| 604-021-00-1 | sodium 2-biphenylate; 2-phenylphenol, sodium salt |
205-055-6 | 132-27-4 | Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Achtg. |
H302 H335 H315 H318 H400 |
|||
| 604-022-00-7 | 2,2-dimethyl-1,3-benzodioxol-4-ol | 400-900-7 | 22961-82-6 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 604-023-00-2 | 2,4-dichloro-3-ethylphenol | 401-060-4 | - | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
|||
| 604-024-00-8 | 4,4-isobutylethylidenediphenol | 401-720-1 | 6807-17-6 | Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H319 H400 H410 |
GHS08 GHS09 Gef. |
H360F *** H319 H410 |
|||
| 604-025-00-3 | 2,5-bis(1,1-dimethylbutyl)hydroquinone | 400-220-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-026-00-9 | 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) | 400-270-3 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-027-00-4 | 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone | 400-530-6 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H411 |
|||
| 604-028-00-X | 4-amino-3-fluorophenol | 402-230-0 | 399-95-1 | Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H302 H317 H411 |
GHS08 GHS07 GHS09 Gef. |
H350 H302 H317 H411 |
|||
| 604-029-00-5 | 1-naphtol | 201-969-4 | 90-15-3 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H335 H315 H318 |
GHS05 GHS07 Gef. |
H312 H302 H335 H315 H318 |
|||
| 604-030-00-0 | Bisphenol A; 4,4′-Isopropylidendiphenol |
201-245-8 | 80-05-7 | Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 |
H360F H335 H318 H317 |
GHS08 GHS05 GHS07 Gef. |
H360F H335 H318 H317 |
|||
| 604-031-00-6 | guaiacol | 201-964-7 | 90-05-1 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Achtg. |
H302 H319 H315 |
|||
| 604-032-00-1 | thymol | 201-944-8 | 89-83-8 | Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H314 H411 |
|||
| 604-033-00-7 | isobutyl but-3-enoate | 401-170-2 | 24342-03-8 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | |||
| 604-034-00-2 | 4,4'-thiodi-o-cresol | 403-330-7 | 24197-34-0 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 604-035-00-8 | 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol | 404-160-6 | - | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 604-036-00-3 | 4,4'-oxybis(ethylenethio)diphenol | 404-590-4 | 90884-29-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 604-037-00-9 | 3,5-xylenol; 3,5-dimethylphenol |
203-606-5 | 108-68-9 | Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Gef. |
H311 H301 H314 |
|||
| 604-038-00-4 | 4-chloro-3,5-dimethylphenol; [1] chloroxylenol [2] |
201-793-8 [1] 215-316-6 [2] |
88-04-0 [1] 1321-23-9 [2] |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H315 H317 |
GHS07 Achtg. |
H302 H319 H315 H317 |
|||
| 604-039-00-X | ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl |
266-362-9 | 66441-23-4 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 604-040-00-5 | fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide |
276-439-9 | 72178-02-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 604-041-00-0 | acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2] |
256-634-5 [1] 263-560-7 [2] |
50594-66-6 [1] 62476-59-9 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H315 H318 H410 |
|||
| 604-042-00-6 | 4-nitrosophenol | 203-251-6 | 104-91-6 | Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H341 H302 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H341 H302 H318 H411 |
|||
| 604-043-00-1 | monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether |
203-083-3 | 103-16-2 | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 604-044-00-7 | mequinol; 4-methoxyphenol; hydroquinone monomethyl ether |
205-769-8 | 150-76-5 | Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Achtg. |
H302 H319 H317 |
|||
| 604-045-00-2 | 2,3,5-trimethylhydroquinone | 211-838-3 | 700-13-0 | Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H335 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H332 H335 H315 H318 H317 H410 |
|||
| 604-046-00-8 | 4-(4-isopropoxyphenylsulfonyl)phenol | 405-520-5 | 95235-30-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-047-00-3 | 4-(4-tolyloxy)biphenyl | 405-730-7 | 51601-57-1 | STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Achtg. |
H373 ** H413 |
|||
| 604-048-00-9 | 4,4',4''-(ethan-1,1,1-triyl)triphenol | 405-800-7 | 27955-94-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-049-00-4 | 4-4'-methylenebis(oxyethylenethio)diphenol | 407-480-4 | 93589-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-051-00-5 | 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol | 401-110-5 | 87113-78-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 604-052-00-0 | 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) | 403-800-1 | 103597-45-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-053-00-6 | 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol | 410-760-9 | 157661-93-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 604-054-00-1 | reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol |
412-020-0 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 604-055-00-7 | 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane | 413-900-7 | 85954-11-6 | Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Achtg. |
H351 H317 |
|||
| 604-056-00-2 | 2-(2-hydroxy-3,5-dinitroanilino)ethanol | 412-520-9 | 99610-72-7 | Flam. Sol. 2 Repr. 2 Acute Tox. 4 * |
H228 H361f *** H302 |
GHS02 GHS07 GHS08 Gef. |
H228 H361f *** H302 |
|||
| 604-057-00-8 | Reaktionsmasse aus Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-5,6-didodecylphenol; n = 5 oder 6 | 401-680-5 | - | Aquatic Chronic 4 | H413 | H413 | ||||
| 604-058-00-3 | 1,2-bis(3-methylphenoxy)ethane | 402-730-9 | 54914-85-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 604-059-00-9 | 2-n-hexadecylhydroquinone | 406-400-5 | - | STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H373 ** H315 H317 H413 |
GHS08 GHS07 Achtg. |
H373 ** H315 H317 H413 |
|||
| 604-060-00-4 | 9,9-bis(4-hydroxyphenyl)fluorene | 406-950-6 | 3236-71-3 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
|||
| 604-061-00-X | reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones wheresec-tetradecyl= 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl |
407-740-7 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Achtg. |
H315 H317 H412 |
|||
| 604-062-00-5 | 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol | 411-220-5 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 604-063-00-0 | 5,6-dihydroxyindole | 412-130-9 | 3131-52-0 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 604-064-00-6 | 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol | 411-380-6 | 147315-50-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-065-00-1 | 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) | 407-460-5 | 111850-25-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 604-066-00-7 | reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol |
414-550-8 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 604-067-00-2 | reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) |
414-520-4 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 604-068-00-8 | (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride | 415-170-5 | 90274-24-1 | Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 |
H332 H302 H317 |
GHS07 Achtg. |
H332 H302 H317 |
|||
| 604-069-00-3 | 2-(1-methylpropyl)-4-tert-butylphenol | 421-740-4 | 51390-14-8 | Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Gef. |
H314 H411 |
|||
| 604-070-00-9 | triclosan; 2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol |
222-182-2 | 3380-34-5 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
M=100 | ||
| 604-071-00-4 | 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol | 425-600-3 | 110726-28-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-072-00-X | 1,2-bis(phenoxymethyl)benzene | 428-620-0 | 10403-74-4 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 604-073-00-5 | (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | 428-010-4 | 82413-20-5 | Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360F*** H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H351 H360F*** H317 H410 |
|||
| 604-074-00-0 | tetrabromobisphenol-A; 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol |
201-236-9 | 79-94-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol |
205-426-2 | 140-66-9 | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
M=10 | ||
| 604-076-00-1 | phenolphthalein | 201-004-7 | 77-09-8 | Carc. 1B Muta. 2 Repr. 2 |
H350 H341 H361f*** |
GHS08 Gef. |
H350 H341 H361f*** |
Carc. 1B; H350: C ≥ 1 % | ||
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | 419-750-9 | 98809-58-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-079-00-8 | 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | 428-970-4 | 13595-25-0 | Repr. 2 Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H317 H411 |
GHS08 GHS07 GHS09 Achtg. |
H361f*** H317 H411 |
|||
| 604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | 432-560-0 | 61721-07-1 | Acute Tox. 4 * Skin Corr. 1a Skin Sens. 1 Aquatic Chronic 2 |
H332 H314 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H332 H314 H317 H411 |
|||
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | 433-130-5 | 1571-75-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 604-082-00-4 | 2-chloro-6-fluoro-phenol | 433-890-8 | 2040-90-6 | Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H340 H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H340 H361f*** H302 H314 H317 H411 |
|||
| 604-083-00-X | 4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH4Cl), pentachlorophosphorane and phenol | 439-270-3 | 260408-02-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | 441-000-4 | 121219-07-6 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 604-087-00-1 | reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol |
433-640-8 | - | Pyr. Sol. 1 Aquatic Chronic 4 |
H250 H413 |
GHS02 Gef. |
H250 H413 |
EUH044 | ||
| 604-089-00-2 | 2-methyl-5-tert-butylthiophenol | 444-970-7 | - | Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Gef. |
H226 H361d*** H373** H304 H319 H315 H317 H336 H410 |
|||
| 604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. 2 Skin Irrit. 2 Eye Dam. 1 |
H361f H315 H318 |
GHS08 GHS05 Gef. |
H361f H315 H318 |
|||
| 604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether | 407-980-2 | 80844-07-1 | Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Achtg. |
H362 H410 |
M = 100 M = 1 000 |
||
| 604-092-00-9 | Phenol, dodecyl-, verzweigt; [1] Phenol, 2-dodecyl-, verzweigt; [2] Phenol, 3-dodecyl-, verzweigt; [3] Phenol, 4-dodecyl-, verzweigt; [4] Phenol, (tetrapropenyl) Derivate [5] |
310-154-3 [1] [2] [3] [4] [5] |
121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] |
Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360F H314 H318 H400 H410 |
GHS08 GHS05 GHS09 Gef. |
H360F H314 H410 |
M = 10 M = 10 |
||
| 604-093-00-4 | Clorofen; Chlorophen; 2-Benzyl-4-chlorphenol |
204-385-8 | 120-32-1 | Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361f H332 H315 H317 H318 H373 (Nieren) H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H351 H361f H332 H315 H317 H318 H373 (Nieren) H410 |
M = 1 M = 100 |
||
| 605-001-00-5 | formaldehyde ...% | 200-001-8 | 50-00-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H351 H331 H311 H301 H314 H317 |
GHS06 GHS08 GHS05 Gef. |
H351 H331 H311 H301 H314 H317 |
* Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % STOT SE 3; H335: C ≥ 5 % Skin Sens. 1; H317: C ≥ 0,2 % |
B D | |
| 605-002-00-0 | 1,3,5-trioxan; trioxymethylene |
203-812-5 | 110-88-3 | Flam. Sol. 1 Repr. 2 STOT SE 3 |
H228 H361d *** H335 |
GHS02 GHS08 GHS07 Gef. |
H228 H361d *** H335 |
T | ||
| 605-003-00-6 | acetaldehyde; ethanal |
200-836-8 | 75-07-0 | Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H224 H351 H319 H335 |
GHS02 GHS08 GHS07 Gef. |
H224 H351 H319 H335 |
|||
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde |
204-639-8 | 123-63-7 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | |||
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde |
203-600-2 | 108-62-3 | Flam. Sol. 2 Acute Tox. 4 * |
H228 H302 |
GHS02 GHS07 Achtg. |
H228 H302 |
|||
| 605-006-00-2 | butyraldehyde | 204-646-6 | 123-72-8 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 605-007-00-8 | 1,1-dimethoxyethane; dimethyl acetal |
208-589-8 | 534-15-6 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 605-008-00-3 | acrolein; prop-2-enal; acrylaldehyde |
203-453-4 | 107-02-8 | Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H225 H330 H300 H311 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Gef. |
H225 H330 H300 H311 H314 H410 |
EUH071 | Skin Corr. 1B; H314: C ≥ 0,1 % M = 100 M = 1 |
D |
| 605-009-00-9 | crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] |
224-030-0 [1] 204-647-1 [2] |
4170-30-3 [1] 123-73-9 [2] |
Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
GHS02 GHS06 GHS08 GHS05 GHS09 Gef. |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
|||
| 605-010-00-4 | 2-furaldehyde | 202-627-7 | 98-01-1 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H331 H301 H312 H319 H335 H315 |
GHS06 GHS08 Gef. |
H351 H331 H301 H312 H319 H335 H315 |
|||
| 605-011-00-X | 2-chlorobenzaldehyde; o-chlorobenzaldehyde |
201-956-3 | 89-98-5 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 605-012-00-5 | benzaldehyde | 202-860-4 | 100-52-7 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 605-013-00-0 | Chloralose (INN); (R)-1,2-O-(2,2,2-Trichlorethyliden)-α-D-glucofuranose; Glucochloralose; Anhydroglucochloral |
240-016-7 | 15879-93-3 | Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H301 H336 H400 H410 |
GHS06 GHS09 Gef. |
H332 H301 H336 H410 |
M = 10 M = 10 |
C | |
| 605-014-00-6 | chloral hydrate; 2,2,2-trichloroethane-1,1-diol |
206-117-5 | 302-17-0 | Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Gef. |
H301 H319 H315 |
|||
| 605-015-00-1 | 1,1-diethoxyethane; acetal |
203-310-6 | 105-57-7 | Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 |
H225 H319 H315 |
GHS02 GHS07 Gef. |
H225 H319 H315 |
|||
| 605-016-00-7 | glyoxal...%; ethandial...% |
203-474-9 | 107-22-2 | Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H341 H332 H319 H315 H317 |
GHS07 GHS08 Achtg. |
H341 H332 H319 H315 H317 |
* | B | |
| 605-017-00-2 | 1,3-dioxolane | 211-463-5 | 646-06-0 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 605-018-00-8 | propanal; propionaldehyde |
204-623-0 | 123-38-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Gef. |
H225 H319 H335 H315 |
|||
| 605-019-00-3 | citral | 226-394-6 | 5392-40-5 | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 605-020-00-9 | safrole; 5-allyl-1,3-benzodioxole |
202-345-4 | 94-59-7 | Carc. 1B Muta. 2 Acute Tox. 4 * |
H350 H341 H302 |
GHS08 GHS07 Gef. |
H350 H341 H302 |
|||
| 605-021-00-4 | formaldehyde, reaction products with butylphenol | 294-145-9 | 91673-30-2 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 605-022-00-X | Glutaral; Glutaraldehyd; 1,5-Pentandial |
203-856-5 | 111-30-8 | Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 a Aquatic Acute 1 Aquatic Chronic 2 |
H330 H301 H335 H314 H334 H317 H400 H411 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H330 H301 H335 H314 H334 H317 H410 |
EUH071 | STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1 |
|
| 605-023-00-5 | 5-Chlor-2-(4-chlorphenoxy)phenol; [DCPP] |
429-290-0 | 3380-30-1 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
M = 10 M = 10 |
||
| 605-024-00-0 | 2-bromo-5-hydroxy-4-methoxybenzaldehyde | 426-540-0 | 2973-59-3 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 605-025-00-6 | chloroacetaldehyde | 203-472-8 | 107-20-0 | Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H351 H330 H311 H301 H314 H400 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H351 H330 H311 H301 H314 H400 |
STOT SE 3; H335: C ≥ 5 % | ||
| 605-026-00-1 | 2,5,7,7-tetramethyloctanal | 405-690-0 | 114119-97-0 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Achtg. |
H315 H317 H411 |
|||
| 605-027-00-7 | reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde |
410-480-7 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 605-028-00-2 | β-methyl-3-(1-methylethyl)-benzenepropanal | 412-050-4 | 125109-85-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 605-029-00-8 | 2-cyclohexylpropanal | 412-270-0 | 2109-22-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 605-030-00-3 | 1-(p-methoxyphenyl)acetaldehyde oxime | 411-510-1 | 3353-51-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 605-031-00-9 | reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate; water(Including free water and water in hydrated 2,2-dimethoxyethanal)] |
421-890-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 605-032-00-4 | 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal | 425-370-4 | 93957-50-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 605-033-00-X | reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal |
425-910-9 | 32480-08-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 605-034-00-5 | reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde |
429-860-9 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 605-035-00-0 | (E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal | 426-330-9 | 177964-68-0 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H319 H317 H413 |
GHS07 Achtg. |
H319 H317 H413 |
|||
| 605-036-00-6 | 2-bromomalonaldehyde | 430-470-6 | 2065-75-0 | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 605-037-00-1 | trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde |
421-800-1 | 120578-03-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | 433-900-0 | 55066-49-4 | Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H315 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H315 H317 H411 |
|||
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | 441-810-8 | 116313-85-0 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Gef. |
H302 H318 H317 |
|||
| 605-040-00-8 | Hydroxyisohexyl-3-cyclohexencarboxaldehyd (INCI); Reaktionsmasse von 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd und 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [1] 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [2] 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [3] |
- [1] 250-863-4 [2] 257-187-9 [3] |
130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3] |
Skin Sens. 1 A | H317 | GHS07 Achtg. |
H317 | |||
| 606-001-00-8 | acetone; propan-2-one; propanone |
200-662-2 | 67-64-1 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
EUH066 | ||
| 606-002-00-3 | butanone; ethyl methyl ketone |
201-159-0 | 78-93-3 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
EUH066 | ||
| 606-003-00-9 | heptan-3-one; butyl ethyl ketone |
203-388-1 | 106-35-4 | Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 |
H226 H332 H319 |
GHS02 GHS07 Achtg. |
H226 H332 H319 |
|||
| 606-004-00-4 | 4-methylpentan-2-one; isobutyl methyl ketone |
203-550-1 | 108-10-1 | Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Gef. |
H225 H332 H319 H335 |
EUH066 | ||
| 606-005-00-X | 2,6-dimethylheptan-4-one; di-isobutyl ketone |
203-620-1 | 108-83-8 | Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Achtg. |
H226 H335 |
STOT SE 3; H335: C ≥ 10 % | ||
| 606-006-00-5 | pentan-3-one; diethyl ketone |
202-490-3 | 96-22-0 | Flam. Liq. 2 STOT SE 3 STOT SE 3 |
H225 H335 H336 |
GHS02 GHS07 Gef. |
H225 H335 H336 |
EUH066 | ||
| 606-007-00-0 | 3-methylbutan-2-one; methyl isopropyl ketone |
209-264-3 | 563-80-4 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 606-009-00-1 | 4-methylpent-3-en-2-one; mesityl oxide |
205-502-5 | 141-79-7 | Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Achtg. |
H226 H332 H312 H302 |
* | ||
| 606-010-00-7 | cyclohexanone | 203-631-1 | 108-94-1 | Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 606-011-00-2 | 2-methylcyclohexanone | 209-513-6 | 583-60-8 | Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 606-012-00-8 | 3,5,5-trimethylcyclohex-2-enone; isophorone |
201-126-0 | 78-59-1 | Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H351 H312 H302 H319 H335 |
GHS08 GHS07 Achtg. |
H351 H312 H302 H319 H335 |
STOT SE 3; H335: C ≥ 10 % | ||
| 606-013-00-3 | p-benzoquinone; quinone |
203-405-2 | 106-51-4 | Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H331 H301 H319 H335 H315 H400 |
GHS06 GHS09 Gef. |
H331 H301 H319 H335 H315 H400 |
M=10 | ||
| 606-014-00-9 | Chlorphacinon (ISO); 2-[(4-Chlorphenyl)(phenyl)acetyl]-1H-inden-1,3(2H)-dion |
223-003-0 | 3691-35-8 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,1 % STOT RE 2; H373 (Blut): 0,01 % ≤ C < 0,1 % M = 1 M = 1 |
||
| 606-016-00-X | pindone (ISO); 2-pivaloylindan-1,3-dione |
201-462-8 | 83-26-1 | Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H301 H372 ** H410 |
|||
| 606-017-00-5 | diketene; diketen |
211-617-1 | 674-82-8 | Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
D | ||
| 606-018-00-0 | dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone |
204-210-5 | 117-80-6 | Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H315 H410 |
|||
| 606-019-00-6 | chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one |
205-601-3 | 143-50-0 | Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H351 H311 H301 H410 |
|||
| 606-020-00-1 | 5-methylheptan-3-one | 208-793-7 | 541-85-5 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Achtg. |
H226 H319 H335 |
STOT SE 3; H335: C ≥ 10 % | ||
| 606-021-00-7 | N-Methyl-2-pyrrolidon; 1-Methyl-2-pyrrolidon | 212-828-1 | 872-50-4 | Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 |
H360D*** H335 H315 H319 |
GHS08 GHS07 Gef. |
H360D*** H335 H315 H319 |
STOT SE 3; H335: C ≥ 10 % | ||
| 606-022-00-2 | 1-phenyl-3-pyrazolidone | 202-155-1 | 92-43-3 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 606-023-00-8 | 4-methoxy-4-methylpentan-2-one | 203-512-4 | 107-70-0 | Flam. Liq. 3 Acute Tox. 4 ((*)) |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 606-024-00-3 | heptan-2-one; methyl amyl ketone |
203-767-1 | 110-43-0 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) |
H226 H332 H302 |
GHS02 GHS07 Achtg. |
H226 H332 H302 |
|||
| 606-025-00-9 | cyclopentanone | 204-435-9 | 120-92-3 | Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 |
H226 H319 H315 |
GHS02 GHS07 Achtg. |
H226 H319 H315 |
|||
| 606-026-00-4 | 5-methylhexan-2-one; isoamyl methyl ketone |
203-737-8 | 110-12-3 | Flam. Liq. 3 Acute Tox. 4 (*) |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 606-027-00-X | heptan-4-one; di-n-propyl ketone |
204-608-9 | 123-19-3 | Flam. Liq. 3 Acute Tox. 4 (*) |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 606-028-00-5 | 2,4-dimethylpentan-3-one; di-isopropyl ketone |
209-294-7 | 565-80-0 | Flam. Liq. 2 Acute Tox. 4 (*) |
H225 H332 |
GHS02 GHS07 Gef. |
H225 H332 |
|||
| 606-029-00-0 | pentane-2,4-dione; acetylacetone |
204-634-0 | 123-54-6 | Flam. Liq. 3 Acute Tox. 4 (*) |
H226 H302 |
GHS02 GHS07 Achtg. |
H226 H302 |
|||
| 606-030-00-6 | hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone |
209-731-1 | 591-78-6 | Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 |
H226 H361f (*)(*)(*) H372 (*)(*) H336 |
GHS02 GHS08 GHS07 Gef. |
H226 H361f (*)(*)(*) H372 (*)(*) H336 |
|||
| 606-031-00-1 | 3-propanolide; 1,3-propiolactone |
200-340-1 | 57-57-8 | Carc. 1B Acute Tox. 2 (*) Eye Irrit. 2 Skin Irrit. 2 |
H350 H330 H319 H315 |
GHS06 GHS08 Gef. |
H350 H330 H319 H315 |
|||
| 606-032-00-7 | hexachloroacetone | 204-129-5 | 116-16-5 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 606-033-00-2 | 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole |
243-761-6 | 20354-26-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Achtg. |
H312 H302 H319 H315 H411 |
|||
| 606-034-00-8 | metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one |
244-209-7 | 21087-64-9 | Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
M=10 | ||
| 606-035-00-3 | chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon |
216-920-2 | 1698-60-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 606-036-00-9 | quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one |
219-455-3 | 2439-01-2 | Repr. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f (*)(*)(*) H332 H312 H302 H373 (*)(*) H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361f (*)(*)(*) H332 H312 H302 H373 (*)(*) H319 H317 H410 |
|||
| 606-037-00-4 | triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone |
256-103-8 | 43121-43-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 606-038-00-X | diphacinone (ISO); 2-diphenylacetylindan-1,3-dione |
201-434-5 | 82-66-6 | Acute Tox. 2 (*) STOT RE 1 |
H300 H372 (*)(*) |
GHS06 GHS08 Gef. |
H300 H372 (*)(*) |
|||
| 606-039-00-5 | 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one | 400-680-2 | - | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H332 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H410 |
|||
| 606-040-00-0 | (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride | 401-840-4 | 55845-90-4 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 606-041-00-6 | 2-Methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-on | 400-600-6 | 71868-10-5 | Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H360FD H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H360FD H302 H411" |
|||
| 606-042-00-1 | acetophenone | 202-708-7 | 98-86-2 | Acute Tox. 4 (*) Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 606-043-00-7 | 2,4-di-tert-butylcyclohexanone | 405-340-7 | 13019-04-0 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 606-044-00-2 | 2,4,6-trimethylbenzophenone | 403-150-9 | 954-16-5 | Acute Tox. 4 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H410 |
|||
| 606-045-00-8 | oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one |
243-215-7 | 19666-30-9 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-046-00-3 | reaction mass ofcis- andtrans-cyclohexadec-8-en-1-one | 401-700-2 | 3100-36-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-047-00-9 | 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone | 404-360-3 | 119313-12-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-048-00-4 | 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one | 406-480-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-049-00-X | 4-(trans-4-propylcyclohexyl)acetophenone | 406-700-6 | 78531-61-0 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-050-00-5 | 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione | 412-480-2 | 72453-58-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-051-00-0 | 4-pentylcyclohexanone | 406-670-4 | 61203-83-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-052-00-6 | 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone | 410-410-5 | 54574-82-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 606-053-00-1 | flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one |
- | 96525-23-4 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-054-00-7 | Isoxaflutol (ISO); 5-Cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluor-2-mesyl-p-tolyl keton | - | 141112-29-0 | Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H400 H410 |
GHS08 GHS09 Achtg. |
H361d*** H410 |
M = 10 M = 100 |
||
| 606-055-00-2 | 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone | 411-180-9 | 92836-10-7 | Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H302 H373 (*)(*) H411 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373 (*)(*) H411 |
|||
| 606-056-00-8 | 4-chloro-3',4'-dimethoxybenzophenone | 404-610-1 | 116412-83-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-057-00-3 | 4-propylcyclohexanone | 406-810-4 | 40649-36-3 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 606-058-00-9 | 4'-fluoro-2,2-dimethoxyacetophenone | 407-500-1 | 21983-80-2 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 606-059-00-4 | 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride | 412-390-3 | 86386-75-6 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Gef. |
H302 H318 H317 |
|||
| 606-060-00-X | reaction mass of:trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane |
412-950-7 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-061-00-5 | (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone | 423-290-4 | 66938-41-8 | Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H400 H410 |
GHS08 GHS09 Achtg. |
H341 H410 |
|||
| 606-062-00-0 | tetrahydrothiopyran-3-carboxaldehyde | 407-330-8 | 61571-06-0 | Repr. 1B Eye Dam. 1 Aquatic Chronic 3 |
H360D (*)(*)(*) H318 H412 |
GHS08 GHS05 Gef. |
H360D (*)(*)(*) H318 H412 |
|||
| 606-063-00-6 | (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal | 410-980-5 | 112704-51-5 | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 606-064-00-1 | pregn-5-ene-3,20-dione bis(ethylene ketal) | 407-450-0 | 7093-55-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-065-00-7 | 1-(4-morpholinophenyl)butan-1-one | 413-790-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-066-00-2 | (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone | 410-440-9 | 164058-20-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-067-00-8 | reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone |
414-870-8 | 96792-67-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-068-00-3 | 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 415-770-7 | 1638-05-7 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 |
H373 (*)(*) H317 H412 |
GHS08 GHS07 Achtg. |
H373 (*)(*) H317 H412 |
|||
| 606-069-00-9 | spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] | 415-460-1 | 154171-76-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-070-00-4 | butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one |
414-790-3 | 138164-12-2 | Repr. 2 Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361fd H302 H315 H410 |
|||
| 606-071-00-X | 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one | 421-050-3 | 13258-43-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-072-00-5 | 3-acetyl-1-phenyl-pyrrolidine-2,4-dione | 421-600-2 | 719-86-8 | STOT RE 2 (*) Aquatic Chronic 2 |
H373 (*)(*) H411 |
GHS08 GHS09 Achtg. |
H373 (*)(*) H411 |
|||
| 606-073-00-0 | 4,4'-bis(dimethylamino)benzophenone; Michler's ketone |
202-027-5 | 90-94-8 | Carc. 1B Muta. 2 Eye Dam. 1 |
H350 H341 H318 |
GHS08 GHS05 Gef. |
H350 H341 H318 |
|||
| 606-074-00-6 | reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene |
425-570-1 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-075-00-1 | 1-benzyl-5-ethoxyimidazolidine-2,4-dione | 417-340-4 | 65855-02-9 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 606-076-00-7 | 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione | 418-630-3 | 136465-99-1 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 606-077-00-2 | (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | 418-650-2 | 104872-06-2 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-078-00-8 | 1-octylazepin-2-one | 420-040-6 | 59227-88-2 | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H411 |
|||
| 606-079-00-3 | 2-n-butyl-benzo[d]isothiazol-3-one | 420-590-7 | 4299-07-4 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H410 |
|||
| 606-081-00-4 | (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one | 419-790-7 | 4229-69-0 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 606-082-00-X | reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane |
406-930-7 | STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H372 (*)(*) H317 H412 |
GHS08 GHS07 Gef. |
H372 (*)(*) H317 H412 |
||||
| 606-083-00-5 | 2-chloro-5-sec-hexadecylhydroquinone | 407-750-1 | 137193-60-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Achtg. |
H319 H315 H317 H412 |
|||
| 606-084-00-0 | 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione | 414-540-3 | 484-33-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-085-00-6 | (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 418-530-1 | 79200-56-9 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Gef. |
H302 H318 H317 |
|||
| 606-086-00-1 | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 422-330-8 | 56973-87-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-087-00-7 | 6-ethyl-5-fluoro-4(3H)-pyrimidone | 422-460-5 | 137234-87-8 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 606-088-00-2 | 2,4,4,7-tetramethyl-6-octen-3-one | 422-520-0 | 74338-72-0 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 606-089-00-8 | reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone |
423-220-2 | 12223-77-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-090-00-3 | 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone | 430-920-1 | 73096-98-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 606-091-00-9 | 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one | 421-320-0 | 118289-55-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-092-00-4 | reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a)(Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one |
422-320-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | ||||
| 606-093-00-X | 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one | 414-470-3 | 95885-13-5 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 606-094-00-5 | N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one | 417-460-7 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-095-00-0 | (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 421-830-3 | 49805-30-3 | Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 606-096-00-6 | 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one | 424-170-4 | 130603-71-3 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 606-097-00-1 | 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone | 424-210-0 | 23911-85-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-098-00-7 | 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione | 431-220-9 | 158574-65-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-099-00-2 | 5-methoxy-4'-(trifluoromethyl)valerophenone | 425-000-1 | 61718-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-100-00-6 | 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one | 425-150-8 | 94723-86-1 | Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H360F*** H302 H317 H412 |
GHS08 GHS07 Gef. |
H360F*** H302 H317 H412 |
|||
| 606-101-00-1 | reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione |
426-050-7 | 165038-51-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 606-102-00-7 | 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone | 431-490-8 | 79876-59-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-103-00-2 | 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone | 426-460-6 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 606-104-00-8 | 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone | 426-830-7 | 78531-59-6 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-105-00-3 | 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione | 431-500-0 | 226065-73-2 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-106-00-9 | 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone | 427-320-7 | 83626-30-6 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-107-00-4 | 8-azaspiro[4.5]decane-7,9-dione | 427-770-4 | 1075-89-4 | Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Gef. |
H301 H411 |
|||
| 606-108-00-X | 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone | 436-710-6 | 756-13-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 606-109-00-5 | 2-(4-methyl-3-pentenyl)anthraquinone | 428-320-1 | 71308-16-2 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 |
H302 H317 H413 |
GHS07 Achtg. |
H302 H317 H413 |
|||
| 606-110-00-0 | 5-ethoxy-5H-furan-2-one | 428-330-4 | 2833-30-9 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H312 H302 H373** H317 |
GHS05 GHS08 GHS07 Gef. |
H314 H312 H302 H373** H317 |
|||
| 606-111-00-6 | 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one | 428-410-9 | 67014-36-2 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 606-112-00-1 | (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one | 428-690-2 | 1668-86-6 | Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Achtg. |
H302 H319 H412 |
|||
| 606-113-00-7 | 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one | 429-040-0 | 272460-97-6 | Eye Dam. 1 Aquatic Chronic 4 |
H318 H413 |
GHS05 Gef. |
H318 H413 |
|||
| 606-114-00-2 | 4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone | 429-150-9 | 67887-47-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-115-00-8 | profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one |
- | 139001-49-3 | Carc. 2 Repr. 2 Skin Sens. 1 |
H351 H361d H317 |
GHS08 GHS07 Achtg. |
H351 H361d H317 |
|||
| 606-116-00-3 | tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one |
- | 149979-41-9 | Carc. 2 Repr. 2 |
H351 H361fd |
GHS08 Achtg. |
H351 H361fd |
|||
| 606-117-00-9 | 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one | 429-460-4 | 7078-98-0 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-118-00-4 | N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine | 429-640-2 | 52870-46-9 | Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H410 |
|||
| 606-119-00-X | (E)-3-methyl-5-cyclopentadecen-1-one | 429-900-5 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 606-120-00-5 | 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one | 430-170-5 | 114625-74-0 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 606-121-00-0 | (+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) | 430-460-1 | 133636-82-5 | Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H410 |
|||
| 606-122-00-6 | 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one | 430-820-8 | 114341-88-7 | Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H302 H373** H315 H318 H317 H410 |
|||
| 606-123-00-1 | 4-hexadecyl-1-phenylpyrazolidin-3-one | 430-840-7 | - | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | 421-080-7 | 161462-35-7 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Achtg. |
H373** H410 |
|||
| 606-125-00-2 | 1-benzylimidazolidine-2,4-dione | 421-340-1 | 6777-05-5 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | 421-470-7 | 99788-75-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 606-128-00-9 | 2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | 422-650-8 | 148935-94-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
423-090-7 | 156732-13-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | 423-860-2 | 56309-94-5 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | 427-230-8 | 5571-36-8 | Repr. 1B STOT RE 2 * Aquatic Chronic 2 |
H360F*** H373** H411 |
GHS08 GHS09 Gef. |
H360F*** H373** H411 |
|||
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | 433-490-3 | 6563-83-3 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | 433-560-3 | 15375-21-0 | Repr. 2 | H361f*** | GHS08 Achtg. |
H361f*** | |||
| 606-135-00-7 | cyclohexadecanone | 438-930-8 | 2550-52-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | 444-350-6 | 133413-70-4 | Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Achtg. |
H319 H413 |
|||
| 606-137-00-8 | trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione | 444-750-0 | 211387-26-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | 444-800-1 | 141645-23-0 | Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Gef. |
H226 H302 H373** H315 H318 H317 H410 |
M=10 | ||
| 606-139-00-9 | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | 444-830-5 | 124379-29-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | 444-860-9 | 474510-57-1 | STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Achtg. |
H373** H410 |
|||
| 606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | 418-410-7 | - | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 606-142-00-5 | reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one |
434-290-9 | - | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
606-143-00-0 |
abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] | _ [1] | 71751-41-2 [1] | Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H300 H330 H372 (Nervensystem) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d H300 H330 H372 (Nervensystem) H410 |
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤ C < 5 % M = 10 000 |
||
| avermectin B1a (purity ≥ 80 %); [2] | 265-610-3 [2] | 65195-55-3 [2] | ||||||||
| 606-144-00-6 | acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate |
- | 57960-19-7 | Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H370 (Lunge) (Einatmung) H373 (Blutkreislauf) H400 H410 |
GHS07 GHS08 GHS09 Gef. |
H317 H370 (Lunge) (Einatmung) H373 (Blutkreislauf) H410 |
M = 1 000 | ||
606-145-00-1 |
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione |
99105-77-8 |
Repr. 2 | H361d | GHS08 | H361d | M = 1 M = 10 |
|||
| STOT RE 2 | H373 (Nieren) | GHS07 | H373 (Nieren) | |||||||
| Skin Sens. 1A | H317 | HS09 | H317 | |||||||
| Aquatic Acute 1 | H400 | Achtg. | ||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one | - | 87820-88-0 | Carc. 2 Acute Tox. 4 Aquatic Chronic 2 |
H351 H302 H411 |
GHS08 GHS07 GHS09 Achtg. |
H351 H302 H411 |
|||
| 606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08 Achtg. |
H361d | |||
| 606-148-00-8 | Carvon (ISO); 2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1] d-Carvon; (5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2] l-Carvon; (5R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3] |
202-759-5 [1] 218-827-2 [2] 229-352-5 [3] |
99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] |
Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 606-149-00-3 | Tembotrion (ISO); 2-{2-Chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyclohexan-1,3-dion | - | 335104-84-2 | Repr. 2 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (Augen, Nieren, Leber) H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361d H373 (Augen, Nieren, Leber) H317 H410 |
M = 100 M = 10 |
||
| 606-150-00-9 | Clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-Chlorallyloxyimino]propyl}-5-[(2RS)- 2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on | - | 99129-21-2 | Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Achtg. |
H302 H317 H412 |
EUH066 | ||
| 606-151-00-4 | Anthrachinon | 201-549-0 | 84-65-1 | Carc. 1B | H350 | GHS08 Gef. |
H350 | |||
| 607-001-00-0 | formic acid ... % | 200-579-1 | 64-18-6 | Skin Corr. 1A | H314 | GHS05 Gef. | H314 | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤ C < 10 % Eye Irrit. 2; H319: 2 % ≤ C < 10 % |
B | |
| 607-002-00-6 | acetic acid ... % | 200-580-7 | 64-19-7 | Flam. Liq. 3 Skin Corr. 1A |
H226 H314 |
GHS02 GHS05 Gef. |
H226 H314 |
Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 25 % ≤ C < 90 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B | |
| 607-003-00-1 | chloroacetic acid | 201-178-4 | 79-11-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H331 H311 H301 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H331 H311 H301 H314 H400 |
STOT SE 3; H335: C ≥ 5 % | ||
| 607-004-00-7 | TCa (ISO); trichloroacetic acid |
200-927-2 | 76-03-9 | Skin Corr. 1a Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
STOT SE 3; H335: C ≥ 1 % | ||
| 607-005-00-2 | TCA-sodium (ISO); sodium trichloroacetate |
211-479-2 | 650-51-1 | STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H400 H410 |
GHS07 GHS09 Achtg. |
H335 H410 |
|||
| 607-006-00-8 | oxalic acid | 205-634-3 | 144-62-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
(*) | ||
| 607-007-00-3 | salts of oxalic acid with the exception of those specified elsewhere in this Annex | - | - | Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
* | A | |
| 607-008-00-9 | acetic anhydride | 203-564-8 | 108-24-7 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B |
H226 H332 H302 H314 |
GHS02 GHS05 GHS07 Gef. |
H226 H332 H302 H314 |
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤ C < 5 % STOT SE 3; H335: C ≥ 5 % |
||
| 607-009-00-4 | phthalic anhydride | 201-607-5 | 85-44-9 | Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H335 H315 H318 H334 H317 |
GHS08 GHS05 GHS07 Gef. |
H302 H335 H315 H318 H334 H317 |
|||
| 607-010-00-X | propionic anhydride | 204-638-2 | 123-62-6 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
||
| 607-011-00-5 | acetyl chloride | 200-865-6 | 75-36-5 | Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Gef. |
H225 H314 |
EUH014 | ||
| 607-012-00-0 | benzoyl chloride | 202-710-8 | 98-88-4 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H332 H312 H302 H314 H317 |
GHS05 GHS07 Gef. |
H332 H312 H302 H314 H317 |
|||
| 607-013-00-6 | dimethyl carbonate | 210-478-4 | 616-38-6 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 607-014-00-1 | methyl formate | 203-481-7 | 107-31-3 | Flam. Liq. 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 |
H224 H332 H302 H319 H335 |
GHS02 GHS07 Gef. |
H224 H332 H302 H319 H335 |
|||
| 607-015-00-7 | ethyl formate | 203-721-0 | 109-94-4 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 |
H225 H332 H302 H319 H335 |
GHS02 GHS07 Gef. |
H225 H332 H302 H319 H335 |
|||
| 607-016-00-2 | propyl formate; [1] isopropyl formate [2] |
203-798-0 [1] 210-901-2 [2] |
110-74-7 [1] 625-55-8 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H225 H319 H335 H336 |
GHS02 GHS07 Gef. |
H225 H319 H335 H336 |
C | ||
| 607-017-00-8 | butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] |
209-772-5 [1] 212-105-0 [2] 208-818-1 [3] |
592-84-7 [1] 762-75-4 [2] 542-55-2 [3] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Gef. |
H225 H319 H335 |
C | ||
| 607-018-00-3 | isopentyl formate; [1] 2-methylbutyl formate [2] |
203-769-2 [1] 252-343-2 [2] |
110-45-2 [1] 35073-27-9 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Gef. |
H225 H319 H335 |
C | ||
| 607-019-00-9 | methyl chloroformate | 201-187-3 | 79-22-1 | Flam. Liq. 2 Acute Tox. 2 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1B |
H225 H330 H312 H302 H314 |
GHS02 GHS06 GHS05 Gef. |
H225 H330 H312 H302 H314 |
|||
| 607-020-00-4 | ethyl chloroformate | 208-778-5 | 541-41-3 | Flam. Liq. 2 Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B |
H225 H330 H302 H314 |
GHS02 GHS06 GHS05 Gef. |
H225 H330 H302 H314 |
|||
| 607-021-00-X | methyl acetate | 201-185-2 | 79-20-9 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
EUH066 | ||
| 607-022-00-5 | ethyl acetate | 205-500-4 | 141-78-6 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
EUH066 | ||
607-023-00-0 |
vinyl acetate |
203-545-4 |
108-05-4 |
Flam. Liq. 2 | H225 | GHS02 | H225 | D |
||
| Carc. 2 | H351 | GHS08 | H351 | |||||||
| Acute Tox. 4 | H332 | GHS07 | H332 | |||||||
| STOT SE 3 | H335 | Gef. | H335 | |||||||
| 607-024-00-6 | propyl acetate; [1] isopropyl acetate [2] |
203-686-1 [1] 203-561-1 [2] |
109-60-4 [1] 108-21-4 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Gef. |
H225 H319 H336 |
EUH066 | C | |
| 607-025-00-1 | n-butyl acetate | 204-658-1 | 123-86-4 | Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Achtg. |
H226 H336 |
EUH066 | ||
| 607-026-00-7 | sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] |
203-300-1 [1] 203-745-1 [2] 208-760-7 [3] |
105-46-4 [1] 110-19-0 [2] 540-88-5 [3] |
Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | EUH066 | C | |
| 607-027-00-2 | methyl propionate | 209-060-4 | 554-12-1 | Flam. Liq. 2 Acute Tox. 4 (*) |
H225 H332 |
GHS02 GHS07 Gef. |
H225 H332 |
|||
| 607-028-00-8 | ethyl propionate | 203-291-4 | 105-37-3 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 607-029-00-3 | n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] |
209-669-5 [1] [2] 208-746-0 [3] |
590-01-2 [1] 591-34-4 [2] 540-42-1 [3] |
Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | C | ||
| 607-030-00-9 | propyl propionate | 203-389-7 | 106-36-5 | Flam. Liq. 3 Acute Tox. 4 (*) |
H226 H332 |
GHS02 GHS07 Achtg. |
H226 H332 |
|||
| 607-031-00-4 | butyl butyrate | 203-656-8 | 109-21-7 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | C | ||
| 607-032-00-X | ethyl acrylate | 205-438-8 | 140-88-5 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 H319 H335 H315 H317 |
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % |
D | |
| 607-033-00-5 | n-butyl methacrylate | 202-615-1 | 97-88-1 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Achtg. |
H226 H319 H335 H315 H317 |
D | ||
| 607-034-00-0 | methyl acrylate; methyl propenoate |
202-500-6 | 96-33-3 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 H319 H335 H315 H317 |
D | ||
| 607-035-00-6 | methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate |
201-297-1 | 80-62-6 | Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H335 H315 H317 |
GHS02 GHS07 Gef. |
H225 H335 H315 H317 |
D | ||
| 607-036-00-1 | 2-methoxyethyl acetate; methylglycol acetate |
203-772-9 | 110-49-6 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) |
H360FD H332 H312 H302 |
GHS08 GHS07 Gef. |
H360FD H332 H312 H302 |
|||
| 607-037-00-7 | 2-ethoxyethyl acetate; ethylglycol acetate |
203-839-2 | 111-15-9 | Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Gef. |
H226 H360FD H332 H312 H302 |
|||
| 607-038-00-2 | 2-butoxyethyl acetate; butylglycol acetate |
203-933-3 | 112-07-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) |
H332 H312 |
GHS07 Achtg. |
H332 H312 |
|||
| 607-039-00-8 | 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid |
202-361-1 | 94-75-7 | Acute Tox. 4 (*) STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H335 H318 H317 H412 |
GHS05 GHS07 Gef. |
H302 H335 H318 H317 H412 |
|||
| 607-040-00-3 | salts of 2,4-D | - | - | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H317 H411 |
A | ||
| 607-041-00-9 | 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid |
202-273-3 | 93-76-5 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H335 H315 H410 |
|||
| 607-042-00-4 | salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid |
- | - | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H335 H315 H410 |
A | ||
| 607-043-00-X | dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid |
217-635-6 | 1918-00-9 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 607-044-00-5 | 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate [2] |
218-951-7 [1] 233-002-7 [2] |
2300-66-5 [1] 10007-85-9 [2] |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Achtg. |
H319 H412 |
|||
| 607-045-00-0 | dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid |
204-390-5 | 120-36-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H315 H318 |
GHS05 GHS07 Gef. |
H312 H302 H315 H318 |
|||
| 607-046-00-6 | salts of dichlorprop | - | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) |
H332 H312 H302 |
GHS07 Achtg. |
H332 H312 H302 |
A | ||
| 607-047-00-1 | fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid |
202-271-2 | 93-72-1 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H315 H410 |
|||
| 607-048-00-7 | salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid |
- | - | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
A | ||
| 607-049-00-2 | mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] |
230-386-8 [1] 202-264-4 [2] |
7085-19-0 [1] 708519-0 [2] |
Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H315 H318 H410 |
M=100 | ||
| 607-050-00-8 | salts of mecoprop | - | - | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H315 H318 H410 |
A | ||
| 607-051-00-3 | MCPa (ISO); 4-chloro-o-tolyloxyacetic acid |
202-360-6 | 94-74-6 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H315 H318 H410 |
|||
| 607-052-00-9 | salts and esters of MCPA | - | - | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H312 H302 H410 |
A | ||
| 607-053-00-4 | MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid |
202-365-3 | 94-81-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-054-00-X | salts and esters of MCPB | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | A | ||
| 607-055-00-5 | endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate |
204-959-8 | 129-67-9 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Gef. |
H301 H312 H319 H335 H315 |
|||
| 607-056-00-0 | Warfarin (ISO); 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-on; [1] (S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [2] (R)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [3] |
201-377-6 [1] 226-907-3 [2] 226-908-9 [3] |
81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] |
Repr. 1 a Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 |
H360D H330 H310 H300 H372 (Blut) H411 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H411 |
Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,5 % STOT RE 2; H373 (Blut): 0,05 % ≤ C < 0,5 % |
||
| 607-057-00-6 | coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin |
201-378-1 | 81-82-3 | STOT RE 2 (*) Aquatic Chronic 3 |
H373 (*)(*) H412 |
GHS08 Achtg. |
H373 (*)(*) H412 |
|||
| 607-058-00-1 | coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin |
204-195-5 | 117-52-2 | Acute Tox. 3 (*) STOT RE 1 Aquatic Chronic 3 |
H301 H372 (*)(*) H412 |
GHS06 GHS08 Gef. |
H301 H372 (*)(*) H412 |
|||
| 607-059-00-7 | Coumatetralyl (ISO); 4-Hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)cumarin | 227-424-0 | 5836-29-3 | Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 |
H360D H330 H311 H300 H372 (Blut) H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H311 H300 H372 (Blut) H410 |
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 1,0 % STOT RE 2; H373 (Blut) 0,1 % ≤ C < 1,0 % M = 10 |
||
| 607-060-00-2 | dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) |
200-632-9 | 66-76-2 | STOT RE 1 Acute Tox. 4 (*) Aquatic Chronic 2 |
H372 (*)(*) H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H372 (*)(*) H302 H411 |
|||
| 607-061-00-8 | acrylic acid; prop-2-enoic acid |
201-177-9 | 79-10-7 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1a Aquatic Acute 1 |
H226 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H226 H332 H312 H302 H314 H400 |
STOT SE 3; H335: C ≥ 1 % | D | |
| 607-062-00-3 | n-butyl acrylate | 205-480-7 | 141-32-2 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Achtg. |
H226 H319 H335 H315 H317 |
D | ||
| 607-063-00-9 | isobutyric acid | 201-195-7 | 79-31-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 607-064-00-4 | benzyl chloroformate | 207-925-0 | 501-53-1 | Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Gef. |
H314 H410 |
STOT SE 3; H335: C ≥ 5 % | ||
| 607-065-00-X | bromoacetic acid | 201-175-8 | 79-08-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1a Skin Sens. 1 Aquatic Acute 1 |
H331 H311 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Gef. |
H331 H311 H301 H314 H317 H400 |
|||
| 607-066-00-5 | dichloroacetic acid | 201-207-0 | 79-43-6 | Skin Corr. 1a Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
|||
| 607-067-00-0 | dichloroacetyl chloride | 201-199-9 | 79-36-7 | Skin Corr. 1a Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Gef. |
H314 H400 |
|||
| 607-068-00-6 | iodoacetic acid | 200-590-1 | 64-69-7 | Acute Tox. 3 (*) Skin Corr. 1A |
H301 H314 |
GHS06 GHS05 Gef. |
H301 H314 |
|||
| 607-069-00-1 | ethyl bromoacetate | 203-290-9 | 105-36-2 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) |
H330 H310 H300 |
GHS06 Gef. |
H330 H310 H300 |
|||
| 607-070-00-7 | ethyl chloroacetate | 203-294-0 | 105-39-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 |
H331 H311 H301 H400 |
GHS06 GHS09 Gef. |
H331 H311 H301 H400 |
|||
| 607-071-00-2 | ethyl methacrylate | 202-597-5 | 97-63-2 | Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H319 H335 H315 H317 |
GHS02 GHS07 Gef. |
H225 H319 H335 H315 H317 |
D | ||
| 607-072-00-8 | 2-hydroxyethyl acrylate | 212-454-9 | 818-61-1 | Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H311 H314 H317 H400 |
GHS06 GHS05 GHS09 Gef. |
H311 H314 H317 H400 |
(*) Skin Sens. 1; H317: C ≥ 0,2 % |
D | |
| 607-073-00-3 | 4-CPa (ISO); 4-chlorophenoxyacetic acid |
204-581-3 | 122-88-3 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-074-00-9 | chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid |
201-599-3 | 85-34-7 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-075-00-4 | chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate |
238-413-5 | 14437-17-3 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 607-076-00-X | dodine(ISO); dodecylguanidinium acetate |
219-459-5 | 2439-10-3 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H319 H315 H410 |
|||
| 607-077-00-5 | erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate |
- | 136-25-4 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-078-00-0 | fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate |
- | 4301-50-2 | Acute Tox. 1 Acute Tox. 2 (*) |
H310 H300 |
GHS06 Gef. |
H310 H300 |
|||
| 607-079-00-6 | kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate |
- | 4234-79-1 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Chronic 2 |
H311 H302 H411 |
GHS06 GHS09 Gef. |
H311 H302 H411 |
|||
| 607-080-00-1 | chloroacetyl chloride | 201-171-6 | 79-04-9 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 1 Skin Corr. 1a Aquatic Acute 1 |
H331 H311 H301 H372 (*)(*) H314 H400 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H331 H311 H301 H372 (*)(*) H314 H400 |
EUH014 EUH029 |
||
| 607-081-00-7 | fluoroacetic acid | 205-631-7 | 144-49-0 | Acute Tox. 2 (*) Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Gef. |
H300 H400 |
|||
| 607-082-00-2 | fluoroacetates, soluble | - | - | Acute Tox. 2 (*) Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Gef. |
H300 H400 |
A | ||
| 607-083-00-8 | 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid |
202-366-9 | 94-82-6 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-084-00-3 | salts of 2,4-DB | - | - | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
A | ||
| 607-085-00-9 | benzyl benzoate | 204-402-9 | 120-51-4 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-086-00-4 | diallyl phthalate | 205-016-3 | 131-17-9 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-088-00-5 | methacrylic acid; 2-methylpropenoic acid |
201-204-4 | 79-41-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
STOT SE 3; H335: C ≥ 1 % | D | |
| 607-089-00-0 | propionic acid ... % | 201-176-3 | 79-09-4 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B | |
| 607-090-00-6 | thioglycolic acid | 200-677-4 | 68-11-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B |
H331 H311 H301 H314 |
GHS06 GHS05 Gef. |
H331 H311 H301 H314 |
(*) | ||
| 607-091-00-1 | trifluoroacetic acid . . . % | 200-929-3 | 76-05-1 | Acute Tox. 4 (*) | H332 | GHS05 | H332 | * | B | |
| Skin Corr. 1a Aquatic Chronic 3 |
H314 H412 |
GHS07 Gef. |
H314 H412 |
|||||||
| 607-092-00-7 | methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] |
208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] |
547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Achtg. |
H226 H319 H335 |
C | ||
| 607-093-00-2 | propionyl chloride | 201-170-0 | 79-03-8 | Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Gef. |
H225 H314 |
EUH014 | B D | |
| 607-094-00-8 | peracetic acid . . . % | 201-186-8 | 79-21-0 | Flam. Liq. 3 Org. Perox. D (*)(*)(*)(*) Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1a Aquatic Acute 1 |
H226 H242 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H226 H242 H332 H312 H302 H314 H400 |
(*) STOT SE 3; H335: C ≥ 1 % |
B D | |
| 607-095-00-3 | maleic acid | 203-742-5 | 110-16-7 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H335 H315 H317 |
GHS07 Achtg. |
H302 H319 H335 H315 H317 |
Skin Sens. 1; H317: C ≥ 0,1 % | ||
| 607-096-00-9 | maleic anhydride | 203-571-6 | 108-31-6 | Acute Tox. 4 (*) Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H302 H314 H334 H317 |
GHS08 GHS05 GHS07 Gef. |
H302 H314 H334 H317 |
|||
| 607-097-00-4 | benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride |
209-008-0 | 552-30-7 | STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H335 H318 H334 H317 |
GHS08 GHS05 GHS07 Gef. |
H335 H318 H334 H317 |
|||
| 607-098-00-X | benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride |
201-898-9 | 89-32-7 | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Gef. |
H318 H334 H317 |
|||
| 607-099-00-5 | 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalic anhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] |
201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] |
85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H334 H317 H412 |
GHS08 GHS05 Gef. |
H318 H334 H317 H412 |
C | ||
| 607-100-00-9 | benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) |
219-348-1 | 2421-28-5 | Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Achtg. |
H319 H335 |
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
||
| 607-101-00-4 | 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride | 204-077-3 | 115-27-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
||
| 607-102-00-X | cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylic anhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] |
201-604-9 [1] 236-086-3 [2] 238-009-9 [3] |
85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Gef. |
H318 H334 H317 |
C | ||
| 607-103-00-5 | succinic anhydride | 203-570-0 | 108-30-5 | Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H302 H319 H335 |
GHS07 Achtg. |
H302 H319 H335 |
* Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
||
| 607-104-00-0 | cyclopentane-1,2,3,4-tetracarboxylic dianhydride | 227-964-7 | 6053-68-5 | Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Achtg. |
H319 H335 |
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
||
| 607-105-00-6 | 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] |
204-957-7 [1] 212-557-9 [2] 220-384-5 [3] |
129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Gef. |
H318 H334 H317 |
C | ||
| 607-106-00-1 | 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride | - | 123748-85-6 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H302 H319 H335 H315 H334 |
GHS08 GHS07 Gef. |
H302 H319 H335 H315 H334 |
STOT SE 3; H335: C ≥ 10 % | C | |
| 607-107-00-7 | 2-ethylhexyl acrylate | 203-080-7 | 103-11-7 | STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H335 H315 H317 |
GHS07 Achtg. |
H335 H315 H317 |
D | ||
| 607-108-00-2 | 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3] |
220-852-9 [1] 213-663-8 [2] 247-118-0 [3] |
2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] |
Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Gef. |
H331 H311 H301 H314 H317 |
(*) Skin Sens. 1; H317: C ≥ 0,2 % |
C D | |
| 607-109-00-8 | hexamethylene diacrylate; hexane-1,6-diol diacrylate |
235-921-9 | 13048-33-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-110-00-3 | pentaerythritol triacrylate | 222-540-8 | 3524-68-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-111-00-9 | 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate |
239-701-3 | 15625-89-5 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-112-00-4 | 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate |
218-741-5 | 2223-82-7 | Acute Tox. 3 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Gef. |
H311 H319 H315 H317 |
(*) | D | |
| 607-113-00-X | isobutyl methacrylate | 202-613-0 | 97-86-9 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H226 H319 H335 H315 H317 H400 |
GHS02 GHS07 GHS09 Achtg. |
H226 H319 H335 H315 H317 H400 |
D | ||
| 607-114-00-5 | ethylene dimethacrylate | 202-617-2 | 97-90-5 | STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Achtg. |
H335 H317 |
STOT SE 3; H335: C ≥ 10 % | D | |
| 607-115-00-0 | isobutyl acrylate | 203-417-8 | 106-63-8 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 |
H226 H332 H312 H315 H317 |
GHS02 GHS07 Achtg. |
H226 H332 H312 H315 H317 |
D | ||
| 607-116-00-6 | cyclohexyl acrylate | 221-319-3 | 3066-71-5 | STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H335 H315 H411 |
GHS07 GHS09 Achtg. |
H335 H315 H411 |
STOT SE 3; H335: C ≥ 10 % | D | |
| 607-117-00-1 | 2,3-epoxypropyl acrylate; glycidyl acrylate |
203-440-3 | 106-90-1 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Gef. |
H331 H311 H301 H314 H317 |
(*) Skin Sens. 1; H317: C ≥ 0,2 % |
D | |
| 607-118-00-7 | 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate |
243-105-9 | 19485-03-1 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Gef. |
H312 H314 H317 |
D | ||
| 607-119-00-2 | tetramethylene diacrylate; 1,4-butyleneglycol diacrylate |
213-979-6 | 1070-70-8 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Gef. |
H312 H314 H317 |
D | ||
| 607-120-00-8 | 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate |
223-791-6 | 4074-88-8 | Acute Tox. 3 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Gef. |
H311 H319 H315 H317 |
(*) Skin Sens. 1; H317: C ≥ 0,2 % |
D | |
| 607-121-00-3 | 8,9,10-trinorborn-2-yl acrylate | - | 10027-06-2 | Acute Tox. 4 (*) Skin Irrit. 2 Skin Sens. 1 |
H312 H315 H317 |
GHS07 Achtg. |
H312 H315 H317 |
D | ||
| 607-122-00-9 | pentaerythritol tetraacrylate | 225-644-1 | 4986-89-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-123-00-4 | 2,3-Epoxypropylmethacrylat; Glycidylmethacrylat |
203-441-9 | 106-91-2 | Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1 |
H350 H341 H360F H311 H302 H335 H372 (Atemwege) (Einatmung) H318 H314 H317 |
GHS08 GHS06 GHS05 Gef. |
H350 H341 H360F H311 H302 H335 H372 (Atemwege) (Einatmung) H314 H317 |
D | ||
| 607-124-00-X | 2-hydroxyethyl methacrylate | 212-782-2 | 868-77-9 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-125-00-5 | 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate [2] |
213-090-3 [1] 220-426-2 [2] |
923-26-2 [1] 2761-09-3 [2] |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
C D | ||
| 607-126-00-0 | 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate |
216-853-9 | 1680-21-3 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-127-00-6 | 2-diethylaminoethyl methacrylate | 203-275-7 | 105-16-8 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H319 H315 H317 |
GHS07 Achtg. |
H332 H319 H315 H317 |
D | ||
| 607-128-00-1 | 2-tert-butylaminoethyl methacrylate | 223-228-4 | 3775-90-4 | Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Achtg. |
H319 H315 H317 |
D | ||
| 607-129-00-7 | ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] |
202-598-0 [1] 211-694-1 [2] |
97-64-3 [1] 687-47-8 [2] |
Flam. Liq. 3 STOT SE 3 Eye Dam. 1 |
H226 H335 H318 |
GHS02 GHS05 GHS07 Gef. |
H226 H335 H318 |
C | ||
| 607-130-00-2 | pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] |
211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] |
628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] |
Flam. Liq. 3 | H226 | GHS02 | H226 | EUH066 | C | |
| 607-131-00-8 | isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] |
203-322-1 [1] 210-852-7 [2] 219-449-0 [3] |
105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] |
Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | C | ||
| 607-132-00-3 | 2-dimethylaminoethyl methacrylate | 220-688-8 | 2867-47-2 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H315 H317 |
GHS07 Achtg. |
H312 H302 H319 H315 H317 |
D | ||
| 607-133-00-9 | monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H335 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H411 |
STOT SE 3; H335: C ≥ 10 % | A | |
| 607-134-00-4 | monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex | - | - | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
STOT SE 3; H335: C ≥ 10 % | A | |
| 607-135-00-X | butyric acid | 203-532-3 | 107-92-6 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 607-136-00-5 | butyryl chloride | 205-498-5 | 141-75-3 | Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Gef. |
H225 H314 |
|||
| 607-137-00-0 | methyl acetoacetate | 203-299-8 | 105-45-3 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-138-00-6 | butyl chloroformate; chloroformic acid butyl ester |
209-750-5 | 592-34-7 | Flam. Liq. 3 Acute Tox. 3 (*) Skin Corr. 1B |
H226 H331 H314 |
GHS02 GHS06 GHS05 Gef. |
H226 H331 H314 |
|||
| 607-139-00-1 | 2-chloropropionic acid | 209-952-3 | 598-78-7 | Acute Tox. 4 (*) Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Gef. |
H302 H314 |
|||
| 607-140-00-7 | isobutyryl chloride | 201-194-1 | 79-30-1 | Flam. Liq. 2 Skin Corr. 1A |
H225 H314 |
GHS02 GHS05 Gef. |
H225 H314 |
|||
| 607-141-00-2 | oxydiethylene bis(chloroformate) | 203-430-9 | 106-75-2 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H315 H318 H411 |
|||
| 607-142-00-8 | propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate |
203-687-7 | 109-61-5 | Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H314 |
GHS02 GHS06 GHS05 Gef. |
H225 H331 H314 |
|||
| 607-143-00-3 | valeric acid | 203-677-2 | 109-52-4 | Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Gef. |
H314 H412 |
|||
| 607-144-00-9 | adipic acid | 204-673-3 | 124-04-9 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-145-00-4 | methanesulphonic acid | 200-898-6 | 75-75-2 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 607-146-00-X | fumaric acid | 203-743-0 | 110-17-8 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-147-00-5 | oxalic acid diethylester; diethyl oxalate |
202-464-1 | 95-92-1 | Acute Tox. 4 (*) Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 607-148-00-0 | guanidinium chloride; guanadine hydrochloride |
200-002-3 | 50-01-1 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Achtg. |
H302 H319 H315 |
|||
| 607-149-00-6 | urethane (INN); ethyl carbamate |
200-123-1 | 51-79-6 | Carc. 1B | H350 | GHS08 Gef. |
H350 | |||
| 607-150-00-1 | endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid |
205-660-5 | 145-73-3 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Gef. |
H301 H312 H319 H335 H315 |
|||
| 607-151-00-7 | propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite |
219-006-1 | 2312-35-8 | Carc. 2 Acute Tox. 3 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H315 H318 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H351 H331 H315 H318 H410 |
M=10 | ||
| 607-152-00-2 | 2,3,6-TBa (ISO); 2,3,6-trichlorobenzoic acid |
200-026-4 | 50-31-7 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-153-00-8 | benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid |
223-297-0 | 3813-05-6 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Achtg. |
H319 H315 H412 |
|||
| 607-154-00-3 | ethylN-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO) |
244-845-5 | 22212-55-1 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-155-00-9 | 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s |
- | 2079-00-7 | Acute Tox. 2 (*) | H300 | GHS06 Gef. |
H300 | |||
| 607-156-00-4 | chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate |
201-270-4 | 80-33-1 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H315 H410 |
|||
| 607-157-00-X | Difenacoum (ISO); 3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycumarin | 259-978-4 | 56073-07-5 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
||
| 607-158-00-5 | sodium salt of chloroacetic acid; sodium chloroacetate |
223-498-3 | 3926-62-3 | Acute Tox. 3 (*) Skin Irrit. 2 Aquatic Acute 1 |
H301 H315 H400 |
GHS06 GHS09 Gef. |
H301 H315 H400 |
|||
| 607-159-00-0 | chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate |
208-110-2 | 510-15-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-160-00-6 | isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) |
- | 51337-71-4 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-161-00-1 | diethanolamine salt of 4-CPA | - | - | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-162-00-7 | dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate [2] |
200-923-0 [1] 204-828-5 [2] |
75-99-0 [1] 127-20-8 [2] |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Gef. |
H315 H318 H412 |
|||
| 607-163-00-2 | 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid |
208-293-9 | 520-45-6 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-164-00-8 | sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate |
224-580-1 | 4418-26-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-165-00-3 | diclofop-methyl (ISO) methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; |
257-141-8 | 51338-27-3 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 607-166-00-9 | medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate |
219-634-6 | 2487-01-6 | Acute Tox. 3 (*) Acute Tox. 4 (*) |
H301 H312 |
GHS06 Gef. |
H301 H312 |
|||
| 607-167-00-4 | sodium 3-chloroacrylate | - | 4312-97-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 607-168-00-X | dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome |
- | 83-59-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H400 H410 |
GHS06 GHS09 Gef. |
H311 H302 H410 |
|||
| 607-169-00-5 | sodium fluoroacetate | 200-548-2 | 62-74-8 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 |
H330 H310 H300 H400 |
GHS06 GHS09 Gef. |
H330 H310 H300 H400 |
|||
| 607-170-00-0 | bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate |
250-859-2 | 31895-22-4 | Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H312 H302 H410 |
|||
| 607-172-00-1 | Brodifacoum (ISO); 4-Hydroxy-3-(3-(4′-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)cumarin |
259-980-5 | 56073-10-0 | Repr. 1 a Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 10 M = 10 |
||
| 607-173-00-7 | dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate | 400-460-6 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-174-00-2 | reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate | 400-580-9 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-175-00-8 | methyl 2-(2-nitrobenzylidene)acetoacetate | 400-650-9 | 39562-27-1 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-176-00-3 | reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) | 400-830-7 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-177-00-9 | tribenuron-methyl (ISO); methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate |
401-190-1 | 101200-48-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
M = 100 | ||
| 607-178-00-4 | methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate | 401-340-6 | 83055-99-6 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-179-00-X | (benzothiazol-2-ylthio)succinic acid | 401-450-4 | 95154-01-1 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-180-00-5 | potassium 2-hydroxycarbazole-1-carboxylate | 401-630-2 | 96566-70-0 | Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H302 H319 H335 H412 |
GHS07 Achtg. |
H302 H319 H335 H412 |
|||
| 607-181-00-0 | 3,5-dichloro-2,4-difluorobenzoyl fluoride | 401-800-6 | 101513-70-6 | Acute Tox. 3 (*) Skin Corr. 1B Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 |
H331 H314 H302 H317 H412 |
GHS06 GHS05 Gef. |
H331 H314 H302 H317 H412 |
EUH029 | ||
| 607-182-00-6 | methyl 3-sulphamoyl-2-thenoate | 402-050-2 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-183-00-1 | zinc 2-hydroxy-5-C13-18alkylbenzoate | 402-280-3 | - | Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Achtg. |
H319 H315 H411 |
|||
| 607-184-00-7 | S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate | 402-290-8 | 85702-90-5 | Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 |
H226 H334 H317 |
GHS02 GHS08 Gef. |
H226 H334 H317 |
|||
| 607-185-00-2 | ethyltrans-3-dimethylaminoacrylate | 402-650-4 | 1117-37-9 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-186-00-8 | quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid |
402-780-1 | 84087-01-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-187-00-3 | bis(2,2,6,6-tetramethyl-4-piperidyl) succinate | 402-940-0 | 62782-03-0 | Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Achtg. |
H319 H412 |
|||
| 607-188-00-9 | hydrogen sodiumN-carboxylatoethyl-N-octadec-9-enylmaleamate | 402-970-4 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-189-00-4 | trimethylenediaminetetraacetic acid | 400-400-9 | 1939-36-2 | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 607-190-00-X | methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) | 401-890-7 | 77402-03-0 | Carc. 1B Muta. 1B Acute Tox. 4 (*) Eye Irrit. 2 |
H350 H340 H302 H319 |
GHS08 GHS07 Gef. |
H350 H340 H302 H319 |
|||
| 607-191-00-5 | isobutyl 3,4-epoxybutyrate | 401-920-9 | 100181-71-3 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 607-192-00-0 | disodiumN-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate | 402-360-8 | 92511-22-3 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-194-00-1 | propylene carbonate | 203-572-1 | 108-32-7 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-195-00-7 | 2-methoxy-1-methylethyl acetate | 203-603-9 | 108-65-6 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | |||
| 607-196-00-2 | heptanoic acid | 203-838-7 | 111-14-8 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 607-197-00-8 | Nonansäure | 203-931-2 | 112-05-0 | Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 |
H315 H319 H412 |
GHS07 Achtg. |
H315 H319 H412 |
|||
| 607-198-00-3 | propyl 3,4,5-trihydroxybenzoate | 204-498-2 | 121-79-9 | Acute Tox. 4 (*) Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 607-199-00-9 | octyl 3,4,5-trihydroxybenzoate | 213-853-0 | 1034-01-1 | Acute Tox. 4 (*) Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 607-200-00-2 | dodecyl 3,4,5-trihydroxybenzoate | 214-620-6 | 1166-52-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-201-00-8 | thiocarbonyl chloride | 207-341-6 | 463-71-8 | Acute Tox. 3 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H331 H302 H319 H335 H315 |
GHS06 Gef. |
H331 H302 H319 H335 H315 |
|||
| 607-203-00-9 | 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate | 279-452-8 | 80387-97-9 | Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H360D (*)(*)(*) H317 H412 |
GHS08 GHS07 Gef. |
H360D (*)(*)(*) H317 H412 |
|||
| 607-204-00-4 | (chlorophenyl)(chlorotolyl)methane, mixed isomers | 400-140-6 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-205-00-X | methyl chloroacetate | 202-501-1 | 96-34-4 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 3 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H331 H301 H335 H315 H318 |
GHS02 GHS06 GHS05 Gef. |
H226 H331 H301 H335 H315 H318 |
|||
| 607-206-00-5 | isopropyl chloroacetate | 203-301-7 | 105-48-6 | Flam. Liq. 3 Acute Tox. 3 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H301 H319 H335 H315 |
GHS02 GHS06 Gef. |
H226 H301 H319 H335 H315 |
|||
| 607-207-00-0 | haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) |
402-560-5 | 87237-48-7 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-208-00-6 | 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers | 403-000-2 | 91853-67-7 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 607-209-00-1 | reaction mass ofO,O'-diisopropyl (pentathio)dithioformate andO,O'-diisopropyl (trithio)dithioformate andO,O'-diisopropyl (tetrathio)dithioformate | 403-030-6 | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 607-210-00-7 | methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) | 403-230-3 | 77402-05-2 | Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 |
H350 H340 H314 H317 |
GHS08 GHS05 GHS07 Gef. |
H350 H340 H314 H317 |
|||
| 607-211-00-2 | methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate | 403-270-1 | 6386-39-6 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-212-00-8 | poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate | 403-300-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-213-00-3 | ethyl 3,3-bis(tert-pentylperoxy)butyrate | 403-320-2 | 67567-23-1 | Org. Perox. D**** Flam. Liq. 3 Aquatic Chronic 2 |
H242 H226 H411 |
GHS02 GHS09 Gef. |
H242 H226 H411 |
|||
| 607-214-00-9 | N,N-hydrazinodiacetic acid | 403-510-5 | 19247-05-3 | Acute Tox. 3 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 |
H301 H373 (*)(*) H317 H412 |
GHS06 GHS08 Gef. |
H301 H373 (*)(*) H317 H412 |
|||
| 607-215-00-4 | 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid | 403-920-4 | 107551-67-7 | Acute Tox. 4 (*) Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 607-216-00-X | glutamic acid, reaction products withN-(C12-14-alkyl)propylenediamine | 403-950-8 | - | Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H330 H302 H314 H400 |
GHS06 GHS05 GHS09 Gef. |
H330 H302 H314 H400 |
|||
| 607-217-00-5 | 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate | 403-960-2 | - | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-218-00-0 | dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid |
403-980-1 | 15165-67-0 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-219-00-6 | bis(2-ethylhexyl) dithiodiacetate | 404-510-8 | 62268-47-7 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 607-221-00-7 | 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid | 404-550-6 | - | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-222-00-2 | 6-(2,3-dimethylmaleimido)hexyl methacrylate | 404-870-6 | 63740-41-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-223-00-8 | transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyltrans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate |
405-060-5 | 118712-89-3 | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 607-224-00-3 | methyl 2-(3-nitrobenzylidene)acetoacetate | 405-270-7 | 39562-17-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-225-00-9 | 3-azidosulfonylbenzoic acid | 405-310-3 | 15980-11-7 | Self-React. C (*)(*)(*)(*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 |
H241 H373 (*)(*) H318 H317 |
GHS02 GHS08 GHS05 GHS07 Gef. |
H241 H373 (*)(*) H318 H317 |
|||
| 607-226-00-4 | reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate | 405-360-6 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H315 H318 H317 H412 |
GHS05 GHS07 Gef. |
H315 H318 H317 H412 |
|||
| 607-227-00-X | potassium 2-amino-2-methylpropionate octahydrate | 405-560-3 | 120447-91-8 | Acute Tox. 4 (*) Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Gef. |
H302 H314 |
|||
| 607-228-00-5 | bis(2-methoxyethyl) phthalate | 204-212-6 | 117-82-8 | Repr. 1B | H360Df | GHS08 Gef. |
H360Df | |||
| 607-229-00-0 | diethylcarbamoyl chloride | 201-798-5 | 88-10-8 | Carc. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H332 H302 H319 H335 H315 |
GHS08 GHS07 Achtg. |
H351 H332 H302 H319 H335 H315 |
|||
| 607-230-00-6 | 2-ethylhexanoic acid | 205-743-6 | 149-57-5 | Repr. 2 | H361d (*)(*)(*) | GHS08 Achtg. |
H361d (*)(*)(*) | |||
| 607-231-00-1 | clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid |
216-935-4 | 1702-17-6 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-232-00-7 | pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl)S-octyl thiocarbonate |
259-686-7 | 55512-33-9 | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 607-233-00-2 | hexyl acrylate | 219-698-5 | 2499-95-8 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H317 H411 |
|||
| 607-234-00-8 | flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid |
207-397-1 | 467-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-235-00-3 | mecrilate; methyl 2-cyanoacrylate |
205-275-2 | 137-05-3 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
STOT SE 3; H335: C ≥ 10 % | ||
| 607-236-00-9 | ethyl 2-cyanoacrylate | 230-391-5 | 7085-85-0 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Achtg. |
H319 H335 H315 |
STOT SE 3; H335: C ≥ 10 % | ||
| 607-237-00-4 | benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole |
276-942-3 | 72850-64-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-238-00-X | tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methylN-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate |
- | 102851-06-9 | Acute Tox. 4 (*) Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H315 H410 |
|||
| 607-239-00-5 | fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate |
254-485-0 | 39515-41-8 | Acute Tox. 2 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H330 H301 H312 H410 |
|||
| 607-240-00-0 | cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalic anhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalic anhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] |
216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] |
1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Gef. |
H318 H334 H317 |
C | ||
| 607-241-00-6 | hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalic anhydride [4] |
243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] |
19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Gef. |
H318 H334 H317 |
C | ||
| 607-242-00-1 | tetrachlorophthalic anhydride | 204-171-4 | 117-08-8 | Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H317 H400 H410 |
GHS08 GHS05 GHS09 Gef. |
H318 H334 H317 H410 |
|||
| 607-243-00-7 | sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] |
217-846-3 [1] 246-590-5 [2] 258-527-9 [3] |
1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] |
Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-244-00-2 | isooctyl acrylate | 249-707-8 | 29590-42-9 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H410 |
STOT SE 3; H335: C ≥ 10 % | ||
| 607-245-00-8 | tert-butyl acrylate | 216-768-7 | 1663-39-4 | Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H312 H302 H335 H315 H317 H411 |
GHS02 GHS07 GHS09 Gef. |
H225 H332 H312 H302 H335 H315 H317 H411 |
D | ||
| 607-246-00-3 | allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester |
202-473-0 | 96-05-9 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 |
H226 H331 H312 H302 H400 |
GHS02 GHS06 GHS09 Gef. |
H226 H331 H312 H302 H400 |
|||
| 607-247-00-9 | dodecyl methacrylate | 205-570-6 | 142-90-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H410 |
STOT SE 3; H335: C ≥ 10 % | ||
| 607-248-00-4 | naptalam-sodium (ISO); sodiumN-naphth-1-ylphthalamate |
205-073-4 | 132-67-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-249-00-X | (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate | 256-032-2 | 42978-66-5 | Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Achtg. |
H319 H335 H315 H317 H411 |
STOT SE 3; H335: C ≥ 10 % | ||
| 607-250-00-5 | 4H-3,1-benzoxazine-2,4(1H)-dione | 204-255-0 | 118-48-9 | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 607-251-00-0 | 2-methoxypropyl acetate | 274-724-2 | 70657-70-4 | Flam. Liq. 3 Repr. 1B STOT SE 3 |
H226 H360D (*)(*)(*) H335 |
GHS02 GHS08 GHS07 Gef. |
H226 H360D (*)(*)(*) H335 |
|||
| 607-252-00-6 | lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) |
415-130-7 | 91465-08-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Gef. |
H330 H301 H312 H410 |
M=10000 | ||
| 607-253-00-1 | cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
269-855-7 | 68359-37-5 | Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H331 H400 H410 |
GHS06 GHS09 Gef. |
H300 H331 H410 |
M=1000 | ||
| 607-254-00-7 | α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin |
269-855-7 | 68359-37-5 | Acute Tox. 2 (*) Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H300 H410 |
|||
| 607-255-00-2 | fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid |
- | 69377-81-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-256-00-8 | azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate |
- | 131860-33-8 | Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H400 H410 |
GHS06 GHS09 Gef. |
H331 H410 |
|||
| 607-257-00-3 | isopropyl propionate | 211-300-8 | 637-78-5 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | |||
| 607-258-00-9 | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate | 403-990-6 | 70950-45-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-259-00-4 | methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate | 404-130-2 | 105560-93-8 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-260-00-X | ethyl 2-(3-nitrobenzylidene)acetoacetate | 404-490-0 | 39562-16-8 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-261-00-5 | iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate | 404-800-4 | 118832-72-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-262-00-0 | 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 405-050-0 | 86393-33-1 | Acute Tox. 4 (*) Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 607-263-00-6 | potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate | 405-680-6 | - | Self-heat. 2 (*)(*)(*)(*) Aquatic Chronic 2 |
H252 H411 |
GHS02 GHS09 Achtg. |
H252 H411 |
|||
| 607-264-00-1 | 2-chloro-4-(methylsulfonyl)benzoic acid | 406-520-8 | 53250-83-2 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-265-00-7 | ethyl-2-chloro-2,2-diphenylacetate | 406-580-5 | 52460-86-3 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 607-266-00-2 | reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid |
406-890-0 | 130296-87-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-267-00-8 | tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | 407-620-4 | 33610-13-8 | Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Gef. |
H334 H317 H412 |
|||
| 607-268-00-3 | 2-methylpropyl (R)-2-hydroxypropanoate | 407-770-0 | 61597-96-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-269-00-9 | (R)-2-(4-hydroxyphenoxy)propanoic acid | 407-960-3 | 94050-90-5 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-270-00-4 | 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane | 410-730-5 | 90498-90-1 | Acute Tox. 4 (*) | H312 | GHS07 Achtg. |
H312 | |||
| 607-271-00-X | 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane | 417-420-9 | 156324-82-2 | Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Achtg. |
H319 H411 |
|||
| 607-272-00-5 | fluroxypyr-meptyl (ISO); methylheptyl,O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl,O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] |
279-752-9 [1] [2] |
81406-37-3 [1] 154486-27-8 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-273-00-0 | ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate | 404-520-2 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-274-00-6 | 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate | 405-350-1 | 54527-73-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-275-00-1 | sodium benzoyloxybenzene-4-sulfonate | 405-450-5 | 66531-87-1 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-276-00-7 | bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex | 405-635-0 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 607-277-00-2 | reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate |
405-720-2 | - | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H317 H411 |
|||
| 607-278-00-8 | reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate |
405-760-0 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-279-00-3 | reaction mass ofn-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate |
405-960-8 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-280-00-9 | sodium 4-chloro-1-hydroxybutane-1-sulfonate | 406-190-5 | 54322-20-2 | Acute Tox. 4 (*) Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Achtg. |
H302 H319 H317 |
|||
| 607-281-00-4 | reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates | 407-000-3 | 127519-17-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-282-00-X | 2-acetoxymethyl-4-benzyloxybut-1-yl acetate | 407-140-5 | 131266-10-9 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-283-00-5 | E-ethyl-4-oxo-4-phenylcrotonate | 408-040-4 | 15121-89-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H312 H302 H315 H318 H317 H410 |
|||
| 607-284-00-0 | reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) |
410-040-4 | 136213-76-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-285-00-6 | reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate |
410-065-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
||||
| 607-286-00-1 | reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate | 410-070-8 | 141880-36-6 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-287-00-7 | O'-methylO-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate | 410-140-8 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-288-00-2 | tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, wherea is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18,d is 22 or 23 or 24 or 25 and wheree andf together are 2 and 4 or 4 and 2 respectively | 410-160-7 | 148732-74-5 | Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Achtg. |
H319 H317 H412 |
|||
| 607-289-00-8 | 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid | 410-370-9 | 105488-33-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-290-00-3 | reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate |
410-540-2 | - | Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H317 H410 |
|||
| 607-291-00-9 | dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate | 410-630-1 | 104051-92-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-292-00-4 | reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid |
410-640-6 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 607-293-00-X | reaction mass of:N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate |
410-650-0 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H411 |
|||
| 607-294-00-5 | sodium 2-benzoyloxy-1-hydroxyethane-sulfonate | 410-680-4 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-295-00-0 | reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate |
410-800-5 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-296-00-6 | reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid | 410-830-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-297-00-1 | (E -E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) | 410-960-6 | 92761-26-7 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-298-00-7 | 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate | 411-010-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-299-00-2 | methyl 3-(acetylthio)-2-methyl-propanoate | 411-040-7 | 97101-46-7 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 607-300-00-6 | trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) wherea=1,2,3,4b=8,9,10,11c=15,16,17,18d=22,23,24,25 | 411-430-7 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-301-00-1 | reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid |
411-860-5 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-302-00-7 | reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid |
411-910-6 | - | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H411 |
|||
| 607-303-00-2 | 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 413-760-7 | 93107-30-3 | Repr. 2 Aquatic Chronic 3 |
H361f (*)(*)(*) H412 |
GHS08 Achtg. |
H361f (*)(*)(*) H412 |
|||
| 607-304-00-8 | fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate |
274-125-6 | 69806-50-4 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D (*)(*)(*) H400 H410 |
GHS08 GHS09 Gef. |
H360D (*)(*)(*) H410 |
|||
| 607-305-00-3 | fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate |
- | 79241-46-6 | Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H400 H410 |
GHS08 GHS09 Achtg. |
H361d (*)(*)(*) H410 |
|||
| 607-306-00-9 | chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate |
282-714-4 | 84332-86-5 | Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Achtg. |
H351 H411 |
|||
| 607-307-00-4 | vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione |
256-599-6 | 50471-44-8 | Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H360FD H317 H411 |
GHS08 GHS07 GHS09 Gef. |
H351 H360FD H317 H411 |
|||
| 607-308-00-X | esters of 2,4-D | - | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
A | ||
| 607-309-00-5 | carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate |
- | 128639-02-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-310-00-0 | kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate |
- | 143390-89-0 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
|||
| 607-311-00-6 | benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate |
246-591-0 | 25059-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-312-00-1 | methoxyacetic acid | 210-894-6 | 625-45-6 | Repr. 1B Acute Tox. 4 (*) Skin Corr. 1B |
H360FD H302 H314 |
GHS08 GHS05 GHS07 Gef. |
H360FD H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 607-313-00-7 | neodecanoyl chloride | 254-875-0 | 40292-82-8 | Acute Tox. 2 (*) Acute Tox. 4 (*) Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS06 Gef. |
H330 H302 H314 |
STOT SE 3; H335: C ≥ 5 % | ||
| 607-314-00-2 | ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate |
247-525-3 | 26225-79-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-315-00-8 | glyphosate (ISO); N-(phosphonomethyl)glycine |
213-997-4 | 1071-83-6 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 607-316-00-3 | glyphosate-trimesium; glyphosate-trimethylsulfonium |
- | 81591-81-3 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-317-00-9 | bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP |
204-211-0 | 117-81-7 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | |||
| 607-318-00-4 | dibutyl phthalate; DBP |
201-557-4 | 84-74-2 | Repr. 1B Aquatic Acute 1 |
H360Df H400 |
GHS08 GHS09 Gef. |
H360Df H400 |
|||
| 607-319-00-X | deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate |
258-256-6 | 52918-63-5 | Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H410 |
M=1000000 | ||
| 607-320-00-5 | bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate | 413-930-0 | 130066-57-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-321-00-0 | (S)-methyl-2-chloropropionate | 412-470-8 | 73246-45-4 | Flam. Liq. 3 STOT RE 2 (*) Eye Irrit. 2 |
H226 H373 (*)(*) H319 |
GHS02 GHS08 Achtg. |
H226 H373 (*)(*) H319 |
|||
| 607-322-00-6 | 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid | 413-120-7 | 107144-30-9 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-323-00-1 | 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate | 413-850-6 | 123968-25-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-324-00-7 | reaction mass of:N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine |
413-800-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-325-00-2 | (S)-2-chloropropionic acid | 411-150-5 | 29617-66-1 | Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Gef. |
H312 H302 H314 |
|||
| 607-326-00-8 | reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate |
410-720-0 | 141847-13-4 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 607-327-00-3 | 2-(2-iodoethyl)-1,3-propanediol diacetate | 411-780-0 | 127047-77-2 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-328-00-9 | methyl 4-bromomethyl-3-methoxybenzoate | 410-310-1 | 70264-94-7 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 607-329-00-4 | reaction mass of: sodium 2-(C12-18 -n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate |
411-250-9 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-330-00-X | (S)-2,3-dihydro-1H-indole-2-carboxylic acid | 410-860-2 | 79815-20-6 | Repr. 2 STOT RE 2 (*) Skin Sens. 1 |
H361f (*)(*)(*) H373 (*)(*) H317 |
GHS08 GHS07 Achtg. |
H361f (*)(*)(*) H373 (*)(*) H317 |
|||
| 607-332-00-0 | cyclopentyl chloroformate | 411-460-0 | 50715-28-1 | Flam. Liq. 3 Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 |
H226 H331 H302 H373 (*)(*) H318 H317 |
GHS02 GHS06 GHS08 GHS05 Gef. |
H226 H331 H302 H373 (*)(*) H318 H317 |
|||
| 607-333-00-6 | reaction mass of: dodecylN-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecylN-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate |
405-670-1 | - | Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 (*)(*) H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H302 H373 (*)(*) H314 H410 |
|||
| 607-334-00-1 | ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate | 405-880-3 | 100501-62-0 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-335-00-7 | methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate | 406-250-0 | 72619-32-0 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 607-336-00-2 | 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate | 406-560-6 | 122760-85-4 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Achtg. |
H315 H317 H411 |
|||
| 607-337-00-8 | di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate | 406-052-4 | 125078-60-6 | Flam. Liq. 3 Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H302 H315 H318 H411 |
GHS02 GHS05 GHS07 GHS09 Gef. |
H226 H302 H315 H318 H411 |
|||
| 607-338-00-3 | 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate | 406-235-9 | 72531-53-4 | Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Achtg. |
H319 H315 |
|||
| 607-339-00-9 | 2,3,4,5-tetrachlorobenzoylchloride | 406-760-3 | 42221-52-3 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Gef. |
H302 H314 H317 |
|||
| 607-340-00-4 | 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate | 406-990-4 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-341-00-X | (9S)-9-amino-9-deoxyerythromycin | 406-790-7 | 26116-56-3 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 607-342-00-5 | 4-chlorobutyl veratrate | 410-950-1 | 69788-75-6 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-343-00-0 | 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) | 407-410-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-344-00-6 | reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate |
407-810-7 | - | STOT RE 2 (*) | H373 (*)(*) | GHS08 Achtg. |
H373 (*)(*) | |||
| 607-345-00-1 | potassium 2-(2,4-dichlorophenoxy)-(R)-propionate | 413-580-9 | 113963-87-4 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-346-00-7 | 3-icosyl-4-henicosylidene-2-oxetanone | 401-210-9 | 83708-14-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-347-00-2 | sodium (R)-2-(2,4-dichlorophenoxy)propionate | 413-340-3 | 119299-10-4 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-348-00-8 | magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) | 413-360-2 | - | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-349-00-3 | mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate | 411-270-8 | - | Aquatic Chronic 3 | H412 | H412 | ||||
| 607-350-00-9 | bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane | 412-060-9 | 136210-32-7 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-351-00-4 | methylO-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate | 407-550-4 | 69184-17-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-352-00-X | 4,4'-oxydiphthalic anhydride | 412-830-4 | 1823-59-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-353-00-5 | reaction mass of: ethylexo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethylendo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate |
407-520-0 | 80657-64-3 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-354-00-0 | ethyl 2-cyclohexylpropionate | 412-280-5 | 2511-00-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-355-00-6 | p-tolyl 4-chlorobenzoate | 411-530-0 | 15024-10-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-356-00-1 | ethyltrans-2,2,6-trimethylcyclohexanecarboxylate | 412-540-8 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-357-00-7 | reaction mass of:trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran |
412-450-9 | 131766-73-9 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-358-00-2 | (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate | 412-670-5 | 54275-93-3 | Resp. Sens. 1 | H334 | GHS08 Gef. |
H334 | |||
| 607-359-00-8 | (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate | 412-800-0 | 76109-32-5 | Resp. Sens. 1 | H334 | GHS08 Gef. |
H334 | |||
| 607-360-00-3 | sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate | 411-680-7 | 133167-77-8 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-361-00-9 | methyl (R)-2-(4-hydroxyphenoxy)propionate | 411-950-4 | 96562-58-2 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-362-00-4 | reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate |
413-500-2 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H315 H318 H411 |
GHS05 GHS09 Gef. |
H315 H318 H411 |
|||
| 607-363-00-X | methyl-3-methoxyacrylate | 412-900-4 | 5788-17-0 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-364-00-5 | 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione | 413-330-9 | 134724-55-3 | Aquatic Chronic 4 | H413 | H413 | ||||
| 607-365-00-0 | 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride | 410-620-7 | 119154-86-8 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Gef. |
H302 H314 H317 |
|||
| 607-366-00-6 | 3,5-dimethylbenzoyl chloride | 413-010-9 | 6613-44-1 | Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Gef. |
H314 H317 |
|||
| 607-367-00-1 | potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate | 411-640-9 | 153352-59-1 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-368-00-7 | 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole | 411-650-3 | 110895-43-7 | Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H410 |
|||
| 607-369-00-2 | reaction mass of:trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid |
411-660-8 | 147027-04-1 | Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-370-00-8 | 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 412-210-3 | 41620-33-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-371-00-3 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate | 413-410-3 | 88150-62-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-372-00-9 | ethoxylated bis phenol a di-(norbornene carboxylate) | 412-410-0 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-373-00-4 | (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate | 414-200-4 | 119738-06-6 | Muta. 2 Repr. 1B Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360Df H302 H373 (*)(*) H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H341 H360Df H302 H373 (*)(*) H410 |
|||
| 607-374-00-X | 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride | 417-220-1 | 37441-29-5 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-375-00-5 | Flocoumafen (ISO); Reaktionsmasse aus: cis-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin und trans-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin | 421-960-0 | 90035-08-8 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,05 % STOT RE 2; H373 (Blut): 0,005 % ≤ C < 0,05 % M = 10 M = 10 |
||
| 607-376-00-0 | benzyl 2,4-dibromobutanoate | 420-710-8 | 23085-60-1 | Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f (*)(*)(*) H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361f (*)(*)(*) H315 H317 H410 |
|||
| 607-377-00-6 | trans-4-cyclohexyl-L-proline monohydrochloride | 419-160-1 | 90657-55-9 | Repr. 2 Acute Tox. 4 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H361f (*)(*)(*) H302 H315 H318 H317 |
GHS08 GHS05 GHS07 Gef. |
H361f (*)(*)(*) H302 H315 H318 H317 |
|||
| 607-378-00-1 | ammonium (Z)-α-methoxyimino-2-furylacetate | 405-990-1 | 97148-39-5 | Flam. Sol. 2 | H228 | GHS02 Gef. |
H228 | T | ||
| 607-379-00-7 | reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide |
401-230-8 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-380-00-2 | reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate |
407-320-3 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Gef. |
H315 H318 H412 |
|||
| 607-381-00-8 | reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid | 413-710-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-382-00-3 | 2-((4-amino-2-nitrophenyl)amino)benzoic acid | 411-260-3 | 117907-43-4 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-383-00-9 | reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate |
415-430-8 | 86403-32-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H410 |
|||
| 607-384-00-4 | reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate |
413-750-2 | 171090-93-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-385-00-X | Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate | 414-590-6 | 125229-74-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-386-00-5 | reaction mass of: tetradecanoic acid (42,5 -47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5 - 57,5 %) |
412-580-6 | 174591-51-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 607-387-00-0 | reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) |
412-590-0 | 58856-63-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 607-388-00-6 | 4-ethylamino-3-nitrobenzoic acid | 412-090-2 | 2788-74-1 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Achtg. |
H302 H317 H412 |
|||
| 607-389-00-1 | trisodiumN,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate | 414-130-4 | 119710-96-2 | Acute Tox. 4 (*) | H302 | GHS07 Achtg. |
H302 | |||
| 607-390-00-7 | 1,2,3,4-tetrahydro-6-nitro-quinoxaline | 414-270-6 | 41959-35-7 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-391-00-2 | dimethylcyclopropane-1,1-dicarboxylate | 414-240-2 | 6914-71-2 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-392-00-8 | 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate | 414-260-1 | 88938-37-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-393-00-3 | 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 415-750-8 | 106447-44-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-394-00-9 | 5-methylpyrazine-2-carboxylic acid | 413-260-9 | 5521-55-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-395-00-4 | reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate |
410-230-7 | - | Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H317 H411 |
|||
| 607-396-00-X | bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate | 414-840-4 | 147783-69-5 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-397-00-5 | reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) |
415-930-6 | - | Repr. 2 Skin Sens. 1 |
H361f*** H317 |
GHS08 GHS07 Achtg. |
H361f*** H317 |
|||
| 607-398-00-0 | ethylN-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate | 414-820-5 | 125630-94-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-399-00-6 | 2,2-dimethyl 3-methyl-3-butenyl propanoate | 415-610-6 | 104468-21-5 | Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Achtg. |
H315 H412 |
|||
| 607-400-00-X | methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate | 414-400-1 | 32750-89-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-401-00-5 | ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate | 414-450-4 | 88805-65-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Gef. |
H315 H318 H317 |
|||
| 607-402-00-0 | methylN-(phenoxycarbonyl)-L-valinate | 414-500-5 | 153441-77-1 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-403-00-6 | reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol |
414-810-0 | - | STOT RE 2 (*) Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 (*)(*) H318 H400 H410 |
GHS08 GHS05 GHS09 Gef. |
H373 (*)(*) H318 H410 |
|||
| 607-404-00-1 | reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid |
415-190-4 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-405-00-7 | 2-hexyldecyl-p-hydroxybenzoate | 415-380-7 | 148348-12-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-406-00-2 | potassium 2,5-dichlorobenzoate | 415-700-5 | 184637-62-5 | Acute Tox. 4 (*) Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 607-407-00-8 | ethyl 2-carboxy-3-(2-thienyl)propionate | 415-680-8 | 143468-96-6 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Gef. |
H315 H318 H317 |
|||
| 607-408-00-3 | potassiumN-(4-fluorophenyl)glycinate | 415-710-1 | 184637-63-6 | STOT RE 2 (*) Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H373 (*)(*) H318 H317 H412 |
GHS08 GHS05 GHS07 Gef. |
H373 (*)(*) H318 H317 H412 |
|||
| 607-409-00-9 | reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass fromAspergillus terreus |
415-840-7 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-410-00-4 | mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate | 415-880-5 | 779343-34-9 | Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H315 H318 H317 H410 |
|||
| 607-411-00-X | oxiranemethanol, 4-methylbenzene-sulfonate, (S)- | 417-210-7 | 70987-78-9 | Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H350 H341 H318 H317 H411 |
|||
| 607-412-00-5 | ethyl 2-(1-cyanocyclohexyl)acetate | 415-970-4 | 133481-10-4 | Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Chronic 3 |
H302 H373 (*)(*) H412 |
GHS08 GHS07 Achtg. |
H302 H373 (*)(*) H412 |
|||
| 607-413-00-0 | trans-4-phenyl-L-proline | 416-020-1 | 96314-26-0 | Repr. 2 Skin Sens. 1 |
H361f (*)(*)(*) H317 |
GHS08 GHS07 Achtg. |
H361f (*)(*)(*) H317 |
|||
| 607-414-00-6 | tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate | 402-070-1 | 88122-99-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-415-00-1 | poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) | 419-590-1 | - | Flam. Sol. 1 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Gef. |
H228 H317 |
T | ||
| 607-416-00-7 | 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide | 420-730-7 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-417-00-2 | 3-chloropropyl chloroformiate | 425-770-9 | 628-11-5 | Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H331 H302 H373** H315 H318 H317 |
GHS06 GHS05 GHS08 Gef. |
H331 H302 H373** H315 H318 H317 |
|||
| 607-418-00-8 | 2-ethylhexyl 4-aminobenzoate | 420-170-3 | 26218-04-2 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-419-00-3 | (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid | 422-240-9 | 166596-68-5 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-420-00-9 | 2,2-bis(hydroxymethyl)butanoic acid | 424-090-1 | 10097-02-6 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-421-00-4 | cypermethrincis/trans +/- 40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
257-842-9 | 52315-07-8 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H335 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H302 H335 H410 |
|||
| 607-422-00-X | α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
257-842-9 | 67375-30-8 | Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H335 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H301 H373** H335 H410 |
M=1000 | ||
| 607-423-00-5 | esters of mecoprop and of mecoprop-P | - | - | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
A | ||
| 607-424-00-0 | trifloxystrobin (ISO); (E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester |
- | 141517-21-7 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-425-00-6 | metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate |
260-979-7 | 57837-19-1 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Achtg. |
H302 H317 H412 |
|||
| 607-426-00-1 | 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] |
284-032-2 [1] [2] 205-017-9 [3] 210-088-4 [4] |
84777-06-0 [1] [2] 131-18-0 [3] 605-50-5 [4] |
Repr. 1B Aquatic Acute 1 |
H360FD H400 |
GHS08 GHS09 Gef. |
H360FD H400 |
|||
| 607-427-00-7 | bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate |
260-300-4 | 56634-95-8 | Repr. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361d (*)(*)(*) H332 H302 H317 H410 |
|||
| 607-428-00-2 | tetrasodium ethylene diamine tetraacetate | 200-573-9 | 64-02-8 | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 607-429-00-8 | edetic acid; (EDTA) |
200-449-4 | 60-00-4 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-430-00-3 | BBP; benzyl butyl phthalate e |
201-622-7 | 85-68-7 | Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Gef. |
H360Df H410 |
|||
| 607-431-00-9 | prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate |
245-387-9 | 23031-36-9 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Gef. |
H331 H302 H410 |
|||
| 607-432-00-4 | S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] |
[1] [2] |
87392-12-9 [1] 178961-20-1 [2] |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-433-00-X | cypermethrincis/trans +/- 80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
257-842-9 | 52315-07-8 | Acute Tox. 4 (*) STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H315 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H335 H315 H317 H410 |
|||
| 607-434-00-5 | mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid |
240-539-0 | 16484-77-8 | Acute Tox. 4 (*) Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 607-435-00-0 | 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate | 416-810-6 | 111969-64-3 | STOT RE 2 (*) Eye Dam. 1 Aquatic Chronic 2 |
H373 (*)(*) H318 H411 |
GHS08 GHS05 GHS09 Gef. |
H373 (*)(*) H318 H411 |
|||
| 607-436-00-6 | 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate | 417-350-9 | - | Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Gef. |
H315 H318 H410 |
|||
| 607-437-00-1 | 3-(4-aminophenyl)-2-cyano-2-propenoic acid | 417-480-6 | 252977-62-1 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-438-00-7 | methyl-2-[(aminosulfonyl)methyl]benzoate | 419-010-5 | 112941-26-1 | Acute Tox. 4 (*) Eye Irrit. 2 |
H302 H319 |
GHS07 Achtg. |
H302 H319 |
|||
| 607-439-00-2 | methyl tetrahydro-2-furancarboxylate | 420-670-1 | 37443-42-8 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-440-00-8 | methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate | 421-220-7 | 144740-59-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-441-00-3 | 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid | 421-490-6 | 167684-63-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-442-00-9 | benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate | 416-050-5 | 87460-09-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-444-00-X | reaction mass of:cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate |
416-230-3 | 35541-81-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-445-00-5 | Iron (III) tris(4-methylbenzenesulfonate) | 420-960-8 | 77214-82-5 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-446-00-0 | methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate | 416-240-8 | 155522-12-6 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-447-00-6 | sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate | 416-370-5 | 156738-27-1 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-448-00-1 | 2,3,5,6-tetrafluorobenzoic acid | 416-800-1 | 652-18-6 | Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Gef. |
H315 H318 |
|||
| 607-449-00-7 | reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] |
417-080-1 | - | Self-react. D (*)(*)(*)(*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Gef. |
H242 H317 H410 |
|||
| 607-450-00-2 | 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | 419-040-9 | 89604-92-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-451-00-8 | 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt | 417-640-5 | 161935-19-9 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-453-00-9 | 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) | 418-100-1 | 172964-15-7 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-454-00-4 | reaction mass of:trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid |
418-170-3 | 116193-72-7 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-455-00-X | 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt | 419-520-8 | 172890-93-6 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-456-00-5 | 3-amino-4-chlorobenzoic acid, hexadecyl ester | 419-700-6 | 143269-74-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-457-00-0 | tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) | 420-350-1 | 172277-97-3 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 607-458-00-6 | reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] |
420-850-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-459-00-1 | isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate | 418-930-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-460-00-7 | 3-tridecyloxy-propyl-ammonium 9-octadecenoate | 418-990-1 | 778577-53-0 | STOT RE 2 (*) Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 (*)(*) H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H373 (*)(*) H319 H315 H410 |
|||
| 607-461-00-2 | reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate |
421-160-1 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-462-00-8 | reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates |
421-230-1 | 88230-35-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-463-00-3 | 3-(phenothiazin-10-yl)propionic acid | 421-260-5 | 362-03-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-464-00-9 | reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid |
421-280-4 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-465-00-4 | tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate | 421-440-3 | 778583-04-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-466-00-X | reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate |
421-480-1 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-467-00-5 | 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 419-430-9 | 56533-00-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 (*)(*) H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H312 H302 H373 (*)(*) H314 H410 |
|||
| 607-468-00-0 | reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate |
419-450-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-469-00-6 | disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate | 419-460-2 | 120029-06-3 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-470-00-1 | potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-100-0 | 154336-20-6 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-471-00-7 | 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane | 429-280-6 | 151900-44-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-473-00-8 | pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid | 426-590-3 | 187412-41-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-474-00-3 | (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | 410-430-4 | 117573-89-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-475-00-9 | reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) |
412-940-2 | 148878-18-6 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-476-00-4 | trisodiumN,N-bis(carboxymethyl)-β-alanine | 414-070-9 | 129050-62-0 | Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Gef. |
H314 H412 |
|||
| 607-477-00-X | (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt | 426-740-8 | - | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 607-478-00-5 | tetramethylammonium hydrogen phthalate | 416-900-5 | 79723-02-7 | Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 |
H301 H373 (*)(*) H400 |
GHS06 GHS08 GHS09 Gef. |
H301 H373 (*)(*) H400 |
|||
| 607-479-00-0 | hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate | 418-550-9 | 168689-49-4 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-480-00-6 | 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters |
271-084-6 | 68515-42-4 | Repr. 1B | H360Df | GHS08 Gef. |
H360Df | |||
| 607-481-00-1 | reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate |
430-290-8 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-482-00-7 | N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride | 430-360-8 | 84793-24-8 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-483-00-2 | 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich |
276-158-1 | 71888-89-6 | Repr. 1B | H360D*** | GHS08 Gef. |
H360D*** | |||
| 607-484-00-8 | ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate | 430-480-0 | 221452-67-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-485-00-3 | (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate | 430-510-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-486-00-9 | potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate | 402-110-8 | 110081-40-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-487-00-4 | reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate |
402-660-9 | - | Repr. 1B Aquatic Chronic 3 |
H360D (*)(*)(*) H412 |
GHS08 Gef. |
H360D (*)(*)(*) H412 |
|||
| 607-488-00-X | ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate | 414-210-9 | 147379-38-2 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-489-00-5 | reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate |
414-890-7 | 71302-79-9 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-490-00-0 | N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate | 415-060-7 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-491-00-6 | reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) |
427-140-9 | - | Carc. 2 | H351 | GHS08 Achtg. |
H351 | |||
| 607-492-00-1 | 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate | 415-490-5 | 141773-73-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-493-00-7 | methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate | 415-670-3 | 78850-37-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-494-00-2 | bis(2-ethylhexyl)octylphosphonate | 417-170-0 | 52894-02-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-495-00-8 | sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate | 417-550-6 | 168151-92-6 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-496-00-3 | 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite | 418-310-3 | 126050-54-2 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-497-00-9 | cerium oxide isostearate | 419-760-3 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-498-00-4 | (E)-3,7-dimethyl-2,6-octadienylhexadecanoate | 421-370-3 | 3681-73-0 | Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Achtg. |
H315 H413 |
|||
| 607-499-00-X | bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) | 421-660-1 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H318 H317 H411 |
|||
| 607-500-00-3 | calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate | 421-670-4 | - | Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Achtg. |
H315 H410 |
|||
| 607-501-00-9 | reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives | 421-820-9 | 192268-65-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-502-00-4 | (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate | 422-200-0 | 178277-55-9 | Skin Corr. 1B Acute Tox. 4 (*) Aquatic Chronic 2 |
H314 H302 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H302 H411 |
|||
| 607-503-00-X | 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane | 422-210-5 | 68957-94-8 | Skin Corr. 1B | H314 | GHS05 Gef. |
H314 | |||
| 607-504-00-5 | diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | 422-670-7 | - | Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361f H301 H373** H410 |
|||
| 607-505-00-0 | pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate | 422-930-1 | Aquatic Chronic 3 | H412 | - | H412 | ||||
| 607-506-00-6 | reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate |
422-970-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | ||||
| 607-507-00-1 | potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate | 422-980-2 | 187026-95-5 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-508-00-7 | disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] | 423-110-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-509-00-2 | 2-phenoxyethyl 4-aminobenzoate | 430-880-5 | 88938-23-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-510-00-8 | (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | 427-200-4 | 76646-91-8 | Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Gef. |
H302 H315 H318 H317 |
|||
| 607-511-00-3 | reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid |
423-750-4 | - | Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Achtg. |
H319 H411 |
|||
| 607-512-00-9 | trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate | 423-970-0 | 182926-43-8 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-513-00-4 | reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid |
423-200-3 | - | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-514-00-X | potassiumN-(1-methoxy-1-oxobut-2-en-3-yl)valinate | 427-240-2 | 134841-35-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-515-00-5 | reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate |
429-650-7 | 147732-60-3 | Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Achtg. |
H319 H411 |
|||
| 607-516-00-0 | N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine | 429-670-6 | 105996-54-1 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-517-00-6 | (S)-α-(acetylthio)benzenepropanoic acid | 430-300-0 | 76932-17-7 | Acute Tox. 4 (*) Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Gef. |
H302 H318 H317 |
|||
| 607-518-00-1 | 3-oxoandrost-4-ene-17-β-carboxylic acid | 414-990-0 | 302-97-6 | Repr. 2 Aquatic Chronic 4 |
H361f H413 |
GHS08 Achtg. |
H361f H413 |
|||
| 607-519-00-7 | poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-280-0 | 176429-27-9 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H335 H315 H318 H410 |
|||
| 607-520-00-2 | reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate |
427-740-0 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-521-00-8 | tetraethylN,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate | 429-270-1 | 136210-30-5 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-522-00-3 | sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate | 429-720-7 | 184246-86-4 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-523-00-9 | reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10’-diamino-6,6',13,13’-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10’[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate | 430-200-7 | - | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-524-00-4 | tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters | 430-310-5 | - | Aquatic Chronic 4 | H413 | H413 | ||||
| 607-525-00-X | (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | 431-520-1 | 64485-90-1 | Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 |
H228 H351 H412 |
GHS02 GHS08 Gef. |
H228 H351 H412 |
|||
| 607-526-00-5 | cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane |
- | 15263-53-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-527-00-0 | reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate |
423-180-6 | - | STOT RE 2 (*) | H373 (*)(*) | GHS08 Achtg. |
H373 (*)(*) | |||
| 607-528-00-6 | (S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid | 430-900-2 | 192725-50-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-529-00-1 | benzylcis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate | 426-070-6 | 67299-45-0 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-530-00-7 | reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate | 406-040-9 | 125643-61-0 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-531-00-2 | methyl 3-amino-4,6-dibromo-2-methyl-benzoate | 425-190-6 | 119916-05-1 | STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Achtg. |
H373** H411 |
|||
| 607-532-00-8 | (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt | 425-510-4 | 167944-94-7 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-533-00-3 | pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-910-4 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-534-00-9 | ethyl 2-(3-benzoylphenyl)propanoate | 414-920-9 | 60658-04-0 | Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H372** H317 H411 |
GHS06 GHS08 GHS09 Gef. |
H301 H372** H317 H411 |
|||
| 607-535-00-4 | potassium 4-iodo-2-sulfonato-benzoic acid | 426-620-5 | - | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-536-00-X | (2,6-xylyloxy) acetic acid | 430-910-7 | 13335-71-2 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Gef. |
H302 H318 H412 |
|||
| 607-537-00-5 | isopropylammonium 2-(3-benzoylphenyl)propionate | 417-970-1 | - | Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H372** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H301 H312 H372** H318 H410 |
|||
| 607-539-00-6 | propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate | 431-000-2 | 198705-81-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-540-00-1 | 1-(mercaptomethyl)cyclopropylacetic acid | 420-240-3 | 162515-68-6 | Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H312 H302 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H314 H312 H302 H317 H411 |
|||
| 607-541-00-7 | [(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) | 421-940-1 | 28698-31-9 | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 607-542-00-2 | methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate | 422-110-1 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-543-00-8 | poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-480-8 | 176429-22-4 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H335 H315 H318 H410 |
|||
| 607-544-00-3 | ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate | 427-490-2 | 158585-86-5 | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-545-00-9 | 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate | 424-070-0 | 94346-09-5 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-546-00-4 | reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate |
424-290-7 | 188070-47-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-547-00-X | 18-methylnonadecyl 2,2-dimethylpropanoate | 424-370-1 | 125496-22-2 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Achtg. |
H315 H317 H413 |
|||
| 607-548-00-5 | 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate | 431-010-7 | 154486-26-7 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 607-549-00-0 | methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate | 424-430-7 | 125778-19-0 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-550-00-6 | 2-amino-4-bromo-5-chlorobenzoic acid | 424-700-4 | - | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-551-00-1 | tetrabutylammonium 2-amino-6-iodopurinate | 424-710-9 | 156126-48-6 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H373** H315 H318 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H312 H302 H373** H315 H318 H317 H411 |
|||
| 607-552-00-7 | hexadecyl 3-amino-4-isopropoxybenzoate | 424-830-1 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-553-00-2 | 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt | 424-850-0 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-554-00-8 | 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid | 424-870-1 | 27624-67-5 | Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 |
H201 H318 H412 |
GHS01 GHS05 Gef. |
H201 H318 H412 |
|||
| 607-555-00-3 | 1,1,3,3-tetramethylbutylperoxypivalate | 424-980-8 | 22288-41-1 | Flam. Liq. 2 Org. Perox. D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H242 H315 H317 H411 |
GHS02 GHS07 GHS09 Gef. |
H225 H242 H315 H317 H411 |
|||
| 607-556-00-9 | 2-acetoxymethylene-4-acetylphenylacetate | 425-160-2 | 24085-06-1 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. | H302 H373** H318 H317 H410 |
|||
| 607-557-00-4 | salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid | 425-210-3 | 169939-84-8 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-558-00-X | 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolane-2-carboxylate | 425-250-1 | 147027-10-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-559-00-5 | coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid | 425-400-6 | 179986-09-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-560-00-0 | (R,S)-2-butyloctanedioic acid | 431-210-4 | 50905-10-7 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-561-00-6 | sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate | 425-460-3 | - | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-562-00-1 | reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate |
425-530-3 | 98769-75-6 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 607-563-00-7 | 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid | 431-250-2 | 171850-30-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-564-00-2 | 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate | 425-730-0 | 51178-75-7 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-565-00-8 | 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate | 425-820-1 | 88150-42-9 | Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H301 H373** H318 H410 |
|||
| 607-566-00-3 | reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate |
426-140-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-567-00-9 | potassium 3-iodo-6-methylbenzenesulfonate | 426-300-5 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-568-00-4 | potassium 2-chloro-3-(benzyloxy)propionate | 426-350-8 | 138666-92-9 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Gef. |
H302 H373** H318 H317 |
|||
| 607-569-00-X | reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate |
426-470-0 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-570-00-5 | sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate | 426-520-1 | 71420-85-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-571-00-0 | 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate | 431-400-7 | 57374-49-9 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-572-00-6 | diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate | 426-790-0 | 162208-27-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H312 H302 H373** H317 H410 |
|||
| 607-573-00-1 | reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate |
426-840-1 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-574-00-7 | [1R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate | 426-890-4 | 77341-67-4 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-575-00-2 | 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt | 426-900-7 | - | STOT SE 3 Aquatic Chronic 3 |
H335 H412 |
GHS07 Achtg. |
H335 H412 |
|||
| 607-576-00-8 | branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate | 427-030-0 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-577-00-3 | (2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate | 427-100-0 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Gef. |
H302 H318 H317 H412 |
|||
| 607-578-00-9 | ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate | 427-110-5 | - | Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 4 |
H302 H373** H413 |
GHS08 GHS07 Achtg. |
H302 H373** H413 |
|||
| 607-579-00-4 | diethyl[(p-ethoxyanilino)methylene]malonate | 431-430-0 | 103976-28-9 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | 422-360-1 | 100491-29-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-581-00-5 | ethyl 2-ethoxy-4-carboxymethylbenzoate | 427-630-2 | 99469-99-5 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-582-00-0 | reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate |
427-650-1 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-583-00-6 | 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid | 427-680-5 | 188907-52-0 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-584-00-1 | trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate | 427-710-7 | 215612-56-9 | Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Gef. |
H318 H317 H412 |
|||
| 607-585-00-7 | strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate | 427-930-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-586-00-2 | dodecyl 3-amino-4-chlorobenzoate | 428-020-9 | 6195-20-6 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-587-00-8 | ethylcis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate | 428-030-3 | 67914-69-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373** H410 |
|||
| 607-588-00-3 | reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate |
428-050-2 | - | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-589-00-9 | tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate | 428-070-1 | 91788-83-9 | STOT RE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H372** H302 H410 |
|||
| 607-590-00-4 | hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate | 428-140-1 | 210706-50-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-591-00-X | reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate |
428-400-4 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-592-00-5 | di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate | 428-870-0 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-593-00-0 | 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate | 429-000-2 | 159235-16-2 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-594-00-6 | ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 429-020-1 | 204254-96-6 | STOT RE 2 * Skin Sens. 1 |
H373** H317 |
GHS08 GHS07 Achtg. |
H373** H317 |
|||
| 607-595-00-1 | N-amidino-N-methylglycine-2-oxopropionate | 429-120-5 | 208535-04-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-596-00-7 | ethyl 2-(4-phenoxyphenyl)lactate | 429-220-9 | 132584-17-9 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-597-00-2 | tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate | 429-230-3 | - | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-598-00-8 | trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate | 429-240-8 | 212652-59-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-599-00-3 | 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate | 431-610-9 | 68860-54-8 | Org. Perox. D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Gef. |
H242 H317 H410 |
|||
| 607-600-00-7 | (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate | 431-700-8 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-601-00-2 | 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate | 429-370-5 | 220410-74-2 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 607-602-00-8 | ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate | 429-680-0 | 122665-86-5 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-603-00-3 | lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate | 429-730-1 | 193562-37-7 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-604-00-9 | guanidinium benzoate | 429-820-0 | 26739-54-8 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 607-605-00-4 | methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate | 429-890-2 | 144550-06-1 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-606-00-X | (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid | 430-100-3 | 86978-24-7 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 607-607-00-5 | reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol |
430-180-1 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-608-00-0 | pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate | 430-210-1 | - | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-609-00-6 | ethyl (3R)-4-cyano-3-hydroxybutanoate | 430-220-6 | 141942-85-0 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-610-00-1 | trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate | 430-280-3 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-611-00-7 | methyl 3-amino-2,2,3-trimethylbutyrate | 431-720-7 | 90886-53-6 | Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Gef. |
H314 H302 H412 |
|||
| 607-612-00-2 | reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate |
432-190-1 | 182176-52-9 | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 |
H302 H373** H318 |
GHS05 GHS08 GHS07 Gef. |
H302 H373** H318 |
|||
| 607-613-00-8 | reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water |
432-790-1 | Acute Tox. 4* | H332 | GHS07 | H332 | ||||
| Acute Tox. 4* | H312 | GHS05 | H312 | |||||||
| Acute Tox. 4* | H302 | GHS08 | H302 | |||||||
| Skin Corr. 1B | H314 | Gef. | H314 | |||||||
| STOT SE 2 | H371 (Augen) | H371 (Augen) | ||||||||
| 607-614-00-3 | 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid | 426-480-5 | 63562-33-4 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 607-615-00-9 | reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance | 431-120-5 | - | Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H331 H302 H319 H317 |
GHS06 Gef. |
H331 H302 H319 H317 |
|||
| 607-616-00-4 | 2,4-dichloro-5-fluorobenzoylchloride | 428-390-1 | 86393-34-2 | STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H335 H315 H318 H317 H412 |
GHS05 GHS07 Gef. |
H335 H315 H318 H317 H412 |
|||
| 607-617-00-X | bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate | 430-700-5 | 10138-36-0 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-618-00-5 | menadione sodium bisulfite; 2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt |
204-987-0 | 130-37-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
|||
| 607-619-00-0 | menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) |
277-543-7 | 73581-79-0 | Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Achtg. |
H319 H315 H410 |
|||
| 607-620-00-6 | trisodium nitrilotriacetate | 225-768-6 | 5064-31-3 | Carc. 2 Acute Tox. 4 * Eye Irrit. 2 |
H351 H302 H319 |
GHS08 GHS07 Achtg. |
H351 H302 H319 |
Carc. 2; H351: C ≥ 5 % | ||
| 607-621-00-1 | milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] |
- | - | Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Achtg. |
H332 H302 H410 |
M=100 | ||
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | 231-057-1 | 7425-14-1 | Repr. 2 | H361d*** | GHS08 Achtg. |
H361d*** | |||
| 607-623-00-2 | Diisobutylphthalat | 201-553-2 | 84-69-5 | Repr. 1B | H360Df | GHS08 Gef. |
H360Df | |||
| 607-624-00-8 | perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] |
217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] |
1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] |
Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Lact. Aquatic Chronic 2 |
H351 H360D*** H372** H332 H302 H362 H411 |
GHS08 GHS07 GHS09 Gef. |
H351 H360D*** H372** H332 H302 H362 H411 |
|||
| 607-625-00-3 | clodinafop-propargyl (ISO) | - | 105512-06-9 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373** H317 H410 |
Skin Sens. 1; H317: C ≥ 0,001 % M=1 |
||
| 607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | 401-290-5 | 103112-35-2 | Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Gef. |
H350 H410 |
|||
| 607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | 416-360-0 | 162221-28-5 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-628-00-X | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | 419-240-6 | 171054-89-0 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | 419-270-1 | 123599-82-6 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | 419-560-6 | 4369-14-6 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H332 H314 H317 H412 |
GHS05 GHS07 Gef. |
H332 H314 H317 H412 |
|||
| 607-631-00-6 | reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate |
442-300-8 | - | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | 420-210-1 | 111244-14-5 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | 440-480-2 | 341026-59-3 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-634-00-2 | (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate |
420-610-4 | 36394-75-9 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Gef. |
H302 H314 H317 |
|||
| 607-635-00-8 | trisodiumN-(3-propionato)-l-aspartate | 422-090-4 | 172737-80-3 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-636-00-3 | 1-bromo-2-methylpropyl propionate | 422-900-6 | 158894-67-8 | Flam. Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 |
H226 H351 H314 H317 |
GHS02 GHS05 GHS08 GHS07 Gef. |
H226 H351 H314 H317 |
|||
| 607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | 423-730-5 | 250688-43-8 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | 431-090-3 | 190085-41-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | 431-770-1 | 216698-07-6 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid |
431-930-9 | 43028-69-9 | Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | 432-210-7 | 141631-22-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 607-643-00-1 | dimethyl (2S)-2-hydroxysuccinate | 432-310-0 | 617-55-0 | Flam. Liq. 3 Eye Dam. 1 Skin Sens. 1 |
H226 H318 H317 |
GHS02 GHS05 GHS07 Gef. |
H226 H318 H317 |
|||
| 607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | 432-350-9 | 81752-87-6 | Skin Irrit. 2 | H315 | GHS07 Achtg. |
H315 | |||
| 607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | 432-550-6 | 243858-01-7 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-646-00-8 | d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate |
432-960-5 | 124655-09-0 | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane | 433-530-1 | 143446-73-5 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 |
H302 H317 H400 |
GHS07 GHS09 Achtg. |
H302 H317 H400 |
|||
| 607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | 433-690-0 | 167678-46-8 | Skin Corr. 1a Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Gef. |
H314 H317 |
|||
| 607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | 433-910-5 | 145153-52-2 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | 434-360-9 | 91125-43-8 | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-652-00-0 | ethylN2-dodecanoyl-l-argininate hydrochloride | 434-630-6 | 60372-77-2 | Eye Dam. 1 Aquatic Acute 1 |
H318 H400 |
GHS05 GHS09 Gef. |
H318 H400 |
|||
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | 434-840-8 | 225786-91-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-654-00-1 | (S)-3-hydroxy-γ-butyrolactone | 434-990-4 | 7331-52-4 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-655-00-7 | ethyl 6,8-dichlorooctanoate | 435-080-1 | 1070-64-0 | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | 435-350-7 | 141250-43-3 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 436-920-8 | 172399-10-9 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | 440-770-9 | 371921-63-0 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-659-00-9 | pentasodiumN-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | 442-030-0 | 321912-47-4 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | 442-230-8 | 321679-52-1 | Eye Dam. 1 | H318 | GHS05 Gef. |
H318 | |||
| 607-661-00-X | 1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate | 442-850-9 | 114772-40-6 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | 442-860-3 | 87333-22-0 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | 442-980-6 | 127474-91-3 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | 443-120-2 | 393509-79-0 | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 607-665-00-1 | trans-methyl-2-ethyl-but-2-enoate | 443-150-6 | 101226-85-1 | Flam. Liq. 3 | H226 | GHS02 Achtg. |
H226 | |||
| 607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | 443-560-5 | 88784-33-2 | Eye Irrit. 2 | H319 | GHS07 Achtg. |
H319 | |||
| 607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | 444-950-8 | 99464-83-2 | Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Achtg. |
H341 H317 |
|||
| 607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxane | 445-770-2 | 42031-28-7 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | 445-990-9 | 376588-17-9 | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate |
448-700-9 | 500791-70-8 | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Gef. |
H373** H318 H317 H410 |
M=10 | ||
| 607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | 417-310-0 | 72903-27-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 607-672-00-X | reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate |
419-000-0 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | 419-570-0 | - | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 607-675-00-6 | reaction mass of:cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid |
422-260-8 | - | Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Gef. |
H318 H410 |
|||
| 607-676-00-1 | reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid |
423-670-1 | - | Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Gef. |
H318 H317 |
|||
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-ylN-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate | 424-660-8 | - | STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373** H318 H317 |
GHS05 GHS08 GHS07 Gef. |
H373** H318 H317 |
|||
| 607-678-00-2 | reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate |
427-090-8 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-679-00-8 | reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) |
431-440-5 | - | Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Gef. |
H318 H411 |
|||
| 607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | 432-810-9 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-681-00-9 | reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate |
432-910-2 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-682-00-4 | complex reaction mass of Chinese gum rosin post reacted with acrylic acid | 434-230-1 | 144413-22-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-683-00-X | reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) |
435-450-0 | - | Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Achtg. |
H317 H411 |
|||
| 607-684-00-5 | alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | 435-660-2 | 243662-67-1 | Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Achtg. |
H315 H317 |
|||
| 607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | 441-050-7 | - | Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Gef. |
H315 H318 |
|||
| 607-686-00-6 | 6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | 441-550-5 | - | Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Gef. |
H242 H351 |
|||
| 607-687-00-1 | reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) |
442-800-6 | - | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | 444-320-2 | - | Acute Tox. 4 * | H302 | GHS07 Achtg. |
H302 | |||
| 607-689-00-2 | reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate ("para-isomer" includingcis- andtrans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" includingcis- andtrans-isomers) |
444-920-4 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 607-690-00-8 | dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate | 432-860-1 | 255387-46-3 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 607-691-00-3 | magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 448-690-6 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-692-00-9 | zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 446-470-4 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | 443-860-6 | 302776-68-7 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | 443-870-0 | 163520-33-0 | Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 607-696-00-0 | pentyl formate | 211-340-6 | 638-49-3 | Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Gef. |
H226 H319 H335 |
C | ||
| 607-697-00-6 | tert-butyl propionate | - | 20487-40-5 | Flam. Liq. 2 | H225 | GHS02 Gef. |
H225 | C | ||
| 607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | Repr. 1B STOT RE 1 Acute Tox. 4 |
H360F H372 H302 |
GHS07 GHS08 Gef. |
H360F H372 H302 |
|||
607-699-00-7 |
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate |
82657-04-3 |
Carc. 2 | H351 | GHS06 | H351 | M = 10000 M = 100000 |
|||
| Acute Tox. 3 | H331 | GHS08 | H331 | |||||||
| Acute Tox. 2 | H300 | GHS09 | H300 | |||||||
| STOT RE 1 | H372 (Nerven-system) | Gef. | H372 (Nerven-system) | |||||||
| Skin Sens. 1B | H317 | H317 | ||||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| 607-700-00-0 | indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] |
173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | M = 1 M = 1 |
|||
| Acute Tox. 4 | H332 | GHS08 | H332 | |||||||
| STOT RE 1 | H372 (Blut, Nervensystem, Herz) | GHS09 | H372 (Blut, Nervensystem, Herz) | |||||||
| Skin Sens. 1B | H317 | Gef. | H317 | |||||||
| Aquatic Acute 1 | H400 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | ||||||||
| reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] |
144171-61-9 [2] | |||||||||
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | |||
607-703-00-7 |
ammoniumpentadeca-fluorooctanoate |
223-320-4 |
3825-26-1 |
Carc. 2 | H351 | GHS08 | H351 | |||
| Repr. 1B | H360D | GHS07 | H360D | |||||||
| Lact. | H362 | GHS05 | H362 | |||||||
| Acute Tox. 4 | H332 | Gef. | H332 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 (Leber) | H372 (Leber) | ||||||||
| Eye Dam.1 | H318 | H318 | ||||||||
607-704-00-2 |
perfluorooctanoic acid |
206-397-9 |
335-67-1 |
Carc. 2 | H351 | GHS08 | H351 | |||
| Repr. 1B | H360D | GHS07 | H360D | |||||||
| Lact. | H362 | GHS05 | H362 | |||||||
| Acute Tox. 4 | H332 | Gef. | H332 | |||||||
| Acute Tox. 4 | H302 | H302 | ||||||||
| STOT RE 1 | H372 (Leber) | H372 (Leber) | ||||||||
| Eye Dam. 1 | H318 | H318 | ||||||||
| 607-705-00-8 | benzoic acid | 200-618-2 | 65-85-0 | STOT RE 1 Skin Irrit. 2 Eye Dam. 1 |
H372 (Lunge) (Einatmen) H315 H318 |
GHS08 GHS05 Gef. |
H372 (Lunge) (Einatmen) H315 H318 |
|||
| 607-706-00-3 | methyl 2,5-dichlorobenzoate | 220-815-7 | 2905-69-3 | Acute Tox. 4 STOT SE 3 Aquatic Chronic 2 |
H302 H336 H411 |
GHS07 GHS09 Achtg. |
H302 H336 H411 |
|||
| 607-707-00-9 | Fenoxaprop-P-ethyl (ISO); Ethyl (2R)-2-{4-[(6-chlor-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoat | - | 71283-80-2 | STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 (Nieren) H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H373 (Nieren) H317 H410 |
M = 1 M = 1 |
||
| 607-708-00-4 | Octansäure | 204-677-5 | 124-07-2 | Skin Corr. 1C Aquatic Chronic 3 |
H314 H412 |
GHS05 Gef. |
H314 H412 |
|||
| 607-709-00-X | Decansäure | 206-376-4 | 334-48-5 | Skin Irrit. 2 Eye Irrit. 2 Aquatic Chronic 3 |
H315 H319 H412 |
GHS07 Achtg. |
H315 H319 H412 |
|||
| 607-710-00-5 | 1,2-Benzoldicarbonsäure, Dihexylester, verzweigt und linear | 271-093-5 | 68515-50-4 | Repr. 1B | H360FD | GHS08 Gef. |
H360FD | |||
| 607-711-00-0 | Spirotetramat (ISO); (5s,8s)-3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-ylethylcarbonat | - | 203313-25-1 | Repr. 2 STOT SE 3 Eye Irrit. 2 Skin Sens. 1a Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H335 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H361fd H335 H319 H317 H410 |
M = 1 M = 1 |
||
| 607-712-00-6 | Dodemorphacetat; 4-Cyclododecyl-2,6-dimethylmorpholin-4-ium acetat | 250-778-2 | 31717-87-0 | Repr. 2 STOT RE 2 Skin Corr. 1C Skin Sens. 1a Aquatic Chronic 1 |
H361d H373 (Leber) H314 H317 H410 |
GHS08 GHS05 GHS07 GHS09 Gef. |
H361d H373 (Leber) H314 H317 H410 |
EUH071 | M = 1 | |
| 607-713-00-1 | Fenpyroximat (ISO); Tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylen]amino}oxy)methyl]benzoat | - | 134098-61-6 | Acute Tox. 3 Acute Tox. 2 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H330 H317 H400 H410 |
GHS06 GHS09 Gef. |
H301 H330 H317 H410 |
M = 100 M = 1 000 |
||
| 607-714-00-7 | Triflusulfuron-methyl; Methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoat | - | 126535-15-7 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Achtg. |
H351 H410 |
M = 100 M = 10 |
||
| 607-715-00-2 | Bifenazat (ISO); Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazincarboxylat | 442-820-5 | 149877-41-8 | STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H373 H317 H410 |
M = 1 M = 1 |
||
| 607-716-00-8 | Bromadiolon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-on | 249-205-9 | 28772-56-7 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,005 % STOT RE 2; H373 (Blut): 0,0005 % ≤ C < 0,005 % M = 1 M = 1 |
||
| 607-717-00-3 | Difethialon (ISO); 3-[3-(4′-Brombiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-on |
- | 104653-34-1 | Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D H330 H310 H300 H372 (Blut) H400 H410 |
GHS08 GHS06 GHS09 Gef. |
H360D H330 H310 H300 H372 (Blut) H410 |
EUH070 | Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (Blut): C ≥ 0,02 % STOT RE 2; H373 (Blut): 0,002 % ≤ C < 0,02 % M = 100 M = 100 |
|
| 607-718-00-9 | Perfluornonan-1-säure [1] und ihre Natrium- [2] und Ammoniumsalze [3] | 206-801-3 [1] [2] [3] |
375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3] |
Carc. 2 Repr. 1B Lakt. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam. 1 |
H351 H360Df H362 H332 H302 H372 (Leber, Thymus, Milz) H318 |
GSH08 GSH07 GHS05 Gef. |
H351 H360Df H362 H332 H302 H372 (Leber, Thymus, Milz) H318 |
|||
| 607-719-00-4 | Dicyclohexylphthalat | 201-545-9 | 84-61-7 | Repr. 1B Skin Sens. 1 |
H360D H317 |
GHS08 GHS07 Gef. |
H360D H317 |
|||
| 607-720-00-X | Nonadecafluordecansäure; [1] Ammoniumnonadecafluordecanoat; [2] Natriumnonadecafluordecanoat [3] |
206-400-3 [1] 221-470-5 [2] [3] |
335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] |
Carc. 2 Repr. 1B Lact. |
H351 H360Df H362 |
GHS08 Gef. |
H351 H360Df H362 |
|||
| 607-721-00-5 | N,N'-Methylendimorpholin; N,N'-Methylenbismorpholin; [aus N,N2-Methylenbismorpholin freigesetztes Formaldehyd]; [MBM] |
227-062-3 | 5625-90-1 | Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Eye Dam.1 |
H350 H341 H332 H312 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 H318 |
GHS08 GHS07 GHS05 Gef. |
H350 H341 H332 H312 H302 H373 (Magen-Darm-Trakt, Atemwege) H314 H317 |
EUH071 | 8 9 |
|
| 607-722-00-0 | 2,3,5,6-Tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyanoprop- 1-enyl)-2,2-dimethylcyclopropancarboxylat; Epsilon-momfluorothrin |
- | 1065124-65-3 | Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H371 (Nervensystem) H400 H410 |
GHS07 GHS08 GHS09 Achtg. |
H302 H371 (Nervensystem) H410 |
M = 100 M = 100 |
||
| 607-723-00-6 | Tefluthrin (ISO); 2,3,5,6-Tetrafluor-4-methylbenzyl-(1RS,3RS)-3- [(Z)-2-chlor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropancarboxylat |
- | 79538-32-2 | Acute Tox. 1 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
M = 10.000 M = 10.000 |
||
| 608-001-00-3 | acetonitrile; cyanomethane |
200-835-2 | 75-05-8 | Flam. Liq. 2 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 |
H225 H332 H312 H302 H319 |
GHS02 GHS07 Gef. |
H225 H332 H312 H302 H319 |
|||
| 608-002-00-9 | trichloroacetonitrile | 208-885-7 | 545-06-2 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Gef. |
H331 H311 H301 H411 |
|||
| 608-003-00-4 | acrylonitrile | 203-466-5 | 107-13-1 | Flam. Liq. 2 Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Gef. |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
(*) | D | |
| 608-004-00-X | 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin |
200-909-4 | 75-86-5 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Gef. |
H330 H310 H300 H410 |
|||
| 608-005-00-5 | n-butyronitrile | 203-700-6 | 109-74-0 | Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H311 H301 |
GHS02 GHS06 Gef. |
H225 H331 H311 H301 |
|||
| 608-006-00-0 | bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol |
216-882-7 | 1689-84-5 | Repr. 2 Acute Tox. 2 (*) Acute Tox. 3 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H330 H301 H317 H410 |
M=10 | ||
| 608-007-00-6 | ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile |
216-881-1 | 1689-83-4 | Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H410 |
M=10 | ||
| 608-008-00-1 | chloroacetonitrile | 203-467-0 | 107-14-2 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Gef. |
H331 H311 H301 H411 |
|||
| 608-009-00-7 | malononitrile | 203-703-2 | 109-77-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
|||
| 608-010-00-2 | methacrylonitrile; 2-methyl-2-propene nitrile |
204-817-5 | 126-98-7 | Flam. Liq. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Sens. 1 |
H225 H331 H311 H301 H317 |
GHS02 GHS06 Gef. |
H225 H331 H311 H301 H317 |
(*) Skin Sens. 1; H317: C ≥ 0,2 % |
D | |
| 608-011-00-8 | oxalonitrile; cyanogen |
207-306-5 | 460-19-5 | Press. Gas Flam. Gas 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Gef. |
H220 H331 H410 |
U | ||
| 608-012-00-3 | benzonitrile | 202-855-7 | 100-47-0 | Acute Tox. 4 (*) Acute Tox. 4 (*) |
H312 H302 |
GHS07 Achtg. |
H312 H302 |
|||
| 608-013-00-9 | 2-chlorobenzonitrile | 212-836-5 | 873-32-5 | Acute Tox. 4 (*) Acute Tox. 4 (*) Eye Irrit. 2 |
H312 H302 H319 |
GHS07 Achtg. |
H312 H302 H319 |
|||
| 608-014-00-4 | chlorothalonil (ISO); tetrachloroisophthalonitrile |
217-588-1 | 1897-45-6 | Carc. 2 Acute Tox. 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H335 H318 H317 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Gef. |
H351 H330 H335 H318 H317 H410 |
M=10 | ||
| 608-015-00-X | dichlobenil (ISO); 2,6-dichlorobenzonitrile |
214-787-5 | 1194-65-6 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H312 H411 |
GHS07 GHS09 Achtg. |
H312 H411 |
|||
| 608-016-00-5 | 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene | 401-550-8 | 1897-41-2 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 608-017-00-0 | bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate |
216-885-3 | 1689-99-2 | Repr. 2 Acute Tox. 3 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H331 H302 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H331 H302 H317 H410 |
M=10 | ||
| 608-018-00-6 | ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate |
223-375-4 | 3861-47-0 | Repr. 2 Acute Tox. 3 (*) Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H301 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H301 H319 H317 H410 |
M=10 | ||
| 608-019-00-1 | 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN |
201-132-3 | 78-67-1 | Self-react. C Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 3 |
H242 H332 H302 H412 |
GHS02 GHS07 Gef. |
H242 H332 H302 H412 |
T | ||
| 608-020-00-7 | diphenoxymethylenecyanamide | 427-300-8 | 79463-77-7 | Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Gef. |
H318 H412 |
|||
| 608-021-00-2 | 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile | 403-710-2 | 76823-93-3 | Acute Tox. 4 (*) Skin Sens. 1 |
H302 H317 |
GHS07 Achtg. |
H302 H317 |
|||
| 608-022-00-8 | 3,7-dimethyloctanenitrile | 403-620-3 | 40188-41-8 | Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Achtg. |
H315 H317 H411 |
|||
| 608-023-00-3 | fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile |
406-140-2 | 114369-43-6 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 608-024-00-9 | 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile | 407-650-8 | 97460-76-9 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-025-00-4 | 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile | 410-970-0 | 117568-27-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-026-00-X | 3-cyano-3,5,5-trimethylcyclohexanone | 411-490-4 | 7027-11-4 | Acute Tox. 4 (*) STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 (*)(*) H317 H412 |
GHS08 GHS07 Achtg. |
H302 H373 (*)(*) H317 H412 |
|||
| 608-027-00-5 | reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile |
412-660-0 | - | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-028-00-0 | 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate | 413-510-7 | 147374-67-2 | STOT RE 2 (*) Skin Sens. 1 Aquatic Chronic 2 |
H373 (*)(*) H317 H411 |
GHS08 GHS09 Achtg. |
H373 (*)(*) H317 H411 |
|||
| 608-029-00-6 | 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile | 411-990-2 | 68612-94-2 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 608-030-00-1 | N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide | 412-340-0 | 147741-93-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 608-031-00-7 | 2-benzyl-2-methyl-3-butenitrile | 407-870-4 | 97384-48-0 | Acute Tox. 4 (*) Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 608-032-00-2 | acetamiprid (ISO); (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine |
- | 135410-20-7 | Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Achtg. |
H302 H412 |
|||
| 608-033-00-8 | N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide | 407-970-8 | 75511-91-0 | Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Achtg. |
H317 H412 |
|||
| 608-034-00-3 | chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile |
- | 122453-73-0 | Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Gef. |
H331 H302 H410 |
M=100 | ||
| 608-035-00-9 | (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile | 419-290-9 | - | Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Achtg. |
H317 H413 |
|||
| 608-036-00-4 | 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile | 419-060-8 | 79026-02-1 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-037-00-X | reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile |
422-190-8 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | ||||
| 608-038-00-5 | 2,2,4-trimethyl-4-phenyl-butane-nitrile | 422-580-8 | 75490-39-0 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 608-039-00-0 | 2-phenylhexanenitrile | 423-460-8 | 3508-98-3 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 608-040-00-6 | 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) | 423-490-1 | 130755-46-3 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 608-041-00-1 | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | 423-500-4 | 138401-24-8 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | 421-810-4 | 194602-27-2 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H317 H411 |
|||
| 608-043-00-2 | 3-(cis-3-hexenyloxy)propanenitril | 415-220-6 | 142653-61-0 | Acute Tox. 3 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Gef. |
H331 H302 H410 |
|||
| 608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | 423-740-1 | 10461-98-0 | Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 608-046-00-9 | 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile | 425-310-7 | 77889-90-8 | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-047-00-4 | 2-piperidin-1-yl-benzonitrile | 427-330-1 | 72752-52-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-048-00-X | 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile | 427-450-4 | 152630-47-2 | Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Achtg. |
H302 H373** H317 H411 |
|||
| 608-049-00-5 | 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile | 429-180-2 | 157362-53-3 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 608-050-00-0 | reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile |
429-760-5 | - | Aquatic Chronic 4 | H413 | - | H413 | |||
| 608-051-00-6 | (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-760-2 | 219861-18-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 608-052-00-1 | (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-770-7 | 128173-52-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 608-053-00-7 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-780-1 | 103146-25-4 | Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 608-054-00-2 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate | 430-790-6 | - | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H317 H411 |
|||
| 608-055-00-8 | Fipronil (ISO); (±)-5-Amino-1-(2,6-dichlor-α,α,α-trifluor-p-tolyl)-4-trifluormethylsulfinylpyrazol-3-carbonitril |
424-610-5 | 120068-37-3 | Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H311 H331 H372* H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H301 H311 H331 H372* H410 |
M = 1 000 M = 10 000 |
||
| 608-056-00-3 | N-methyl-N-cyanomethylmorpholiniummethylsulfate | 429-340-1 | - | Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Gef. |
H302 H318 |
|||
| 608-057-00-9 | 4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate | 431-200-1 | 208538-34-5 | Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Gef. |
H302 H318 H317 |
|||
| 608-058-00-4 | esfenvalerate (ISO); (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate |
- | 66230-04-4 | Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H317 H400 H410 |
GHS06 GHS09 Gef. |
H331 H301 H317 H410 |
M = 10000 | ||
| 608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | 421-240-6 | 120068-79-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | |||
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | 421-300-1 | 138564-59-7 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | 422-810-7 | 82380-18-5 | Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Gef. |
H302 H318 H411 |
|||
| 608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | 441-070-6 | 61826-76-4 | Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Gef. |
H301 H318 H317 H410 |
|||
| 608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | 433-720-2 | - | Aquatic Chronic 3 | H412 | - | H412 | |||
| 608-065-00-2 | salts of bromoxynil with the exception of those specified elsewhere in this Annex | - | - | Repr. 2 Acute Tox. 2 (*) Acute Tox. 3 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H330 H301 H317 H410 |
M=10 | A | |
| 608-066-00-8 | salts of ioxynil with the exception of those specified elsewhere in this Annex | - | - | Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H361d (*)(*)(*) H331 H301 H312 H373 (*)(*) H319 H410 |
M=10 | A | |
| 608-067-00-3 | 3,7-Dimethylocta-2,6-diennitril | 225-918-0 | 5146-66-7 | Muta. 1B | H340 | GHS08 Gef. |
H340 | |||
| 609-001-00-6 | 1-nitropropane | 203-544-9 | 108-03-2 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) |
H226 H332 H312 H302 |
GHS02 GHS07 Achtg. |
H226 H332 H312 H302 |
(*) | ||
| 609-002-00-1 | 2-nitropropane | 201-209-1 | 79-46-9 | Flam. Liq. 3 Carc. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) |
H226 H350 H332 H302 |
GHS02 GHS08 GHS07 Gef. |
H226 H350 H332 H302 |
|||
609-003-00-7 |
nitrobenzene |
202-716-0 |
98-95-3 |
Carc. 2. | H351 | GHS06 | H351 | |||
| Repr. 1B | H360F | GHS08 | H360F | |||||||
| Acute Tox. 3 | H301 | Gef. | H301 | |||||||
| Acute Tox. 3 | H331 | H331 | ||||||||
| Acute Tox. 3 | H311 | H311 | ||||||||
| STOT RE 1 | H372 (Blut) | H372 (Blut) | ||||||||
| Aquatic Chronic 3 | H412 | H412 | ||||||||
| 609-004-00-2 | dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] |
246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] |
25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] |
Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 (*)(*) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H373 (*)(*) H410 |
|||
| 609-005-00-8 | 1,3,5-trinitrobenzene | 202-752-7 | 99-35-4 | Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H330 H310 H300 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H330 H310 H300 H373** H410 |
|||
| 609-006-00-3 | 4-nitrotoluene | 202-808-0 | 99-99-0 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H331 H311 H301 H373 (*)(*) H411 |
GHS06 GHS08 GHS09 Gef. |
H331 H311 H301 H373 (*)(*) H411 |
|||
| 609-007-00-9 | 2,4-dinitrotoluene; [1] dinitrotoluene [2] |
204-450-0 [1] 246-836-1 [2] |
121-14-2 [1] 25321-14-6 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f*** H331 H311 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H341 H361f*** H331 H311 H301 H373** H410 |
|||
| 609-008-00-4 | 2,4,6-trinitrotoluene; TNT |
204-289-6 | 118-96-7 | Expl. 1.1 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H201 H331 H311 H301 H373 (*)(*) H411 |
GHS01 GHS06 GHS08 GHS09 Gef. |
H201 H331 H311 H301 H373 (*)(*) H411 |
|||
| 609-009-00-X | 2,4,6-trinitrophenol; picric acid |
201-865-9 | 88-89-1 | Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H201 H331 H311 H301 |
GHS01 GHS06 Gef. |
H201 H331 H311 H301 |
|||
| 609-010-00-5 | salts of picric acid | - | - | Unst. Expl Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) |
H201 H331 H311 H301 |
GHS01 GHS06 Gef. |
H201 H331 H311 H301 |
T | ||
| 609-011-00-0 | 2,4,6-trinitroanisole | - | 606-35-9 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Chronic 2 |
H201 H332 H312 H302 H411 |
GHS01 GHS07 GHS09 Achtg. |
H201 H332 H312 H302 H411 |
|||
| 609-012-00-6 | 2,4,6-trinitro-m-cresol | 210-027-1 | 602-99-3 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) |
H201 H332 H312 H302 |
GHS01 GHS07 Achtg. |
H201 H332 H312 H302 |
|||
| 609-013-00-1 | 2,4,6-trinitro-m-xylene | 211-187-5 | 632-92-8 | Expl. 1.1 Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) |
H201 H332 H312 H302 H373 (*)(*) |
GHS01 GHS08 GHS07 Achtg. |
H201 H332 H312 H302 H373 (*)(*) |
|||
| 609-015-00-2 | 4-nitrophenol; p-nitrophenol |
202-811-7 | 100-02-7 | Acute Tox. 4 (*) Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) |
H332 H312 H302 H373 (*)(*) |
GHS08 GHS07 Achtg. |
H332 H312 H302 H373 (*)(*) |
|||
| 609-016-00-8 | dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] |
247-096-2 [1] 275-732-9 [2] |
25550-58-7 [1] 71629-74-8 [2] |
Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 (*)(*) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H311 H301 H373 (*)(*) H410 |
|||
| 609-018-00-9 | 2,4,6-trinitroresorcinol; styphnic acid |
201-436-6 | 82-71-3 | Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Gef. |
H201 H332 H312 H302 |
|||
| 609-019-00-4 | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate |
239-290-0 | 15245-44-0 | Unst. Expl Repr. 1a Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 (*)(*) H400 H410 |
GHS01 GHS08 GHS07 GHS09 Gef. |
H200 H360Df H332 H302 H373 (*)(*) H410 |
1 | ||
| 609-019-01-1 | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser) |
239-290-0 | 15245-44-0 | Expl. 1.1 Repr. 1a Acute Tox. 4 (*) Acute Tox. 4 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 (*)(*) H400 H410 |
GHS01 GHS08 GHS07 GHS09 Gef. |
H201 H360Df H332 H302 H373 (*)(*) H410 |
1 | ||
| 609-020-00-X | DNOC (ISO); 4,6-dinitro-o-cresol |
208-601-1 | 534-52-1 | Muta. 2 Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H310 H300 H315 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS07 GHS09 Gef. |
H341 H330 H310 H300 H315 H318 H317 H410 |
EUH044 | ||
| 609-021-00-5 | sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] |
219-007-7 [1] [2] |
2312-76-7 [1] 5787-96-2 [2] |
Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 (*)(*) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H331 H311 H301 H373 (*)(*) H410 |
|||
| 609-022-00-0 | ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide |
221-037-0 | 2980-64-5 | Acute Tox. 2 (*) Acute Tox. 1 Acute Tox. 2 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 (*)(*) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H330 H310 H300 H373 (*)(*) H410 |
|||
| 609-023-00-6 | dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups |
254-408-0 | 39300-45-3 | Repr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H332 H302 H373** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H360D*** H332 H302 H373** H315 H317 H410 |
M=100 | ||
| 609-024-00-1 | binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate |
207-612-9 | 485-31-4 | Repr. 1B Acute Tox. 4 (*) Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H360D (*)(*)(*) H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H360D (*)(*)(*) H312 H302 H410 |
|||
| 609-025-00-7 | dinoseb(ISO); 6-sec-butyl-2,4-dinitrophenol |
201-861-7 | 88-85-7 | Repr. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360Df H311 H301 H319 H410 |
EUH044 | ||
| 609-026-00-2 | salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | - | - | Repr. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360Df H311 H301 H319 H410 |
EUH044 | A | |
| 609-027-00-8 | dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate |
- | 63919-26-6 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 609-028-00-3 | dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol |
205-042-5 | 131-89-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
|||
| 609-029-00-9 | salts and esters of dinex | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
A | ||
| 609-030-00-4 | dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol |
215-813-8 | 1420-07-1 | Repr. 1B Acute Tox. 2 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H360D (*)(*)(*) H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360D (*)(*)(*) H300 H311 H410 |
EUH044 | ||
| 609-031-00-X | salts and esters of dinoterb | - | - | Repr. 1B Acute Tox. 2 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H360D (*)(*)(*) H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H360D (*)(*)(*) H300 H311 H410 |
A | ||
| 609-032-00-5 | bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime |
236-129-6 | 13181-17-4 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 609-033-00-0 | dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol |
- | 4097-36-3 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
|||
| 609-034-00-6 | salts and esters of dinosam | - | - | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Gef. |
H331 H311 H301 H410 |
A | ||
| 609-035-00-1 | nitroethane | 201-188-9 | 79-24-3 | Flam. Liq. 3 Acute Tox. 4 (*) Acute Tox. 4 (*) |
H226 H332 H302 |
GHS02 GHS07 Achtg. |
H226 H332 H302 |
(*) | ||
| 609-036-00-7 | nitromethane | 200-876-6 | 75-52-5 | Flam. Liq. 3 Acute Tox. 4 (*) |
H226 H302 |
GHS02 GHS07 Achtg. |
H226 H302 |
(*) | ||
| 609-037-00-2 | 5-nitroacenaphthene | 210-025-0 | 602-87-9 | Carc. 1B | H350 | GHS08 Gef. |
H350 | |||
| 609-038-00-8 | 2-nitronaphthalene | 209-474-5 | 581-89-5 | Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Gef. |
H350 H411 |
|||
| 609-039-00-3 | 4-nitrobiphenyl | 202-204-7 | 92-93-3 | Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Gef. |
H350 H411 |
|||
| 609-040-00-9 | nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether |
217-406-0 | 1836-75-5 | Carc. 1B Repr. 1B Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360D (*)(*)(*) H302 H400 H410 |
GHS08 GHS07 GHS09 Gef. |
H350 H360D (*)(*)(*) H302 H410 |
|||
| 609-041-00-4 | 2,4-dinitrophenol | 200-087-7 | 51-28-5 | Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 |
H331 H311 H301 H373 (*)(*) H400 |
GHS06 GHS08 GHS09 Gef. |
H331 H311 H301 H373 (*)(*) H400 |
|||
| 609-042-00-X | pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine |
254-938-2 | 40487-42-1 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 609-043-00-5 | quintozene (ISO); pentachloronitrobenzene |
201-435-0 | 82-68-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 609-044-00-0 | tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene |
204-178-2 | 117-18-0 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H317 H410 |
|||
| 609-045-00-6 | reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 |
- | 8069-76-9 | Acute Tox. 4 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Achtg. |
H302 H410 |
|||
| 609-046-00-1 | trifluralin (ISO) (containing < 0,5 ppm NPDA); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA) |
216-428-8 | 1582-09-8 | Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Achtg. |
H351 H317 H410 |
M=10 | ||
| 609-047-00-7 | 2-nitroanisole | 202-052-1 | 91-23-6 | Carc. 1B Acute Tox. 4 (*) |
H350 H302 |
GHS08 GHS07 Gef. |
H350 H302 |
|||
| 609-048-00-2 | sodium 3-nitrobenzenesulphonate | 204-857-3 | 127-68-4 | Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Achtg. |
H319 H317 |
|||
| 609-049-00-8 | 2,6-dinitrotoluene | 210-106-0 | 606-20-2 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 |
GHS06 GHS08 Gef. |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 |
|||
| 609-050-00-3 | 2,3-dinitrotoluene | 210-013-5 | 602-01-7 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H400 H410 |
GHS06 GHS08 GHS09 Gef. |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H410 |
|||
| 609-051-00-9 | 3,4-dinitrotoluene | 210-222-1 | 610-39-9 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 |
GHS06 GHS08 GHS09 Gef. |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 |
|||
| 609-052-00-4 | 3,5-dinitrotoluene | 210-566-2 | 618-85-9 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 3 |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 |
GHS06 GHS08 Gef. |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H412 |
|||
| 609-053-00-X | hydrazine-trinitromethane | 414-850-9 | - | Expl. 1.1 (*)(*)(*)(*) Self-react. a Carc. 1B Acute Tox. 3 (*) Acute Tox. 3 (*) Skin Sens. 1 |
H201 H240 H350 H331 H301 H317 |
GHS01 GHS06 GHS08 Gef. |
H201 H240 H350 H331 H301 H317 |
|||
| 609-054-00-5 | 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] |
200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4] [5] |
66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4] [5] |
Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H331 H311 H301 H373 (*)(*) H411 |
GHS06 GHS08 GHS09 Gef. |
H331 H311 H301 H373 (*)(*) H411 |
|||
| 609-055-00-0 | 2,5-dinitrotoluene | 210-581-4 | 619-15-8 | Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 (*) Acute Tox. 3 (*) Acute Tox. 3 (*) STOT RE 2 (*) Aquatic Chronic 2 |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 |
GHS06 GHS08 GHS09 Gef. |
H350 H341 H361f (*)(*)(*) H331 H311 H301 H373 (*)(*) H411 |
|||
| 609-056-00-6 | 2,2-dibromo-2-nitroethanol | 412-380-9 | 69094-18-4 | Expl. 1.1 Carc. 2 Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1a Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H302 H373 (*)(*) H314 H317 H400 H410 |
GHS01 GHS08 GHS05 GHS07 GHS09 Gef. |
H201 H351 H302 H373 (*)(*) H314 H317 H410 |
(*) STOT SE 3; H335: C ≥ 1 % |
T | |
| 609-057-00-1 | 3-chloro-2,4-difluoronitrobenzene | 411-980-8 | 3847-58-3 | Acute Tox. 4 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Gef. |
H302 H314 H317 H410 |
|||
| 609-058-00-7 | 2-nitro-2-phenyl-1,3-propanediol | 410-360-4 | 5428-02-4 | STOT RE 1 Acute Tox. 4 (*) Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 |
H372 (*)(*) H312 H302 H317 H411 |
GHS08 GHS07 GHS09 Gef. |
H372 (*)(*) H312 H302 H317 H411 |
EUH070 | ||
| 609-059-00-2 | 2-chloro-6-(ethylamino)-4-nitrophenol | 411-440-1 | 131657-78-8 | Acute Tox. 4 (*) Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Achtg. |
H302 H317 H411 |
|||
| 609-060-00-8 | 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 406-305-9 | 92952-81-3 | Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Achtg. |
H315 H411 |
|||
| 609-061-00-3 | (E,Z)-4-chlorophenyl(cyclopropyl)ketoneO-(4-nitrophenylmethyl)oxime | 406-100-4 | 94097-88-8 | Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Achtg. |
H317 H410 |
|||
| 609-062-00-9 | 2-bromo-2-nitropropanol | 407-030-7 | 24403-04-1 | Acute Tox. 3 (*) Acute Tox. 4 (*) STOT RE 2 (*) Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H373 (*)(*) H314 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Gef. |
H311 H302 H373 (*)(*) H314 H317 H410 |
|||
| 609-063-00-4 | 2-[(4-chloro-2-nitrophenyl)amino]ethanol | 413-280-8 | 59320-13-7 | Acute Tox. 4 (*) Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Achtg. |
H302 H411 |
|||
| 609-064-00-X | mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione |
- | 104206-82-8 | Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Achtg. |
H410 | |||
| 609-065-00-5 | 2-nitrotoluene | 201-853-3 | 88-72-2 | Carc. 1B Muta. 1B Repr. 2 Acute Tox. 4 (*) Aquatic Chronic 2 |
H350 H340 H361f (*)(*)(*) H302 H411 |
GHS08 GHS07 GHS09 Gef. |
H350 H340 H361f (*)(*)(*) H302 H411 |
|||
| 609-067-00-6 | sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine | 416-280-6 | 156769-97-0 | Skin Sens. 1 | H317 | GHS07 Achtg. |
H317 | |||
| 609-068-00-1 | musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene |
201-329-4 | 81-15-2 | Expl. 1.1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H400 H410 |
GHS01 GHS08 GHS09 Achtg. |
H201 H351 H410 |
T | ||
| 609-069-00-7 | musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone |
201-328-9 | 81-14-1 | Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
|||||